{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25259914",
                "http://www.ncbi.nlm.nih.gov/pubmed/26373274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                "http://www.ncbi.nlm.nih.gov/pubmed/28969871",
                "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                "http://www.ncbi.nlm.nih.gov/pubmed/19029249",
                "http://www.ncbi.nlm.nih.gov/pubmed/24836024",
                "http://www.ncbi.nlm.nih.gov/pubmed/22989712"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25259914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Telomere clustering is required for the homologous recombination events that maintain chromosome ends in cells relying on alternative lengthening of telomeres (ALT)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760773",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Alternative lengthening of telomeres (ALT) is a telomerase-independent telomere maintenance mechanism that occurs in a subset of cancers."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22989712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Approximately 10% of all cancers, but a higher proportion of sarcomas, use the recombination-based alternative lengthening of telomeres (ALT) to maintain telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11439347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 353,
                    "text": "However there is at least one alternative mechanism of telomere lengthening (ALT) which is characterized by heterogeneous and elongated telomeres in the absence of telomerase activity (TA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Alternative lengthening of telomeres (ALT) is an enigmatic process that allows certain cancers to maintain telomeres in the absence of telomerase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26373274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "In this issue of Cancer Cell, Ramamoorthy and Smith report that cancer cells that maintain their chromosome ends through alternative lengthening of telomeres (ALT) display persistent sister telomere cohesion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Some human cancers maintain telomeres using alternative lengthening of telomeres (ALT), a process thought to be due to recombination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Alternative lengthening of telomeres (ALT) involves homology-directed telomere synthesis."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                "http://www.ncbi.nlm.nih.gov/pubmed/25024372",
                "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                "http://www.ncbi.nlm.nih.gov/pubmed/26329882",
                "http://www.ncbi.nlm.nih.gov/pubmed/25170079",
                "http://www.ncbi.nlm.nih.gov/pubmed/22753116",
                "http://www.ncbi.nlm.nih.gov/pubmed/26554817",
                "http://www.ncbi.nlm.nih.gov/pubmed/18585098",
                "http://www.ncbi.nlm.nih.gov/pubmed/28795382",
                "http://www.ncbi.nlm.nih.gov/pubmed/28336912"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 221,
                    "offsetInEndSection": 336,
                    "text": "FGF21 is secreted from liver upon fasting and acts on adipose tissue to promote lipolysis and responses to fasting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28795382",
                    "endSection": "abstract",
                    "offsetInBeginSection": 827,
                    "offsetInEndSection": 970,
                    "text": "Fibroblast growth factor 21 (FGF21) and adiponectin represent the two major hormones secreted from the liver and adipose tissues, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 124,
                    "offsetInEndSection": 220,
                    "text": "FGF19 is secreted from intestine upon feeding and acts on liver to suppress bile acid synthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25170079",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 336,
                    "text": "Fibroblast growth factor 21 (FGF21), a hormone that is predominantly secreted by the liver, exerts a broad range of effects upon the metabolism of carbohydrates and lipids."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 19,
                    "text": "Klotho and \u03b2Klotho."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 442,
                    "text": "FGF23 is secreted from bone and acts on kidney to inhibit phosphate reabsorption and vitamin D synthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22396160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 642,
                    "offsetInEndSection": 813,
                    "text": "This chapter overviews function of Klotho family proteins as obligate coreceptors for endocrine FGFs and discusses potential link between Klothos and age-related diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25024372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 281,
                    "offsetInEndSection": 617,
                    "text": "Prolonged fasting induces activation of the transcription factor peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) in the liver and subsequent hepatic production of FGF21, which enters into the brain to activate the hypothalamic-pituitary-adrenal (HPA) axis for release of corticosterone, thereby stimulating hepatic gluconeogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26329882",
                    "endSection": "abstract",
                    "offsetInBeginSection": 229,
                    "offsetInEndSection": 328,
                    "text": "The small intestine of neonatal (but not adult) mice highly expresses \u03b2-Klotho in the luminal area."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 737,
                    "offsetInEndSection": 938,
                    "text": "Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388932",
                "http://www.ncbi.nlm.nih.gov/pubmed/22004789",
                "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                "http://www.ncbi.nlm.nih.gov/pubmed/17439941",
                "http://www.ncbi.nlm.nih.gov/pubmed/25701678",
                "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                "http://www.ncbi.nlm.nih.gov/pubmed/25504797"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "While neddylation is known to activate cullin (CUL)-RING ubiquitin ligases (CRLs), its role in regulating T cell signaling is poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 197,
                    "offsetInEndSection": 327,
                    "text": "Here, we show that NEDD8 is covalently conjugated to histone 2A (H2A), and that neddylation of H2A antagonizes its ubiquitylation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 655,
                    "text": "Interestingly, RNF168 is itself a substrate for NEDD8, and neddylation of RNF168 is necessary for its E3 ubiquitin activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22004789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 538,
                    "text": "NEDD8 (neural-precursor-cell-expressed developmentally down-regulated 8) is the UBL most closely related to ubiquitin, and its best-studied role is the activation of CRLs (cullin-RING ubiquitin ligases) by its conjugation to a conserved C-terminal lysine residue on cullin proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 656,
                    "offsetInEndSection": 774,
                    "text": "Inhibition of RNF168 neddylation impairs the interaction between RNF168 and its E2 enzyme Ubc13 (also known as UBE2N)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 265,
                    "text": "Unlike RING-type neddylation ligases, HECT-type neddylation ligase remains less defined."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24634510",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "RNF168-mediated H2A neddylation antagonizes ubiquitylation of H2A and regulates DNA damage repair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 266,
                    "offsetInEndSection": 399,
                    "text": "Here, we show that Itch is a novel HECT-type neddylation E3 ligase and we identify JunB as a substrate of Nedd8 modification by Itch."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 168,
                    "offsetInEndSection": 306,
                    "text": "In particular, conjugation of NEDD8 (neddylation) serves to regulate protein ubiquitination through modifications to E3 ubiquitin ligases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "Neddylation is a posttranslational modification that plays important roles in regulating protein structure and function by covalently conjugating NEDD8, an ubiquitin-like small molecule, to the substrate."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                "http://www.ncbi.nlm.nih.gov/pubmed/18054789",
                "http://www.ncbi.nlm.nih.gov/pubmed/19322196",
                "http://www.ncbi.nlm.nih.gov/pubmed/24310611",
                "http://www.ncbi.nlm.nih.gov/pubmed/22139015",
                "http://www.ncbi.nlm.nih.gov/pubmed/18342610",
                "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                "http://www.ncbi.nlm.nih.gov/pubmed/11377793",
                "http://www.ncbi.nlm.nih.gov/pubmed/27760120",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388737"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27760120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 239,
                    "offsetInEndSection": 411,
                    "text": "How DNA damage induces assembly and execution of a DNA replication complex (break-induced replisome) at telomeres or elsewhere in the mammalian genome is poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 599,
                    "text": "The targeting preference for the terminus of replication and DNA double-strand breaks is dependent on the Tn7-encoded protein TnsE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24310611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 324,
                    "text": "DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22139015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 617,
                    "text": "A functional replisome is restored by the reloading of GINS and polymerase \u025b onto DNA in a fashion that is dependent on RAD51 and MRE11 but independent of replication origin assembly and firing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322196",
                    "endSection": "abstract",
                    "offsetInBeginSection": 469,
                    "offsetInEndSection": 677,
                    "text": "Here, we show that the replication checkpoint suppresses the formation of Rad52 foci in an Mrc1-dependent manner and prevents homologous recombination (HR) at chromosome breaks induced by the HO endonuclease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19322196",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 304,
                    "text": "Tolerance to replication stress also depends on the Mec1 kinase, which activates the DNA replication checkpoint in an Mrc1-dependent manner in response to fork arrest."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10754554",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Double-strand breaks in DNA can be repaired by homologous recombination including break-induced replication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18054789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Perturbed DNA replication either activates a cell cycle checkpoint, which halts DNA replication, or decreases the rate of DNA synthesis without activating a checkpoint."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 467,
                    "text": "When DNA double-strand breaks are induced at specific sites in the chromosome, Tn7 transposition is stimulated and insertions are directed proximal to the induced break."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18342610",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 653,
                    "text": "Cleavage is dependent on DNA replication, but the observation of two ends at the break argues that cleavage does not occur at the replication fork."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                "http://www.ncbi.nlm.nih.gov/pubmed/11390511",
                "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                "http://www.ncbi.nlm.nih.gov/pubmed/20305780",
                "http://www.ncbi.nlm.nih.gov/pubmed/22189956",
                "http://www.ncbi.nlm.nih.gov/pubmed/20888336",
                "http://www.ncbi.nlm.nih.gov/pubmed/18220905",
                "http://www.ncbi.nlm.nih.gov/pubmed/16569374",
                "http://www.ncbi.nlm.nih.gov/pubmed/15743780"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1459,
                    "offsetInEndSection": 1723,
                    "text": "CONCLUSIONS\nOur results indicate that TLR2 agonists indirectly inhibit fibrocyte differentiation and that, for some TLR2 agonists, this inhibition involves other cell types in the PBMC population secreting an unknown factor that inhibits fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 793,
                    "offsetInEndSection": 951,
                    "text": "The activated fibrocyte build the collagen of the granulation tissue and then remodel and ensure wound contraction by becoming fibroclasts and myofibroblasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "abstract",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 322,
                    "text": "Since Toll-like receptors (TLRs) are present on monocytes, and pathogens that can infect a wound have and/or release TLR agonists, we examined whether TLR agonists affect fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11390511",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1061,
                    "offsetInEndSection": 1291,
                    "text": "We show that secondary lymphoid chemokine, a ligand of the CCR7 chemokine receptor, acts as a potent stimulus for fibrocyte chemotaxis in vitro and for the homing of injected fibrocytes to sites of cutaneous tissue injury in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 481,
                    "text": "The microscopic, electron microscopic and immunohistochemical observation of biopsy specimens taken at an early stage, at close and regular intervals (every 4 hours), from open skin wounds created in the pig and the monkey, together with quantitative analysis of the various cell types in the granulation tissue, supports the conception that the activated fibrocyte (fibroblast) originates from the fibrocyte of the wound edges and thus completes some earlier experimental studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1041,
                    "offsetInEndSection": 1219,
                    "text": "This factor is not interferon (IFN)-\u03b1, IFN-\u03b3, interleukin (IL)-12, aggregated immunoglobulin G (IgG) or serum amyloid P (SAP), factors known to inhibit fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10851555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 482,
                    "offsetInEndSection": 673,
                    "text": "We describe here the various stages of the differentiation of the wound edge fibrocyte into an activated fibrocyte and its proliferation and migration from the edges to the site of the wound."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 838,
                    "text": "Monoclonal antibodies that bind to Fc gammaRI (CD64) or Fc gammaRII (CD32) also inhibit fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 438,
                    "offsetInEndSection": 586,
                    "text": "As SAP binds to Fc receptors for immunoglobulin G (IgG; Fc gammaRs), Fc gammaR activation may be an inhibitory signal for fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11390511",
                    "endSection": "abstract",
                    "offsetInBeginSection": 918,
                    "offsetInEndSection": 1060,
                    "text": "Because fibrocytes home to sites of tissue injury, we examined the role of chemokine/chemokine receptor interactions in fibrocyte trafficking."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26687445",
                "http://www.ncbi.nlm.nih.gov/pubmed/25385579",
                "http://www.ncbi.nlm.nih.gov/pubmed/24055342",
                "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                "http://www.ncbi.nlm.nih.gov/pubmed/28376483",
                "http://www.ncbi.nlm.nih.gov/pubmed/26536864",
                "http://www.ncbi.nlm.nih.gov/pubmed/27693036",
                "http://www.ncbi.nlm.nih.gov/pubmed/25846769",
                "http://www.ncbi.nlm.nih.gov/pubmed/25972893"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 912,
                    "text": "We show that LOI results in defects in muscle differentiation and hypertrophy and identify primary downstream targets: Igf2 overexpression results in over-activation of MAPK signaling while loss of H19 lncRNA prevents normal down regulation of p53 activity and therefore results in reduced AKT/mTOR signaling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26687445",
                    "endSection": "abstract",
                    "offsetInBeginSection": 754,
                    "offsetInEndSection": 1042,
                    "text": "Our results uncover an unanticipated regulatory circuit involving broad epigenetic alterations by a single abundantly expressed lncRNA that may underlie gene methylation dynamics of development and diseases and suggest that this mode of regulation may extend to other cellular components."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25972893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Long non-coding RNAs (lncRNAs) are transcripts without protein-coding potential but having a pivotal role in numerous biological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1076,
                    "offsetInEndSection": 1260,
                    "text": "This study thus identifies new biochemical roles for the H19 lncRNA and underscores that LOI phenotypes are multigenic so that complex interactions will contribute to disease outcomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24055342",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 332,
                    "text": "However, how H19 acts to regulate gene function has remained enigmatic, despite the recent implication of its encoded miR-675 in limiting placental growth."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29244185",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Loss of imprinting mutations define both distinct and overlapping roles for misexpression of IGF2 and of H19 lncRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26687445",
                    "endSection": "abstract",
                    "offsetInBeginSection": 71,
                    "offsetInEndSection": 273,
                    "text": "Here we report that the developmentally regulated H19 lncRNA binds to and inhibits S-adenosylhomocysteine hydrolase (SAHH), the only mammalian enzyme capable of hydrolysing S-adenosylhomocysteine (SAH)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24055342",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 518,
                    "text": "We noted that vertebrate H19 harbors both canonical and noncanonical binding sites for the let-7 family of microRNAs, which plays important roles in development, cancer, and metabolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27693036",
                    "endSection": "abstract",
                    "offsetInBeginSection": 973,
                    "offsetInEndSection": 1093,
                    "text": "These findings indicated that H19 might regulate the tumor growth and metastasis via miR-140 dependent iASPP regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                    "endSection": "abstract",
                    "offsetInBeginSection": 959,
                    "offsetInEndSection": 1150,
                    "text": "This work thus adds to the body of literature describing the multiple roles in oncogenesis, cellular growth, glucose metabolism, and now regulation of steroidogenesis, of this complex lncRNA."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987820",
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/25390401",
                "http://www.ncbi.nlm.nih.gov/pubmed/22703855",
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/12090544"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma [Formula: see text]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "The FDA approved the use of dinutuximab, in combination with three other agents, for high-risk neuroblastoma, offering patients the first major new treatment in more than a decade."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "Therapy combining dinutuximab with granulocyte macrophage colony stimulating factor, interleukin 2, and isotretinoin has significant side effects; however, these complications are generally predictable and can be managed proactively."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Dinutuximab approved for high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987820",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "Filgrastim-sndz (Zarxio) to help prevent infections related to chemotherapy, dinutuximab (Unituxin) for high-risk pediatric neuroblastoma, and panobinostat (Farydak) for multiple myeloma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Dinutuximab is a monoclonal antibody targeted at disialoganglioside (GD2), a tumor-associated antigen widely expressed in human neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 467,
                    "text": "SUMMARY\nDinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1661,
                    "text": "CONCLUSION\nDinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 308,
                    "text": "The incorporation of dinutuximab into standard treatment regimens for patients with high-risk neuroblastoma has changed the landscape of neuroblastoma therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 511,
                    "text": "GD2 is the first ganglioside proven to be an effective target antigen for cancer immunotherapy with the regulatory approval of dinutuximab, a chimeric anti-GD2 therapeutic antibody."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27550178",
                "http://www.ncbi.nlm.nih.gov/pubmed/26079792",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                "http://www.ncbi.nlm.nih.gov/pubmed/21431156",
                "http://www.ncbi.nlm.nih.gov/pubmed/26518661",
                "http://www.ncbi.nlm.nih.gov/pubmed/8601195"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 544,
                    "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                    "endSection": "abstract",
                    "offsetInBeginSection": 817,
                    "offsetInEndSection": 1103,
                    "text": "Empirical studies on synthetic samples and applications using several ChIP data sets including 16 TF (transcription factor) ChIP-seq data sets and five TF ChIP-exo data sets have demonstrated that our proposed method is capable of finding these motifs with high efficiency and accuracy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 475,
                    "offsetInEndSection": 664,
                    "text": "When applied to our GR and the few available public ChIP-exo data sets, we find that ChIP-exo footprints are protein- and recognition sequence-specific signatures of genomic TF association."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26518661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 631,
                    "text": "We show that Leo1-Paf1 [a subcomplex of the RNA polymerase II-associated factor 1 complex (Paf1C)] is required to prevent the spreading of heterochromatin into euchromatin by mapping the heterochromatin mark H3K9me2 using high-resolution genomewide ChIP (ChIP-exo)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 869,
                    "text": "A significant improvement of the ChIP-seq technique results from the addition of an exonuclease treatment during the immunoprecipitation step (ChIP-exo) that lowers background noise and more importantly increases the identification of binding sites to a level near to single-base resolution by effectively footprinting DNA-bound proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 297,
                    "text": "To identify sequences responsible for recruitment of this transcription factor (TF) to individual loci, we turned to the high-resolution ChIP-exo approach."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27550178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "Recently, a number of advances have been implemented into the core ChIP-seq (chromatin immunoprecipitation coupled with next-generation sequencing) methodology to streamline the process, reduce costs or improve data resolution."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27550178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 952,
                    "offsetInEndSection": 1201,
                    "text": "Application of this input strategy not only significantly enhanced artifact removal from ChIP-exo data, increasing confidence in peak identification and allowing for de novo motif searching, but also afforded discovery of a novel CTCF binding motif."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                "http://www.ncbi.nlm.nih.gov/pubmed/22677107",
                "http://www.ncbi.nlm.nih.gov/pubmed/18179904",
                "http://www.ncbi.nlm.nih.gov/pubmed/2308845",
                "http://www.ncbi.nlm.nih.gov/pubmed/20591530",
                "http://www.ncbi.nlm.nih.gov/pubmed/15313545",
                "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                "http://www.ncbi.nlm.nih.gov/pubmed/26530673"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26530673",
                    "endSection": "abstract",
                    "offsetInBeginSection": 262,
                    "offsetInEndSection": 571,
                    "text": "This approach is indispensable if information about wide range of deletion types in a sample is critical, such as in studies concerning distribution of deletion breakpoints (as opposed to approaches where fraction of a single deletion or a limited set of deletions is used as a proxy for total deletion load)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 299,
                    "offsetInEndSection": 500,
                    "text": "In this study, we investigated the deletion breakpoints of the parkin mutations in 22 families with AR-JP and examined the possible association between these deletion events and meiotic recombinations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3032452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 453,
                    "text": "Members of the Alu family of repetitive sequences are frequently found at the breakpoints and we describe a novel deletion due to homologous recombination between such repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 512,
                    "text": "Seven of the deletions, five of which were unique to a particular animal, did not have direct repeats at the deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 298,
                    "text": "On initial screening of Japanese patients with AR-JP, we had found that approximately half of the parkin mutations are deletions occurring between exons 2 and 5, forming a deletion hot spot."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 244,
                    "text": "The large majority of mitochondrial DNA (mtDNA) deletions analyzed from mitochondrial myopathies and aging humans have been found to be flanked by direct repeats, a finding which has led to the slip-replication hypothesis of deletion formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22677107",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 186,
                    "text": "The Pakistani deletion is 506kb in length, and the second largest \u03b5\u03b3\u03b4\u03b2 thalassemia deletion reported to date."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Large deletions are found in approximately 5% of patients with severe haemophilia A, but only a few deletion breakpoints have been characterised precisely so far."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2308845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 928,
                    "text": "Computer analysis showed a correlation between the location of the deletion breakpoints and sequences in human mtDNA similar to the target sequence for Drosophila topoisomerase II."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19715670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 782,
                    "offsetInEndSection": 1012,
                    "text": "Recent copy number variation (CNV) data from various ethnic groups showed that the deletion hot spot is overlapped by a highly polymorphic CNV region, indicating that the recurrent deletion mutation or CNV is observable worldwide."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27308606",
                "http://www.ncbi.nlm.nih.gov/pubmed/29344130",
                "http://www.ncbi.nlm.nih.gov/pubmed/22258142",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246710",
                "http://www.ncbi.nlm.nih.gov/pubmed/24039610",
                "http://www.ncbi.nlm.nih.gov/pubmed/22319583",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429839"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 965,
                    "text": "Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 545,
                    "text": "Studies on the recently discovered of EBV-encoded microRNAs (ebv-miRNAs) showed that these small molecules function as post-transcriptional gene regulators and may play a role in the carcinogenesis process."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Circular RNA participates in the carcinogenesis and the malignant behavior of cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 756,
                    "text": "Emerging evidence shows that circRNAs play important roles in several diseases, particularly in cancer where they act through regulating protein expression of the pivotal genes that are critical for carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 338,
                    "text": "Reports have shown that EBV produces several viral oncoproteins, yet their pathological roles in carcinogenesis are not fully elucidated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 39,
                    "offsetInEndSection": 208,
                    "text": "According to the currently accepted model of carcinogenesis, several consequential mutations in oncogenes or tumor suppressor genes are necessary for cancer development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 753,
                    "offsetInEndSection": 838,
                    "text": "The importance of several miR-BARTs in carcinogenesis has recently been demonstrated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 515,
                    "text": "Recent studies have mainly been devoted to the function of the circular RNA sponge for miR-7 (ciRS-7) and sex-determining region Y (SRY) by targeting microRNA-7 (miR-7) and microRNA-138 (miR-138), respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 691,
                    "offsetInEndSection": 897,
                    "text": "Furthermore, circRNA, together with its gene silencing ability, also shows its potential in RNA interference (RNAi) therapy by binding to target RNAs, which provides a novel perspective in cancer treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22258142",
                    "endSection": "abstract",
                    "offsetInBeginSection": 175,
                    "offsetInEndSection": 293,
                    "text": "Yiya is a 1.9 kb long intergenic ncRNA gene mapped to chromosome 1q41, a well-established cancer susceptibility locus."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12573800",
                "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                "http://www.ncbi.nlm.nih.gov/pubmed/17555553",
                "http://www.ncbi.nlm.nih.gov/pubmed/23604405",
                "http://www.ncbi.nlm.nih.gov/pubmed/28017472",
                "http://www.ncbi.nlm.nih.gov/pubmed/7076336",
                "http://www.ncbi.nlm.nih.gov/pubmed/23954170",
                "http://www.ncbi.nlm.nih.gov/pubmed/21972134",
                "http://www.ncbi.nlm.nih.gov/pubmed/7375016"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 936,
                    "text": "Mitochondrial MDH increased nardilysin activity about 50%, while nardilysin stabilized mMDH towards heat inactivation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 430,
                    "text": "Nardilysin enhances the alpha-secretase activity of the disintegrin and metalloproteases (ADAMs) 10 and 17, thereby possibly contributing to reduced generation of amyloidogenic fragments from the amyloid precursor protein."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17555553",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12573800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 670,
                    "offsetInEndSection": 956,
                    "text": "This enzyme assay was used to document that both mice null for PC2 as well as mice null for the PC2 cofactor, 7B2, had only trace levels of PC2 activity in various brain regions, while mice heterozygous for these alleles had approximately half of the PC2 activity in most brain regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Gel filtration chromatography showed that nardilysin activity in a rat testis or rat brain extract exhibited an apparent molecular weight of approximately 300 kDa compared to approximately 187 kDa for the purified enzyme."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28017472",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Loss of Nardilysin, a Mitochondrial Co-chaperone for \u03b1-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 817,
                    "text": "Porcine mMDH, but not porcine cytosolic MDH, was shown to form a heterodimer with nardilysin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12573800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 957,
                    "offsetInEndSection": 1102,
                    "text": "PC2 enzymatic activity and PC2 mRNA levels were somewhat discordant suggesting that PC2 mRNA levels do not always reflect PC2 enzymatic activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23954170",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Nardilysin prevents amyloid plaque formation by enhancing \u03b1-secretase activity in an Alzheimer's disease mouse model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 431,
                    "offsetInEndSection": 602,
                    "text": "A prerequisite for the alpha-secretase-stimulating effect of nardilysin on the activity of ADAMs in vivo is cellular co-expression of nardilysin with ADAM10 and/or ADAM17."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                "http://www.ncbi.nlm.nih.gov/pubmed/8295886",
                "http://www.ncbi.nlm.nih.gov/pubmed/762406",
                "http://www.ncbi.nlm.nih.gov/pubmed/20849365",
                "http://www.ncbi.nlm.nih.gov/pubmed/17301213",
                "http://www.ncbi.nlm.nih.gov/pubmed/16572060",
                "http://www.ncbi.nlm.nih.gov/pubmed/17915461",
                "http://www.ncbi.nlm.nih.gov/pubmed/9636858",
                "http://www.ncbi.nlm.nih.gov/pubmed/28164990",
                "http://www.ncbi.nlm.nih.gov/pubmed/18346520"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Mycobacterium tuberculosis is very rarely found in erythema induratum of Bazin; recently, we found an unusual case with positive acid-fast bacilli and polymerase chain reaction for detecting M.\u00a0tuberculosis in both skin lesions of the extremities and the site of Mantoux test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8295886",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 344,
                    "text": "It is demonstrated that tuberculin electrophoresis in chemoprophylaxix for M.tuberculosis infection in adolescents with a marked of hyperergic reaction to the Mantoux test (2TU) contributes to enhancement of nonspecific immunological reactivity, to a decline in immunospecific reactions, and reduction in the response to the Mantoux test (2TU)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28470727",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Mycobacterium tuberculosis found at both skin lesions and Mantoux testing site in a patient with erythema induratum of Bazin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17915461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 257,
                    "offsetInEndSection": 659,
                    "text": "The informative value of the study rapid method for the diagnosis of tuberculosis was generally 1.8 times less than that of the Mantoux tuberculin test with 2 TE of PPD-L (only intensive and hyperergic tuberculin tests were kept in mind): 6.1 times less in patients with small forms; 1.4 times less in the examinees with disseminated processes; 1.5 times greater than in chronic pulmonary tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17915461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 256,
                    "text": "The diagnostic informative value of the Serochek MBT test (Zephyr Biomedicals, India) in detecting serum Mycobacterium tuberculosis antibodies was compared with that of the Mantoux tuberculin test with 2 TE of PPD-L in patients with pulmonary tuberculosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8295886",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "[Effectiveness of chemoprevention of tuberculosis in adolescents with hyperreactivity to the Mantoux test with 2 TU in tuberculin electrophoresis]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20849365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 1031,
                    "text": "We therefore recommend proper clinical assessment and other investigations for the diagnosis of TB in children in settings with a high prevalence of HIV infection and malnutrition, as Mantoux reaction results may be unreliable."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20849365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 803,
                    "text": "Although malnutrition and HIV infection were significantly associated with a negative Mantoux reaction, disseminated TB was not associated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/762406",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 278,
                    "text": "Re-evaluation of recently published figures comparing the tuberculin Tine Test+ and the Mantoux showed that, contrary to original opinion, the Tine Test+ did perform satisfactorily, the reason for the apparent ineffectiveness lying in the original interpretation of the results."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17301213",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                "http://www.ncbi.nlm.nih.gov/pubmed/27172589",
                "http://www.ncbi.nlm.nih.gov/pubmed/21060220",
                "http://www.ncbi.nlm.nih.gov/pubmed/25104323",
                "http://www.ncbi.nlm.nih.gov/pubmed/25920860",
                "http://www.ncbi.nlm.nih.gov/pubmed/25449904",
                "http://www.ncbi.nlm.nih.gov/pubmed/27475263",
                "http://www.ncbi.nlm.nih.gov/pubmed/26936552",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/27217465"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "Serological diagnostics of hepatitis B in clinical laboratories is mainly based on detection of HBs antigen (HBsAg) in human serum or plasma using commercial ELISA kits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "Performance of ELISA HBsAg Test Kits with Use of the Different Types of Panels Containing HBsAg."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1166,
                    "offsetInEndSection": 1278,
                    "text": "An identical set of plasma samples were analyzed utilizing the Bio-Plex Pro\u2122 human cytokine 27-plex immunoassay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 309,
                    "text": "In manufacturing and laboratory practice, sensitivity of ELISA kit is measured against either international or national reference standard."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1393,
                    "offsetInEndSection": 1515,
                    "text": "For 4 of them the measured level of HBsAg varied 10-100 times with the change of the kit or type of monoclonal antibodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1516,
                    "offsetInEndSection": 1668,
                    "text": "The data obtained suggest that each control panel could be a useful tool for estimation of both the kit detection potency and laboratory assay efficacy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1232,
                    "offsetInEndSection": 1392,
                    "text": "Variants of HBsAg were found in 11 sera among 132 HBsAg positive sera titrated in ELISA in the presence of monoclonal antibodies against a-determinant of HBsAg."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12687178",
                    "endSection": "abstract",
                    "offsetInBeginSection": 310,
                    "offsetInEndSection": 520,
                    "text": "This approach is necessary, but limited as it does not take into account factors that influence on HBsAg detection kit potency at low HBsAg concentration and when HBsAg subtypes/variants are present in species."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8222382",
                "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                "http://www.ncbi.nlm.nih.gov/pubmed/19558342",
                "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                "http://www.ncbi.nlm.nih.gov/pubmed/27920715",
                "http://www.ncbi.nlm.nih.gov/pubmed/24121849",
                "http://www.ncbi.nlm.nih.gov/pubmed/10695494",
                "http://www.ncbi.nlm.nih.gov/pubmed/19389587",
                "http://www.ncbi.nlm.nih.gov/pubmed/27428494",
                "http://www.ncbi.nlm.nih.gov/pubmed/23804334"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24121849",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 187,
                    "text": "Alteplase is a licensed thrombolytic treatment for ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 564,
                    "offsetInEndSection": 715,
                    "text": "Ticlopidine (500 mg/day), a new antiplatelet agent, is more effective than aspirin in preventing stroke and death in patients with TIA or minor stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 211,
                    "text": "Thrombolytic therapy is likely to be effective in some patients with stroke, but further improvements may require combination treatment with neuroprotective agents that can be given rapidly with relative safety."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 539,
                    "offsetInEndSection": 657,
                    "text": "Combined glutamate antagonist and thrombolytic therapy may provide increased efficacy and safety for stroke treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 369,
                    "text": "Antithrombotic treatment with an antiplatelet agent or anticoagulant assumes a prior clinical classification into categories of transient ischaemic attack (TIA) or minor stroke, acute partial stable stroke, stroke-in-progression, and completed stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8222382",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Antiplatelet therapy in the treatment of cerebrovascular disease."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24121849",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Thrombolytic dosing in acute ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 862,
                    "offsetInEndSection": 937,
                    "text": "Aspirin has not been directly shown to be effective after completed stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2271790",
                    "endSection": "abstract",
                    "offsetInBeginSection": 716,
                    "offsetInEndSection": 861,
                    "text": "Ticlopidine (500 mg/day) is effective in preventing recurrent stroke, myocardial infarction, or vascular death in patients with completed stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23804334",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 50,
                    "text": "Is sonothrombolysis an effective stroke treatment?"
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12668060",
                "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                "http://www.ncbi.nlm.nih.gov/pubmed/17923143",
                "http://www.ncbi.nlm.nih.gov/pubmed/17234143",
                "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                "http://www.ncbi.nlm.nih.gov/pubmed/14575721",
                "http://www.ncbi.nlm.nih.gov/pubmed/18418417",
                "http://www.ncbi.nlm.nih.gov/pubmed/18278824",
                "http://www.ncbi.nlm.nih.gov/pubmed/24664764",
                "http://www.ncbi.nlm.nih.gov/pubmed/15454965"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Adeno-associated viral (AAV) vector-mediated gene replacement for the treatment of muscular dystrophy represents a promising therapeutic strategy in modern medicine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 834,
                    "text": "Here, we review immunity against AAV vector and transgene in the context of gene delivery specific to muscles for treating muscular dystrophies and non-muscle diseases in large animal models and human trials, factors that influence the intensity of the immune responses, and immune modulatory strategies to prevent unwanted immune responses and induce tolerance to the vector and therapeutic gene for a successful gene therapy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15454965",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 228,
                    "offsetInEndSection": 410,
                    "text": "The paper firstly introduced the AAV vectors and the techniques of eye delivery, then summarized some tested genes that were used in past treatment to retinal degeneration disorders."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Adeno-associated virus (AAV) based gene therapy for eye diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18278824",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 592,
                    "text": "Adeno-associated viruses (AAVs) represent an attractive alternative to adenoviral vector systems as they enable stable and long-term expression and can target a variety of different ocular cell types depending on the capsid serotype; recently clinical trails for congenital blindness was initiated with a vector-based AAV serotype 2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14575721",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 57,
                    "text": "Adeno-associated viral vectors for retinal gene transfer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18418417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 701,
                    "offsetInEndSection": 850,
                    "text": "Here, we review different approaches for treating inherited retinal degenerations and more common acquired retinal disorders using AAV-based vectors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14575721",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Vectors derived from adeno-associated viruses (AAV) represent a promising tool for retinal gene transfer in pre-clinical and clinical settings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18418417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 323,
                    "text": "The most widely used vectors for ocular gene delivery are based on adeno-associated virus (AAV), because they elicit minimal immune responses and mediate long-term transgene expression in a variety of retinal cell types."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                "http://www.ncbi.nlm.nih.gov/pubmed/28635796",
                "http://www.ncbi.nlm.nih.gov/pubmed/14702207",
                "http://www.ncbi.nlm.nih.gov/pubmed/22679745",
                "http://www.ncbi.nlm.nih.gov/pubmed/15005642",
                "http://www.ncbi.nlm.nih.gov/pubmed/24961534",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/19122569",
                "http://www.ncbi.nlm.nih.gov/pubmed/16651823",
                "http://www.ncbi.nlm.nih.gov/pubmed/29450391"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 322,
                    "text": "Citicoline is a unique drug with neuroprotective properties that demonstrated the positive results in patients with stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 776,
                    "text": "Citicoline has been studied worldwide in both ischemic and hemorrhagic clinical stroke with excellent safety and possibly efficacy found in several trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 198,
                    "text": "Data on the mechanism of action of the neuroprotector citicoline, its effectiveness in the experimental models of cerebral ischemia and in patients with ischemic and hemorrhagic stroke are reviewed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 777,
                    "offsetInEndSection": 1015,
                    "text": "A meta-analysis of four randomized US clinical citicoline trials concluded that treatment with oral citicoline within the first 24 h after a moderate to severe stroke is safe and increases the probability of complete recovery at 3 months."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22679745",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Choline-positive neuroprotectors citicoline and choline alfoscerate decreased blood concentration of protein S100 in clinical trial on 52 patients in the first days after acute ischemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Efficacy of citicoline as an acute stroke treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20873404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 455,
                    "text": "The effectiveness of the combined thrombolytic and citicoline therapy was demonstrated in the experimental model of ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1016,
                    "offsetInEndSection": 1129,
                    "text": "Citicoline clinical efficacy trials are now continuing outside of the US in both ischemic and hemorrhagic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28635796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 760,
                    "offsetInEndSection": 1252,
                    "text": "According to the results of clinical trials of the dosage regimen, citicoline administered in the dose of 1000 mg/day for 8 weeks accelerates the regression of hemiplegia; the intravenous injection in the dose of 750 mg/day for 10 days, starting with the first 48 hours of stroke onset symptoms, promotes the recovery of motor and cognitive functions; the intravenous injection in the dose of 1 g within 14 days improves the recovery of consciousness, general condition and functional status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15005642",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 362,
                    "text": "Citicoline has also been investigated as a therapy in stroke patients, although the results of trials to date are inconclusive."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9119402",
                "http://www.ncbi.nlm.nih.gov/pubmed/10022501",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/7689553",
                "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                "http://www.ncbi.nlm.nih.gov/pubmed/28559441",
                "http://www.ncbi.nlm.nih.gov/pubmed/8567751",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                "http://www.ncbi.nlm.nih.gov/pubmed/12686136"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 413,
                    "text": "The LOXL3\u00a0protein contains four scavenger receptor cysteine-rich\u00a0(SRCR) domains in the N-terminus in addition to the C-terminal characteristic domains of the lysyl oxidase\u00a0(LOX) family, such as a copper-binding domain, a cytokine receptor\u2011like domain and residues for the lysyl-tyrosyl quinone cofactor."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 45,
                    "text": "Lysyl oxidase-like protein from bovine aorta."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                    "endSection": "abstract",
                    "offsetInBeginSection": 980,
                    "offsetInEndSection": 1239,
                    "text": "We have isolated a 56-kDa protein identified by amino acid sequencing as the bovine lysyl oxidase-like precursor, which is cleaved at the Arg-Arg-Arg sequence at positions 89-91 by a furin-like activity, as revealed after deblocking of the N-terminal residue."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12686136",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Lysyl oxidase (LOX) and four lysyl oxidase-like proteins, LOXL, LOXL2, LOXL3 and LOXL4, each contain a copper binding site, conserved lysyl and tyrosyl residues that may contribute to quinone co-factor formation, and a cytokine receptor-like domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 987,
                    "text": "It appears therefore that the genes encoding lysyl oxidase and a lysyl oxidase-like protein share a common evolutionary origin and may also be functionally related."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "We have isolated a number of recombinant clones from a human skin fibroblast cDNA library that contain extensive sequence homology to several coding domains within the human lysyl oxidase mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11684696",
                    "endSection": "abstract",
                    "offsetInBeginSection": 81,
                    "offsetInEndSection": 295,
                    "text": "Their deduced amino acid sequences are characterized by a strong similarity in the C-terminal region, corresponding to the lysyl oxidase family catalytic domain, and by marked differences in the N-terminal regions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7689553",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "A novel human cDNA with a predicted protein similar to lysyl oxidase maps to chromosome 15q24-q25."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/26249737",
                "http://www.ncbi.nlm.nih.gov/pubmed/22872134",
                "http://www.ncbi.nlm.nih.gov/pubmed/18805046",
                "http://www.ncbi.nlm.nih.gov/pubmed/19047680",
                "http://www.ncbi.nlm.nih.gov/pubmed/24597762",
                "http://www.ncbi.nlm.nih.gov/pubmed/29195860",
                "http://www.ncbi.nlm.nih.gov/pubmed/16397142",
                "http://www.ncbi.nlm.nih.gov/pubmed/28846098"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 269,
                    "text": "Growth differentiation factor 15 (GDF15), a transforming growth factor (TGF)-beta superfamily member, has been cloned from a placenta cDNA library as a gene product that has promoted activation of pro-matrix metalloproteinase (MMP)2 mediated by membrane type (MT)1-MMP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 874,
                    "offsetInEndSection": 1108,
                    "text": "HT1080 cells transfected with the GDF15 gene, which endogenously express MT1-MMP, synthesize a high-level GDF15 precursor form and a low-level mature form, and treatment of cells with BB94 enhanced production of the GDF15 mature form."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1109,
                    "offsetInEndSection": 1417,
                    "text": "Consistent with GDF15 production, HT1080 cells transfected with the GDF15 gene proliferated almost equally with control cells, and addition of BB94 effectively suppressed growth of HT1080 cells transfected with the GDF15 gene concomitant with the accumulation of the GDF15 mature form, but not control cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Growth differentiation factor-15 (GDF15), a member of the transforming growth factor-\u03b2 superfamily, is associated with human cancer progress."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Cleavage of growth differentiation factor 15 (GDF15) by membrane type 1-matrix metalloproteinase abrogates GDF15-mediated suppression of tumor cell growth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 626,
                    "text": "GDF15 mRNA synthesis was also shown to be induced by treatment of cells with GDF15."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26249737",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Growth differentiation factor-15 (GDF15), a member of the TGF-\u03b2 superfamily, affects tumor biology of certain cancers, but remains poorly understood in bladder cancer cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26249737",
                    "endSection": "abstract",
                    "offsetInBeginSection": 758,
                    "offsetInEndSection": 982,
                    "text": "The expressions of mammary serine protease inhibitor (MASPIN) and N-myc downstream-regulated family genes (NDRG1, NDRG2, and NDRG3) were upregulated by GDF15 overexpressions and rhGDF15 treatments in bladder carcinoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17640303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 542,
                    "text": "Treatment of MCF7 cells with GDF15 induced activation of p53 and enhanced expression of p21, which was abrogated by MT1-MMP expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 231,
                    "text": "Recently, elevated serum GDF15 level was proposed as a marker for mood disorder."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24853856",
                "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                "http://www.ncbi.nlm.nih.gov/pubmed/20215986",
                "http://www.ncbi.nlm.nih.gov/pubmed/27603326",
                "http://www.ncbi.nlm.nih.gov/pubmed/17631027",
                "http://www.ncbi.nlm.nih.gov/pubmed/23717903",
                "http://www.ncbi.nlm.nih.gov/pubmed/25190612",
                "http://www.ncbi.nlm.nih.gov/pubmed/28894914",
                "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                "http://www.ncbi.nlm.nih.gov/pubmed/27639907"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23717903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 550,
                    "text": "This review describes some dysimmune neuromuscular disorders and their recent management: syndrome of peripheral nerve hyperexcitability (treatment of cramps, immunosuppressors); Guillain-Barr\u00e9 syndrome (new mechanisms and consensus treatment); chronic inflammatory demyelinating polyradiculoneuropathy (new indication for the use of pulse dexamethasone, new scores of activity); importance of subcutaneous immunoglobulin in multifocal motor neuropathy and of infusions of rituximab in myasthenia gravis; new entities in myositis and their treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "Ofatumumab is an anti-CD20 IgG1kappa human monoclonal antibody that is being considered by the US Food and Drug Administration and the European Medicines Agency for marketing approval as a treatment for chronic lymphocytic leukemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24853856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 318,
                    "text": "This is the case of a 79-year-old man with chronic lymphocytic leukemia who presented with Guillain-Barr\u00e9 syndrome with features overlapping with the Miller Fisher syndrome and Bickerstaff brainstem encephalitis and positive antiganglioside GQ1b antibody about 6 months after treatment with bendamustine and rituximab."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27603326",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 31,
                    "text": "Rituximab: Uses in Dermatology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27639907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "INTRODUCTION\nRituximab is a chimeric anti-CD20\u00a0monoclonal antibody generally well tolerated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                    "endSection": "abstract",
                    "offsetInBeginSection": 452,
                    "offsetInEndSection": 685,
                    "text": "Here we describe a pediatric patient with steroid-dependent chronic ITP who presented with arthralgia and fever ten days after the second infusion of rituximab (on day 10), and presented with malaise and maculopapular rash on day 21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27603326",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 709,
                    "text": "Currently, rituximab is only FDA-approved for treatment of follicular and diffuse large B-cell non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis (formerly Wegener's granulomatosis) and microscopic polyangiitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 519,
                    "offsetInEndSection": 573,
                    "text": "Ofatumumab might be approved in the US by August 2009."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1056,
                    "text": "To our knowledge, among pediatric patients who received rituximab for chronic ITP, this is the sixth documented case of serum sickness and the only one who manifested an elevated level of HACA."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23493417",
                "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                "http://www.ncbi.nlm.nih.gov/pubmed/16054100",
                "http://www.ncbi.nlm.nih.gov/pubmed/29053959",
                "http://www.ncbi.nlm.nih.gov/pubmed/22907750",
                "http://www.ncbi.nlm.nih.gov/pubmed/25621662",
                "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                "http://www.ncbi.nlm.nih.gov/pubmed/28166452",
                "http://www.ncbi.nlm.nih.gov/pubmed/24754597"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28166452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 284,
                    "text": "Recent evidence has shown that DNA replication stress is a major driver of genomic instability and tumorigenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Oncogene-induced replication stress is recognized as the primary cause of accumulation of DNA damage and genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 947,
                    "text": "Although replication stress has been proven to induce genomic instability and tumorigenesis, recent studies have counterintuitively shown that enhancing replicative stress through further loosening of the remaining checkpoints in cancer cells to induce their catastrophic failure of proliferation may provide an alternative therapeutic approach."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 754,
                    "text": "Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1218,
                    "text": "Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factors that, when mutated or dysfunctional, may enhance genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23493417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 812,
                    "offsetInEndSection": 968,
                    "text": "We also highlight the checkpoint function as an anti-cancer barrier preventing cells malignant transformation following oncogene-induced replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 766,
                    "offsetInEndSection": 930,
                    "text": "Furthermore, overexpression of TBP alone causes the hallmarks of oncogene-induced replication stress, including replication fork slowing, DNA damage and senescence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25621662",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 709,
                    "text": "A model to explain the presence of the three hallmarks listed above, as well as the patterns of genomic instability observed in human cancers, proposes that the genes driving cell proliferation induce DNA replication stress, which, in turn, generates genomic instability and selects for escape from apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27548226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 601,
                    "text": "Cancer cells, however, due to constitutive growth signaling and defective DDR, may exhibit \"replication stress\" -a phenomenon unique to cancer cells that is described as the perturbation of error-free DNA replication and slow-down of DNA synthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29053959",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 794,
                    "text": "In addition to SMARCAL1, other SNF2-family fork remodelers, including ZRANB3 and HLTF, cause nascent DNA degradation and genomic instability in BRCA1/2-deficient cells upon replication stress."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1684050",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584894",
                "http://www.ncbi.nlm.nih.gov/pubmed/8789849",
                "http://www.ncbi.nlm.nih.gov/pubmed/17170912",
                "http://www.ncbi.nlm.nih.gov/pubmed/7517371",
                "http://www.ncbi.nlm.nih.gov/pubmed/23595645",
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/17210911",
                "http://www.ncbi.nlm.nih.gov/pubmed/19043689",
                "http://www.ncbi.nlm.nih.gov/pubmed/1550546"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 943,
                    "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 495,
                    "text": "The osseous labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the cranial vault or base."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684050",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 320,
                    "text": "Significant amounts of genetic information can be recovered from ancient bone: mitochondrial DNA sequences of 800 base pairs have been amplified from a 750-year-old human femur by using the polymerase chain reaction."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684050",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 58,
                    "text": "Analysis of ancient bone DNA: techniques and applications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17170912",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 471,
                    "text": "The objective of this article is to present a personal classification of petrous bone cholesteatomas, a survey of recent surgical attitudes, and our present surgical strategy based on our experience with 54 operations between 1978 and 1990."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8789849",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Morphometric variables on the human petrous portion of the temporal bone can provide identification of sex in fragmented skeletal remains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684050",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "The analysis of DNA from ancient bone has numerous applications in archaeology and molecular evolution."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17170912",
                    "endSection": "abstract",
                    "offsetInBeginSection": 833,
                    "offsetInEndSection": 987,
                    "text": "Five cases with petrous bone cholesteatomas in different locations are described in detail to present the signs and symptoms together with the management."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8789849",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "Sex determination by discriminant function analysis of the petrous portion of the temporal bone."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21041408",
                "http://www.ncbi.nlm.nih.gov/pubmed/11572975",
                "http://www.ncbi.nlm.nih.gov/pubmed/25961948",
                "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                "http://www.ncbi.nlm.nih.gov/pubmed/28520720",
                "http://www.ncbi.nlm.nih.gov/pubmed/9659912",
                "http://www.ncbi.nlm.nih.gov/pubmed/11886074",
                "http://www.ncbi.nlm.nih.gov/pubmed/21445000",
                "http://www.ncbi.nlm.nih.gov/pubmed/1868837",
                "http://www.ncbi.nlm.nih.gov/pubmed/11278282"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21445000",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 514,
                    "text": "We have previously shown that in vitro-transcribed, protein-free U6 and U2 snRNAs can catalyze a two-step splicing reaction in trans on two short RNA oligonucleotides that is identical to the splicing reactions performed by many self-splicing group II introns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 640,
                    "offsetInEndSection": 822,
                    "text": "The splicing of these ultra-short introns was repressed by a splicing inhibitor, spliceostatin A, suggesting that SF3b (a U2 snRNP component) is involved in their splicing processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11572975",
                    "endSection": "abstract",
                    "offsetInBeginSection": 723,
                    "offsetInEndSection": 1540,
                    "text": "We conclude: (i) that short introns in Drosophila melanogaster and Caenorhabditis elegans contain essentially all of the information for their recognition by the splicing machinery, and computer programs that simulate splicing specificity can predict the exact boundaries of approximately 95% of short introns in both organisms; (ii) that in yeast, the 5'ss, branch signal, and 3'ss can accurately identify intron locations but do not precisely determine the location of 3' cleavage in every intron; and (iii) that the 5'ss, branch signal, and 3'ss are not sufficient to accurately identify short introns in plant and human transcripts, but that specific subsets of candidate intronic enhancer motifs can be identified in both human and Arabidopsis that contribute dramatically to the accuracy of splicing simulators."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28520720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 827,
                    "offsetInEndSection": 958,
                    "text": "Short intron splicing efficiency is increased by secondary structure, and we detect both canonical and non-canonical short introns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 479,
                    "text": "By screening an annotated human transcriptome database (H-InvDB), we identified three model ultra-short introns: the 56-nt intron in the HNRNPH1 (hnRNP H1) gene, the 49-nt intron in the NDOR1 (NADPH dependent diflavin oxidoreductase 1) gene, and the 43-nt intron in the ESRP2 (epithelial splicing regulatory protein 2) gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22640740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1369,
                    "text": "Remarkably, shared G-rich intronic sequences in the 49- and 43-nt introns were required for their splicing, suggesting that these ultra-short introns may recruit a novel auxiliary splicing mechanism linked to G-rich intronic splicing enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21041408",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "The U2AF35-related protein Urp has been implicated previously in splicing of the major class of U2-type introns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1868837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 292,
                    "offsetInEndSection": 383,
                    "text": "Instead, AU-rich sequences, a characteristic feature of dicot plant introns, are essential."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25961948",
                    "endSection": "abstract",
                    "offsetInBeginSection": 608,
                    "offsetInEndSection": 819,
                    "text": "We then provide experimental and bioinformatic evidence for the splicing of 15 introns, of which 12 introns were remarkably G-rich and 9 introns contained completely inefficient splice sites and/or branch sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11886074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "We describe in this review, the salient splicing features of group I introns of bacteriophage T4 and propose, a hypothetical model to fit in the self-splicing of nrdB intron of T4 phage."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10996130",
                "http://www.ncbi.nlm.nih.gov/pubmed/19813219",
                "http://www.ncbi.nlm.nih.gov/pubmed/11820729",
                "http://www.ncbi.nlm.nih.gov/pubmed/2866930",
                "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                "http://www.ncbi.nlm.nih.gov/pubmed/2875077",
                "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                "http://www.ncbi.nlm.nih.gov/pubmed/19962663",
                "http://www.ncbi.nlm.nih.gov/pubmed/19283672",
                "http://www.ncbi.nlm.nih.gov/pubmed/3797"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10996130",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 513,
                    "text": "Particular emphasis is placed upon the properties and inhibition of lysyl oxidase, the enzyme which initiates the covalent crosslinking of extracellular collagen molecules converting these to insoluble fibers, and upon the properties and inhibition of prolyl hydroxylase, the intracellular enzyme which hyroxylates proline residues within collagen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11820729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 851,
                    "offsetInEndSection": 1146,
                    "text": "On the other hand, coenzyme A did not stimulate the activity nor the gene expression of two other processing enzymes: lysyl hydroxylase, which provides the sites for glycosylation and crosslinking between collagen peptides, and lysyl oxidase, a fundamental enzyme in intermolecular crosslinking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2866930",
                    "endSection": "abstract",
                    "offsetInBeginSection": 568,
                    "offsetInEndSection": 683,
                    "text": "The results suggest that lysyl oxidase initiates crosslink formation at an early stage in collagen fibrillogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "The deposition of insoluble functional collagen occurs following extracellular proteolytic processing of procollagens by procollagen N- and C-proteinases, fibril formation, and lysyl oxidase dependent cross-linking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                    "endSection": "abstract",
                    "offsetInBeginSection": 430,
                    "offsetInEndSection": 704,
                    "text": "Studies determine whether inhibition of procollagen C-proteinase activity with a specific BMP-1 inhibitor results in perturbations in lysyl oxidase activation, and in collagen processing, deposition, and cross-linking in phenotypically normal cultured murine MC3T3-E1 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Lysyl oxidase catalyzes the formation of crosslinking aldehydes in collagen and elastin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15368541",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "A procollagen C-proteinase inhibitor diminishes collagen and lysyl oxidase processing but not collagen cross-linking in osteoblastic cultures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19813219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Lysyl oxidase (LOX) is a copper-dependent enzyme that initiates covalent crosslinking of elastin precursors by oxidizing peptidyl lysine to aminoadipic semi-aldehydes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2866930",
                    "endSection": "abstract",
                    "offsetInBeginSection": 227,
                    "offsetInEndSection": 482,
                    "text": "The apparent binding affinity of lysyl oxidase for native fibrils is quite similar to that for fibrils prepared from pepsin- or chymotrypsin-digested type I collagen, demonstrating that the enzyme binds to the triple-helical portion of collagen molecules."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3797",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 256,
                    "text": "Activity of lysyl oxidase, an enzyme responsible for production of aldehydic precursors for lysine-derived collagen crosslinks, was measured in tibial metaphyses from chicks receiving different dietary levels of vitamin D and Ca for 2 weeks after hatching."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23992719",
                "http://www.ncbi.nlm.nih.gov/pubmed/2980021",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827946",
                "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                "http://www.ncbi.nlm.nih.gov/pubmed/3881094",
                "http://www.ncbi.nlm.nih.gov/pubmed/7933737",
                "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                "http://www.ncbi.nlm.nih.gov/pubmed/1235315",
                "http://www.ncbi.nlm.nih.gov/pubmed/378143",
                "http://www.ncbi.nlm.nih.gov/pubmed/15480006"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/378143",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "A new method is described for stabilizing dehiscence or instability of median sternotomy incisions using stainless steel retention sutures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23992719",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 384,
                    "text": "We describe an easy and safe way for sternal stenting using conventional sternal steel wires."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Steel wire sternum fixation in patients who underwent median sternotomy for cardiac surgery, is a routine procedure in our clinical practice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 348,
                    "text": "We describe the case of a 51-year-old woman with severe nickel allergy who underwent aortic valve replacement with a nickel-free ON-X prosthesis and sternal closure by Fiberwire # 2 suture without complications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Nickel allergy can raise clinical problems in patients undergoing cardiac surgery who require sternal closure with stainless steel wire."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15480006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 96,
                    "offsetInEndSection": 267,
                    "text": "The standard method of closure uses stainless steel wiring of the sternal halves; however, in complicated sternal closures, sternal cut-through and wire failure can occur."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3881094",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 345,
                    "text": "This article presents a simple, easy-to-perform method of sternal closure utilizing reinforcement of the sternal halves with a material that is less likely to cut through the sternum and that is readily available."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23992719",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Twisted wire stent technique for delayed sternal closure after congenital heart operations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15480006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 826,
                    "offsetInEndSection": 1025,
                    "text": "The use of plate and wire fixation represents an alternate method to conventional techniques to achieve sternal closure, stability, and uncomplicated wound healing in these difficult-to-manage cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2980021",
                    "endSection": "abstract",
                    "offsetInBeginSection": 273,
                    "offsetInEndSection": 408,
                    "text": "These wires occasionally break or pull through bone, resulting in instability of either a portion of the sternum or the entire sternum."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16464717",
                "http://www.ncbi.nlm.nih.gov/pubmed/26774474",
                "http://www.ncbi.nlm.nih.gov/pubmed/22334133",
                "http://www.ncbi.nlm.nih.gov/pubmed/26934309",
                "http://www.ncbi.nlm.nih.gov/pubmed/27662867",
                "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                "http://www.ncbi.nlm.nih.gov/pubmed/28533025",
                "http://www.ncbi.nlm.nih.gov/pubmed/25561718",
                "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                "http://www.ncbi.nlm.nih.gov/pubmed/27068475"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 322,
                    "text": "Here, by using genome-wide binding profiling, we show extensive occupancy of transcription factors of myogenesis (MyoD and Myogenin) at extragenic enhancer regions coinciding with RNA synthesis (i.e., eRNA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 210,
                    "offsetInEndSection": 300,
                    "text": "However, it remains unclear how tightly coupled eRNA production is with enhancer activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 509,
                    "text": "In particular, multiple regions were transcribed to eRNA within the regulatory region of MYOD1, including previously characterized distal regulatory regions (DRR) and core enhancer (CE)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28533025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 329,
                    "offsetInEndSection": 415,
                    "text": "Additionally, eRNA has also served as a marker for global identification of enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28533025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 328,
                    "text": "The correlation between eRNA production and enhancer activity has stimulated studies on the potential role of eRNAs in transcriptional regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 943,
                    "text": "We have uncovered a P-TEFb activation mechanism and reveal altered eRNA expression that is related to abnormal AR function and may potentially be a therapeutic target in CRPC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 342,
                    "offsetInEndSection": 517,
                    "text": "PSA eRNA binds to CYCLIN T1, activates P-TEFb, and promotes cis and trans target gene transcription by increasing serine-2 phosphorylation of RNA polymerase II (Pol II-Ser2p)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26774474",
                    "endSection": "abstract",
                    "offsetInBeginSection": 934,
                    "offsetInEndSection": 1074,
                    "text": "Collectively, these findings illustrate the complex epigenetic circuitry imposed by PGC-1\u03b1 at the eRNA level to fine-tune energy metabolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27662867",
                    "endSection": "abstract",
                    "offsetInBeginSection": 508,
                    "offsetInEndSection": 743,
                    "text": "The procedure can be multiplexed to simultaneously visualize both eRNA and protein-coding transcript at the site of transcriptional elongation, thereby permitting analysis of dynamics between the two transcript species in single cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 518,
                    "offsetInEndSection": 615,
                    "text": "We define an HIV-1 TAR RNA-like (TAR-L) motif in PSA eRNA that is required for CYCLIN T1 binding."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                "http://www.ncbi.nlm.nih.gov/pubmed/28715909",
                "http://www.ncbi.nlm.nih.gov/pubmed/22326347",
                "http://www.ncbi.nlm.nih.gov/pubmed/11248028",
                "http://www.ncbi.nlm.nih.gov/pubmed/8358435",
                "http://www.ncbi.nlm.nih.gov/pubmed/22909319",
                "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                "http://www.ncbi.nlm.nih.gov/pubmed/23591814"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 716,
                    "text": "Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 766,
                    "text": "Rrn3 is the first RNA polymerase I-specific transcription factor shown to be functionally conserved between yeast and mammals, suggesting that at least one mechanism that regulates ribosomal RNA synthesis is conserved among eukaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22326347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 908,
                    "offsetInEndSection": 1186,
                    "text": "Our results showed accumulations of peptidyl-tRNA associated with ribosomes in mutants for release factors (RF1, RF2, and RF3), ribosome recycling factor (RRF), Pth, and transfer-messenger RNA (tmRNA), implying that each of these factors cooperate in rescuing stalled ribosomes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "RNA polymerase I transcription factor Rrn3 is functionally conserved between yeast and human."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 530,
                    "text": "Point mutation of an amino acid that is conserved between the yeast and human proteins compromises the function of each factor, confirming that the observed sequence similarity is functionally significant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10758157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "We have cloned a human cDNA that is related to the RNA polymerase I transcription factor Rrn3 of Saccharomyces cerevisiae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22909319",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "During the initiation stage of eukaryotic mRNA translation, the eIF4G (eukaryotic initiation factor 4G) proteins act as an aggregation point for recruiting the small ribosomal subunit to an mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23591814",
                    "endSection": "abstract",
                    "offsetInBeginSection": 285,
                    "offsetInEndSection": 373,
                    "text": "PIP2 makes a complex with Pol I and the Pol I transcription factor UBF in the nucleolus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22909319",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1274,
                    "offsetInEndSection": 1429,
                    "text": "As the novel eIF4GII sequence diverges from eIF4GI, these data suggest that the eIF4GII N-terminus plays an alternative role in initiation factor assembly."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 13,
                    "text": "RNA function."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19446725",
                "http://www.ncbi.nlm.nih.gov/pubmed/24639348",
                "http://www.ncbi.nlm.nih.gov/pubmed/21749416",
                "http://www.ncbi.nlm.nih.gov/pubmed/23136963",
                "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                "http://www.ncbi.nlm.nih.gov/pubmed/18723831",
                "http://www.ncbi.nlm.nih.gov/pubmed/18707017",
                "http://www.ncbi.nlm.nih.gov/pubmed/15899984",
                "http://www.ncbi.nlm.nih.gov/pubmed/23009808",
                "http://www.ncbi.nlm.nih.gov/pubmed/15075362"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24639348",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Chemokines comprise a family of secreted proteins that activate G protein-coupled chemokine receptors and thereby control the migration of leukocytes during inflammation or immune surveillance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 158,
                    "offsetInEndSection": 255,
                    "text": "CXCL8 (interleukin-8) is a member of the chemokine family that acts on CXCR1 and CXCR2 receptors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 380,
                    "text": "CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7 are also ELR+ chemokine members that bind to these receptors, especially CXCR2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23136963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 101,
                    "offsetInEndSection": 247,
                    "text": "Chemokine (C-X-C motif) ligand 7 (CXCL7) has been found associated with pro-inflammatory responses, but its role in cancer growth remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19446725",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 212,
                    "text": "Poxviruses and herpesviruses encode a unique family of proteins that are secreted from infected cells and bind chemokines, in spite of their lack of amino acid sequence similarity to cellular chemokine receptors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24639348",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Chemokine cooperativity is caused by competitive glycosaminoglycan binding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15899984",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 440,
                    "text": "Platelet-derived chemokines, such as regulated on activation, normal T expressed and secreted (RANTES; CC chemokine ligand 5), platelet factor 4 [PF4; CXC chemokine ligand 4 (CXCL4)], and epithelial neutrophil-activating protein 78 (ENA-78; CXCL5), or precursors, such as beta-thromboglobulin, which can be processed to neutrophil-activating protein-2 (NAP-2; CXCL7), may play an important role in monocyte recruitment during atherogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15075362",
                    "endSection": "abstract",
                    "offsetInBeginSection": 646,
                    "offsetInEndSection": 980,
                    "text": "Other CC chemokines, such as CC chemokine ligand-2 monocyte chemotactic protein-1 (MCP-1/CCL2), MCP-2 (CCL8), and MCP-3 (CCL7) as well as the CXC chemokine receptor-4 (CXCR4) agonist stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12), also dose-dependently enhanced neutrophil chemotaxis toward a suboptimal concentration of IL-8."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24639348",
                    "endSection": "abstract",
                    "offsetInBeginSection": 401,
                    "offsetInEndSection": 603,
                    "text": "An often observed but incompletely understood behavior of chemokines is the ability of unrelated chemokines to enhance the potency with which another chemokine subtype can activate its cognate receptor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19446725",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 661,
                    "text": "Here we focus on methodologies that have been adapted to identify secreted chemokine binding proteins from viruses, to determine their binding specificity for chemokines and to characterize their interaction with the chemokine domains involved in the recognition of chemokine receptors or glycosaminoglycans."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                "http://www.ncbi.nlm.nih.gov/pubmed/12765697",
                "http://www.ncbi.nlm.nih.gov/pubmed/21135052",
                "http://www.ncbi.nlm.nih.gov/pubmed/8273075",
                "http://www.ncbi.nlm.nih.gov/pubmed/19372375",
                "http://www.ncbi.nlm.nih.gov/pubmed/28199210",
                "http://www.ncbi.nlm.nih.gov/pubmed/27618067",
                "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                "http://www.ncbi.nlm.nih.gov/pubmed/21140288"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1710,
                    "offsetInEndSection": 1803,
                    "text": "Targeting TRPM2 systemically represents a promising therapeutic approach for ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1032,
                    "text": "Genetic variants of the TRPM2 gene confer a risk of developing Western Pacific amyotropic lateral sclerosis and parkinsonism-dementia complex and bipolar disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 506,
                    "text": "The temporal relationship between the conversion of atrial flutter to junctional bradycardia and two episodes of thromboembolism strongly suggest a role of the lack of atrial contraction during junctional rhythm for the development of spontaneous echocardiographic contrast and thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27618067",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 40,
                    "text": "Targeting TRPM2 in ROS-Coupled Diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 351,
                    "text": "The G20210A mutation in the prothrombin gene is associated with an increased risk of a first venous thromboembolic episode; few data are available about the long-term risk for recurrent venous thromboembolism and it is not known whether or not carriers of the mutation should be recommended lifelong anticoagulant treatment after the first thrombosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1357,
                    "offsetInEndSection": 1483,
                    "text": "Notably, the pharmacological TRPM2 inhibitor, N-(p-amylcinnamoyl)anthranilic acid, was equally protective in the stroke model."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8273075",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 392,
                    "text": "There is an association between thromboembolism and hereditary deficiency of antithrombin III, protein C or protein S. In young patients, impaired fibrinolytic activity may represent the most common haemostatic abnormality associated with thrombosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25236871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1486,
                    "offsetInEndSection": 1709,
                    "text": "CONCLUSIONS\nAlthough a neuroprotective effect of TRPM2 in vitro is well known, we can show for the first time that the detrimental role of TRPM2 in stroke primarily depends on its role in activating peripheral immune cells."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27805221",
                "http://www.ncbi.nlm.nih.gov/pubmed/27392219",
                "http://www.ncbi.nlm.nih.gov/pubmed/27775637",
                "http://www.ncbi.nlm.nih.gov/pubmed/27119012",
                "http://www.ncbi.nlm.nih.gov/pubmed/29107512",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174309",
                "http://www.ncbi.nlm.nih.gov/pubmed/28125631",
                "http://www.ncbi.nlm.nih.gov/pubmed/28122329",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                "http://www.ncbi.nlm.nih.gov/pubmed/27278486"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Zika virus (ZIKV), a mosquito-transmitted flavivirus, responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, re-emerged in the last decade causing serious human diseases including microcephaly, congenital malformations, and Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27805221",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 234,
                    "text": "Zika virus (ZIKV) is an emergent arbovirus that has attracted attention in the last year as a possible causative agent of congenital malformation; it shows a remarkably increased microcephaly risk during otherwise healthy pregnancies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27775637",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Zika virus (ZIKV) is a flavivirus related to the Dengue, yellow fever and West Nile viruses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27805221",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Analysis of worldwide sequence mutations in Zika virus proteins E, NS1, NS3 and NS5 from a structural point of view."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28174309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Compared with other flaviviruses, Zika virus (ZIKV) is uniquely associated with congenital diseases in pregnant women."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29107512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "Zika virus (ZIKV) has evolved from an overlooked mosquito-borne flavivirus into a global health threat due to its astonishing causal link to microcephaly and other disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27119012",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "There is a suspected link between Brazilian babies born with microcephaly and Zika virus (ZIKV) infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2235,
                    "offsetInEndSection": 2416,
                    "text": "To elucidate the functional significance of glycosylation in ZIKV pathogenicity, recombinant ZIKVs from infectious clones with or without the glycan on the E protein were generated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Zika Virus Encoding Non-Glycosylated Envelope Protein is Attenuated and Defective in Neuroinvasion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 979,
                    "offsetInEndSection": 1127,
                    "text": "The recombinant ZIKV generated from the infectious clone, which contains the VNDT motif, is highly pathogenic and causes lethality in a mouse model."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9399878",
                "http://www.ncbi.nlm.nih.gov/pubmed/9847188",
                "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                "http://www.ncbi.nlm.nih.gov/pubmed/12527516",
                "http://www.ncbi.nlm.nih.gov/pubmed/29354985",
                "http://www.ncbi.nlm.nih.gov/pubmed/15153678",
                "http://www.ncbi.nlm.nih.gov/pubmed/9847138",
                "http://www.ncbi.nlm.nih.gov/pubmed/18312723",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                "http://www.ncbi.nlm.nih.gov/pubmed/11125060"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 205,
                    "text": "EXProt is a non-redundant protein database containing a selection of entries from genome annotation projects and public databases, aimed at including only proteins with an experimentally verified function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 942,
                    "offsetInEndSection": 1189,
                    "text": "CONCLUSION\nIt has been possible to establish a fetal medicine database, which monitors first-trimester screening for chromosomal abnormalities and second-trimester screening for major fetal malformations with the input from already collected data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9847138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1021,
                    "offsetInEndSection": 1276,
                    "text": "MIPS provides access through its WWW server (http://www.mips.biochem.mpg.de) to a spectrum of generic databases, including the above mentioned as well as a database of protein families (PROTFAM), the MITOP database, and the all-against-all FASTA database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9399878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The PROMISE (Prosthetic centres andmetalions in protein activesites) database aims to gather together comprehensive sequence, structural, functional and bibliographic information on proteins which possess prosthetic centres, with an emphasis on active site structure and function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12527516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 476,
                    "text": "A method for online searching through the database is elaborated in this paper by introducing the construction of the medical parasites database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11752251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 206,
                    "offsetInEndSection": 560,
                    "text": "In EXProt release 2.0 we have collected entries from the Pseudomonas aeruginosa community annotation project (PseudoCAP), the Escherichia coli genome and proteome database (GenProtEC) and the translated coding sequences from the Prokaryotes division of EMBL nucleotide sequence database, which are described as having an experimentally verified function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18312723",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 223,
                    "text": "A luminescence database for minerals and materials has been complied from the literature, the aim being to create a resource that will aid in the analysis of luminescence spectral of ionic species in minerals and materials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9847138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 1020,
                    "text": "This report describes the systematic and up-to-date analysis of genomes (PEDANT), a comprehensive database of the yeast genome (MYGD), a database reflecting the progress in sequencing the Arabidopsis thaliana genome (MATD), the database of assembled, annotated human EST clusters (MEST), and the collection of protein sequence data within the framework of the PIR-International Protein Sequence Database (described elsewhere in this volume)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15153678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 715,
                    "offsetInEndSection": 921,
                    "text": "The number of polymorphic microsatellite loci incorporated in our database is over 1,000 in all strains, and the URL site for our database is located at http:// www.shigen.nig.ac.jp /mouse/mmdbj/mouse.html."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9399878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 281,
                    "offsetInEndSection": 366,
                    "text": "The database is available on the World Wide Web at http://bioinf.leeds.ac.uk/promise/"
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                "http://www.ncbi.nlm.nih.gov/pubmed/16390119",
                "http://www.ncbi.nlm.nih.gov/pubmed/8070411",
                "http://www.ncbi.nlm.nih.gov/pubmed/8687178",
                "http://www.ncbi.nlm.nih.gov/pubmed/15987735",
                "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                "http://www.ncbi.nlm.nih.gov/pubmed/16492704",
                "http://www.ncbi.nlm.nih.gov/pubmed/25753366",
                "http://www.ncbi.nlm.nih.gov/pubmed/15771482"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16390119",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 323,
                    "text": "This methodology provides a direct way to use allylic sp3 C-H bonds for forming C-C bonds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24816567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "A novel metal-free synthesis of quinazolinones via dual amination of sp(3) C-H bonds was developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8070411",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1101,
                    "offsetInEndSection": 1233,
                    "text": "It appears that neither the glutamine-rich domains A and B nor the D domain of Sp1 can be replaced by the homologous regions of Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 479,
                    "offsetInEndSection": 596,
                    "text": "Moreover, PIAS1 strongly stimulated SUMO conjugation to Sp3, thus acting as an E3 ligase for SUMO conjugation to Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 65,
                    "offsetInEndSection": 142,
                    "text": "Here we show that Sp3 is a target for SUMO modification in vivo and in vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 372,
                    "text": "Mutational analyses identified the sequence IKXE as essential for SUMO conjugation to Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25412371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "A copper-catalyzed method for the oxidation of allylic and benzylic sp(3) C-H by aqueous tert-butyl hydroperoxide (T-Hydro) in water using a recyclable fluorous ligand has been developed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "Transcription factor Sp3 is silenced through SUMO modification by PIAS1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 64,
                    "text": "Sp3 is a ubiquitous transcription factor closely related to Sp1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15771482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 189,
                    "offsetInEndSection": 335,
                    "text": "The CDC reaction provides a simple and efficient catalytic method to construct beta-nitroamine via the reaction between sp3 C-H and sp3 C-H bonds."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/614471",
                "http://www.ncbi.nlm.nih.gov/pubmed/21994798",
                "http://www.ncbi.nlm.nih.gov/pubmed/12479802",
                "http://www.ncbi.nlm.nih.gov/pubmed/19029936",
                "http://www.ncbi.nlm.nih.gov/pubmed/18785844",
                "http://www.ncbi.nlm.nih.gov/pubmed/25528554",
                "http://www.ncbi.nlm.nih.gov/pubmed/17643367",
                "http://www.ncbi.nlm.nih.gov/pubmed/28292442",
                "http://www.ncbi.nlm.nih.gov/pubmed/20720162",
                "http://www.ncbi.nlm.nih.gov/pubmed/21146412"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/614471",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Minority conflict: the hijacking of a train by South Molukken youngster in the Netherlands."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/614471",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 262,
                    "text": "The hijacking of a train by South Molukken youngsters in the Netherlands is analyzed in terms of the generation gap existing between the post-figurative South Molukken elders and their children who were unsuccessful in their attempts at co-figuration in Holland."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12479802",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 296,
                    "text": "A recent publication in the November 15 issue of Cell shows that the bacterium may accomplish such a feat by hijacking the proteasome machinery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12479802",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 35,
                    "text": "Hijacking the host cell proteasome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21994798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 604,
                    "offsetInEndSection": 723,
                    "text": "In addition, we also present models describing potential mechanisms that coronaviruses could employ for this hijacking."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029936",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "The epithelial polarity program: machineries involved and their hijacking by cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21994798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Pathogens of bacterial and viral origin hijack pathways operating in eukaryotic cells in many ways in order to gain access into the host, to establish themselves and to eventually produce their progeny."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18785844",
                    "endSection": "abstract",
                    "offsetInBeginSection": 251,
                    "offsetInEndSection": 474,
                    "text": "In recent years, it has become evident that protozoan pathogens, including members of the phylum Apicomplexa, also hijack their host cell's functions to access nutrients and to escape cellular defenses and immune responses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18785844",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Hijacking of host cellular functions by the Apicomplexa."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17643367",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Hijacking the DNA damage response to enhance viral replication: gamma-herpesvirus 68 orf36 phosphorylates histone H2AX."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/63655",
                "http://www.ncbi.nlm.nih.gov/pubmed/21169831",
                "http://www.ncbi.nlm.nih.gov/pubmed/25969679",
                "http://www.ncbi.nlm.nih.gov/pubmed/456032",
                "http://www.ncbi.nlm.nih.gov/pubmed/25942668",
                "http://www.ncbi.nlm.nih.gov/pubmed/10413953",
                "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                "http://www.ncbi.nlm.nih.gov/pubmed/11717558",
                "http://www.ncbi.nlm.nih.gov/pubmed/531713",
                "http://www.ncbi.nlm.nih.gov/pubmed/27648387"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/63655",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Familial distribution of chronic tinea imbricata in an untreated Melanesian population was consistent with a genetic predisposition to this disease."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25969679",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Cheek and periorbital peculiar discoid lupus erythematosus: rare clinical presentation mimicking tinea faciei, cutaneous granulomatous disease or blepharitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 262,
                    "text": "Iatrogenic disease (tinea incognito) is a new and more subtle form."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 691,
                    "offsetInEndSection": 893,
                    "text": "We also present a clinical description of the disease, the differential diagnosis and how currently some other emerging diseases such as syphilis in immunocompromised patients can mimic tinea imbricata."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/63655",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 513,
                    "text": "In married couples there was no concordance of the disease above that expected by chance and the observed segregation of tinea imbricata accorded well with that predicted by the genetic hypothesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/531713",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "Tinea capitis formed 20% of all superficial mycotic infections, which in turn represented 12% of all skin disease diagnosed at the skin outpatient department of Al-Jamaheria hospital in Benghazi."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25969679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 100,
                    "offsetInEndSection": 269,
                    "text": "Although DLE is a chronic autoimmune dermatosis, it has a variety of rare clinical presentations, including periorbital DLE, comedonic DLE and hypertrophic DLE recently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 350,
                    "offsetInEndSection": 690,
                    "text": "RECENT FINDINGS\nThis review covers the most interesting aspects of the infrequent disease tinea imbricata, including the historical background, the epidemiologic aspects, highlighting the genetic and racial patterns of susceptibility to the acquisition of the disease, and the immunologic aspects that help to explain its clinical behavior."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10413953",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Tinea pedis in the most common type of dermatophytosis, but can mimic many cutaneous diseases and tend to be chronic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 194,
                    "text": "More recently, the disease has occurred in the immunocompromised patient."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1483697",
                "http://www.ncbi.nlm.nih.gov/pubmed/9760201",
                "http://www.ncbi.nlm.nih.gov/pubmed/17436248",
                "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                "http://www.ncbi.nlm.nih.gov/pubmed/18493052",
                "http://www.ncbi.nlm.nih.gov/pubmed/12802286",
                "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                "http://www.ncbi.nlm.nih.gov/pubmed/8307326",
                "http://www.ncbi.nlm.nih.gov/pubmed/20236111"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1483697",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Mapping of X chromosome translocation breakpoints in females with Duchenne muscular dystrophy with respect to exons of the dystrophin gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17436248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 706,
                    "offsetInEndSection": 957,
                    "text": "In one proband, the deletion breakpoints are associated with DNA fragments containing noncontiguous sequences of chromosome 10, whereas, in the other two families, the breakpoints are within paralogous LCRs, removing approximately 7.2 Mb and 32 genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1765,
                    "text": "A number of recombination-associated motifs were found to be over-represented at translocation breakpoints (including DNA polymerase pause sites/frameshift hotspots, immunoglobulin heavy chain class switch sites, heptamer/nonamer V(D)J recombination signal sequences, translin binding sites, and the chi element) but, with the exception of the translin-binding site and immunoglobulin heavy chain class switch sites, none of these motifs were over-represented at deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9760201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1111,
                    "text": "No deletion or duplication of chromosomal material was found near the breakpoints in patient 3 [46,XX,t(2;6)(q33.1;p12.2)]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 327,
                    "offsetInEndSection": 772,
                    "text": "Using the Gross Rearrangement Breakpoint Database [GRaBD; www.uwcm.ac.uk/uwcm/mg/grabd/grabd.html] (containing 397 germ-line and somatic DNA breakpoint junction sequences derived from 219 different rearrangements underlying human inherited disease and cancer), we have analyzed the sequence context of translocation and deletion breakpoints in a search for general characteristics that might have rendered these sequences prone to rearrangement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1483697",
                    "endSection": "abstract",
                    "offsetInBeginSection": 512,
                    "offsetInEndSection": 693,
                    "text": "The distribution of these and of a further seven translocation breakpoints whose positions are known is compared with that reported for deletions and duplications in affected males."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9760201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 793,
                    "offsetInEndSection": 987,
                    "text": "Molecular characterization of the proximal inversion 7q22.1 breakpoint in patient 2 [46,XY,inv(7)(q22.1q32.1)] revealed the presence of a 4-Mb cryptic deletion between D7S651 and D7S515 markers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1766,
                    "offsetInEndSection": 1918,
                    "text": "Alu sequences were found to span both breakpoints in seven cases of gross deletion that may thus be inferred to have arisen by homologous recombination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                    "endSection": "abstract",
                    "offsetInBeginSection": 930,
                    "offsetInEndSection": 1126,
                    "text": "In addition, the distal breakpoints of two viable albino deletions, which remove part of the tyrosinase gene and extend distally, were localized in the vicinity of the lethal deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12938088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 964,
                    "offsetInEndSection": 1072,
                    "text": "Deletion breakpoints were found to be AT-rich whereas by comparison, translocation breakpoints were GC-rich."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25144332",
                "http://www.ncbi.nlm.nih.gov/pubmed/27780979",
                "http://www.ncbi.nlm.nih.gov/pubmed/24507715",
                "http://www.ncbi.nlm.nih.gov/pubmed/28825722",
                "http://www.ncbi.nlm.nih.gov/pubmed/24974018",
                "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                "http://www.ncbi.nlm.nih.gov/pubmed/27912097",
                "http://www.ncbi.nlm.nih.gov/pubmed/28652379",
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/26342908"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28652379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 193,
                    "offsetInEndSection": 340,
                    "text": "This long non-coding RNA (lncRNA) localizes to nuclear speckles, where it interacts with a subset of splicing factors and modulates their activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27912097",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24507715",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 460,
                    "text": "Here we show that nuclear enriched abundant transcript 1 (NEAT1), an essential lncRNA for the formation of nuclear body paraspeckles, is induced by influenza virus and herpes simplex virus infection as well as by Toll-like receptor3-p38 pathway-triggered poly I:C stimulation, resulting in excess formation of paraspeckles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25144332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 662,
                    "offsetInEndSection": 936,
                    "text": "Recently Arabidopsis RRP6L1, a plant paralog of the conserved nuclear RNA surveillance protein Rrp6, was shown to mediate RdDM through retention of lncRNAs in the chromatin, thereby revealing that accumulation of functional lncRNAs requires more than simply RNA polymerases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24507715",
                    "endSection": "abstract",
                    "offsetInBeginSection": 576,
                    "offsetInEndSection": 839,
                    "text": "We found that splicing factor proline/glutamine-rich (SFPQ), a NEAT1-binding paraspeckle protein, is a repressor of IL8 transcription, and that NEAT1 induction relocates SFPQ from the IL8 promoter to the paraspeckles, leading to transcriptional activation of IL8."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                    "endSection": "abstract",
                    "offsetInBeginSection": 280,
                    "offsetInEndSection": 463,
                    "text": "Here, we describe one lncRNA, Firre, that interacts with the nuclear-matrix factor hnRNPU through a 156-bp repeating sequence and localizes across an ~5-Mb domain on the X chromosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27912097",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1116,
                    "text": "In summary, we describe a p53-regulated, pluripotency-specific lncRNA that safeguards the hESC state by disrupting SIRT6 activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25144332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 296,
                    "text": "In the RdDM pathway, recruitment of the DNA methylation complex is mediated through complementary pairing between scaffold RNAs and Argonaute-associated siRNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                    "endSection": "abstract",
                    "offsetInBeginSection": 775,
                    "offsetInEndSection": 909,
                    "text": "Thus, our data suggest a model in which lncRNAs such as Firre can interface with and modulate nuclear architecture across chromosomes."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                "http://www.ncbi.nlm.nih.gov/pubmed/29296732",
                "http://www.ncbi.nlm.nih.gov/pubmed/22055187",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294014",
                "http://www.ncbi.nlm.nih.gov/pubmed/28846090",
                "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                "http://www.ncbi.nlm.nih.gov/pubmed/26846207",
                "http://www.ncbi.nlm.nih.gov/pubmed/28789639",
                "http://www.ncbi.nlm.nih.gov/pubmed/26656845"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 666,
                    "text": "The method is a fast and sensitive alternative to DNase-seq for assaying chromatin accessibility genome-wide, or to MNase-seq for assaying nucleosome positions in accessible regions of the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Assay for Transposase Accessible Chromatin (ATAC-seq) is an open chromatin profiling assay that is adapted to interrogate chromatin accessibility from small cell numbers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1347,
                    "text": "I-ATAC integrates command-line data processing tools (FASTQC, Trimmomatic, BWA, Picard, ATAC_BAM_shiftrt_gappedAlign.pl, Bedtools and Macs2) into an easy-to-use platform with user interface to automatically pre-process ATAC-seq samples with parallelized and customizable pipelines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1348,
                    "offsetInEndSection": 1565,
                    "text": "Its performance has been tested using public ATAC-seq datasets in GM12878 and CD4+T cells and a feature-based comparison is performed with some available interactive LIMS (Galaxy, SMITH, SeqBench, Wasp, NG6, openBIS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 1052,
                    "text": "Despite a modest sample size, we identified 2,707 independent caQTLs (at a false discovery rate of 10%) and demonstrated how RASQUAL and ATAC-seq can provide powerful information for fine-mapping gene-regulatory variants and for linking distal regulatory elements with gene promoters."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) is a useful method to map genome-wide chromatin accessibility and nucleosome positioning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 307,
                    "text": "This method probes DNA accessibility with hyperactive Tn5 transposase, which inserts sequencing adapters into accessible regions of chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "This unit describes Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq), a method for mapping chromatin accessibility genome-wide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 767,
                    "text": "We illustrate how RASQUAL can be used to maximize association detection by generating the first map of chromatin accessibility QTLs (caQTLs) in a European population using ATAC-seq."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 721,
                    "offsetInEndSection": 867,
                    "text": "Specifically, we are still missing easy-to-use software tools that will enable non-computational scientists to analyze their own ATAC-seq samples."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                "http://www.ncbi.nlm.nih.gov/pubmed/21473016",
                "http://www.ncbi.nlm.nih.gov/pubmed/25524096",
                "http://www.ncbi.nlm.nih.gov/pubmed/24632195",
                "http://www.ncbi.nlm.nih.gov/pubmed/21625552",
                "http://www.ncbi.nlm.nih.gov/pubmed/25799440",
                "http://www.ncbi.nlm.nih.gov/pubmed/22221045",
                "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                "http://www.ncbi.nlm.nih.gov/pubmed/8138784",
                "http://www.ncbi.nlm.nih.gov/pubmed/22222791"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 141,
                    "offsetInEndSection": 368,
                    "text": "However, the highly identical TALE repeat sequences make it challenging to assemble TALEs using conventional cloning approaches, and multiple repeats in one plasmid are easily catalyzed for homologous recombination in bacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 930,
                    "offsetInEndSection": 1164,
                    "text": "This system makes TALEN assembly much simpler than the conventional cloning of two DNA fragments because this strategy combines digestion and ligation into one step using circular vectors and different modules to avoid gel extraction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21625552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 815,
                    "offsetInEndSection": 968,
                    "text": "Assembly is performed in two successive one-pot cloning steps using the Golden Gate cloning method that allows seamless fusion of multiple DNA fragments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22222791",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 311,
                    "text": "The DNA-binding domain of each TALE consists of tandem 34-amino acid repeat modules that can be rearranged according to a simple cipher to target new DNA sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24632195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 324,
                    "text": "TALEs, CRISPR/Cas, and sRNAs can be easily fashioned to bind any specific sequence of DNA (TALEs, CRISPR/Cas) or RNA (sRNAs) because of the simple rules governing their interactions with nucleic acids."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27604899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Transcription activator-like effector nucleases (TALENs) are powerful tools for targeted genome editing in diverse cell types and organisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 412,
                    "offsetInEndSection": 577,
                    "text": "This method takes advantage of uracil-specific excision reagent (USER), an enzyme that can cleave DNA constructs and create long, unique single-strand DNA overhangs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21473016",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "An optimized transcription activator\u2013like effector (TALE) and an improved assembly method promise efficient genome editing and transcriptome modulation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25524096",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "A multiplexed transcription activator-like effector system for detecting specific DNA sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25524096",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 738,
                    "text": "Here, we demonstrate a system in which a TALE protein bound to a nitrocellulose strip has been utilized to capture purified DNA, which is then detected using the binding of a second distinct TALE protein conjugated to a protein tag that is then detected by a dot blot."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7378695",
                "http://www.ncbi.nlm.nih.gov/pubmed/2834426",
                "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                "http://www.ncbi.nlm.nih.gov/pubmed/22240774",
                "http://www.ncbi.nlm.nih.gov/pubmed/8209869",
                "http://www.ncbi.nlm.nih.gov/pubmed/10861657",
                "http://www.ncbi.nlm.nih.gov/pubmed/11705325",
                "http://www.ncbi.nlm.nih.gov/pubmed/16914397",
                "http://www.ncbi.nlm.nih.gov/pubmed/6290548",
                "http://www.ncbi.nlm.nih.gov/pubmed/434730"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2834426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Vulvar Paget's disease, in contrast to its mammary counterpart, has been found to be associated with an underlying apocrine sweat gland carcinoma in about only 1/4 of the cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7378695",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 333,
                    "text": "The frequency and extent of lumbar spondylosis is no greater in patients with Paget's disease (osteitis deformans) affecting the lumbar spine than in control groups, whether or not the disease is accompanied by deformity of vertebrae, and we have found no evidence that Paget's disease predisposes to our enhances lumbar spondylosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Paget's disease of the breast is a disorder of the nipple-areola complex that, while rare, is often associated with an underlying carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22240774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 355,
                    "text": "A high index of suspicion is necessary to diagnose Paget disease in a patient with Darier disease, for a potentially fatal disease could easily be missed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 539,
                    "text": "It is supported by the predominance of breast cancer markers found in Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16914397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Paget's disease is a common skeletal disorder in the elderly; however, monostotic Paget's disease of the patella is very rare and only a few cases have been reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7378695",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 534,
                    "text": "The similarity of distribution of the Paget's disease and of degenerative spondylosis raises the possibility that bone stress may be an aetiological factor in the formation of Paget's disease of bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10861657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Paget disease of the bone is a common skeletal disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 540,
                    "offsetInEndSection": 708,
                    "text": "This article provides an overview of Paget's disease of the breast with special attention to immunohistochemistry and raises the question of new therapeutic approaches."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10861657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 396,
                    "text": "We report the identification and clinical characterization of a large pedigree of Paget disease and demonstrate that the Paget disease gene in this pedigree is not linked to the region on 18q, thus confirming linkage heterogeneity."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3015011",
                "http://www.ncbi.nlm.nih.gov/pubmed/6969580",
                "http://www.ncbi.nlm.nih.gov/pubmed/12760895",
                "http://www.ncbi.nlm.nih.gov/pubmed/9925535",
                "http://www.ncbi.nlm.nih.gov/pubmed/6752115",
                "http://www.ncbi.nlm.nih.gov/pubmed/3489648",
                "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                "http://www.ncbi.nlm.nih.gov/pubmed/3878359",
                "http://www.ncbi.nlm.nih.gov/pubmed/6454378",
                "http://www.ncbi.nlm.nih.gov/pubmed/8494361"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 37,
                    "offsetInEndSection": 167,
                    "text": "8158), M. fortuitum and M. phlei (MPI) produce a constitutive beta-lactamase that has penicillinase and cephalosporinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9925535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "The sequences of the promoter regions and of the structural genes for 13 penicillinase, extended-spectrum, and inhibitor-resistant TEM-type beta-lactamases have been determined, and an updated blaTEM gene nomenclature is proposed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Pseudomonas cepacia 249 produces an inducible beta-lactamase with penicillinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12760895",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 356,
                    "text": "MIC measurements and steady-state kinetic analyses indicate that Bla1 possesses penicillinase activity while Bla2 possesses penicillinase, cephalosporinase, and carbapenem-hydrolyzing activities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3489648",
                    "endSection": "abstract",
                    "offsetInBeginSection": 597,
                    "offsetInEndSection": 941,
                    "text": "AmoR TicR CtnR strains (18%) often produced two beta-lactamases (penicillinase and cephalosporinase) and they were resistant to Amo/CA; in this group, susceptibility to Tic/CA depends on the nature and the amount of the beta-lactamase produced, except for Serratia marcescens for which antibiotic resistance is probably due to other mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 36,
                    "text": "Mycobacterium smegmatis (N.C.T.C."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6969580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 229,
                    "text": "N-Formimidoyl thienamycin (MK0787) was active against beta-lactamase-producing strains and was an effective inhibitor of beta-lactamases extracted and purified from these strains except for plasmid-mediated penicillinase type IV."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3015011",
                    "endSection": "abstract",
                    "offsetInBeginSection": 341,
                    "offsetInEndSection": 567,
                    "text": "With ampicillin, YTR 830 showed the best synergistic activity of the inhibitors against Proteus morganii, Citrobacter freundii, and Enterobacter cloacae and their mutants with a derepressed chromosome-encoded cephalosporinase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16742589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 168,
                    "offsetInEndSection": 170,
                    "text": "2."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11260879",
                "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                "http://www.ncbi.nlm.nih.gov/pubmed/3622005",
                "http://www.ncbi.nlm.nih.gov/pubmed/28803354",
                "http://www.ncbi.nlm.nih.gov/pubmed/7229325",
                "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                "http://www.ncbi.nlm.nih.gov/pubmed/15893082",
                "http://www.ncbi.nlm.nih.gov/pubmed/23778599",
                "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                "http://www.ncbi.nlm.nih.gov/pubmed/8778662"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 499,
                    "offsetInEndSection": 699,
                    "text": "The adults of Haemaphysalis elliptica, the most abundant tick species infesting cats and wild felids, were most numerous on a domestic cat in late winter and in mid-summer, during 2 consecutive years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 287,
                    "text": "Ticks collected from domestic cats (Felis catus), cheetahs (Acinonyx jubatus),caracals (Caracal caracal), African wild cats (Felis lybica), black-footed cats (Felis nigripes), a serval (Leptailurus serval), lions(Panthera leo), and leopards (Panthera pardus) were identified and counted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 515,
                    "text": "Rabies has been confirmed in this region among the above species as well as in a domestic cat (Felis catus) and a cow (Bos indicus) by fluorescent antibody tests (FAT) and/or histopathology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28803354",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 314,
                    "text": "We describe five cases of myiasis of domestic cats, Felis silvestris catus L. (Carnivora: Felidae), reported in 2016 in northern Italy and caused by three Diptera species: Sarcophaga argyrostoma (Robineau-Desvoidy) (Sarcophagidae), Calliphora vicina Robineau-Desvoidy and Lucilia sericata (Meigen) (Calliphoridae)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 132,
                    "text": "from the small intestine of the domestic cat (Felis catus L.) in Malaysia is described and illustrated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 426,
                    "offsetInEndSection": 498,
                    "text": "The domestic cats and wild felids harboured 11 ixodid species in common."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11260879",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "[Bartonella henselae infection in domestic cat and dog fleas]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 425,
                    "text": "Thirteen species of ixodid ticks and one argasid tick were identified from domestic cats and 17 species of ixodid ticks from wild felids."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11260879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "We studied on the infection of domestic cat and dog fleas with Bartonella henselae by polymerase chain reaction (PCR)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11426732",
                    "endSection": "title",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 105,
                    "text": "(Nematoda: Ascaridoidea) from the domestic cat (Felis catus Linnaeus, 1758)."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                "http://www.ncbi.nlm.nih.gov/pubmed/10037138",
                "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                "http://www.ncbi.nlm.nih.gov/pubmed/28533409",
                "http://www.ncbi.nlm.nih.gov/pubmed/21916612",
                "http://www.ncbi.nlm.nih.gov/pubmed/25183525",
                "http://www.ncbi.nlm.nih.gov/pubmed/18662993",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/28938092",
                "http://www.ncbi.nlm.nih.gov/pubmed/23933634"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21916612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 291,
                    "text": "The CCCTC-binding factor (CTCF), which binds insulator elements in vertebrates, also facilitates coordinated gene expression at several gene clusters, including the \u03b2-globin, Igf2/H19 (insulin like growth factor 2/H19 noncoding RNA), and major histocompatibility complex (MHC) class II loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23933634",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1176,
                    "offsetInEndSection": 1406,
                    "text": "This eviction is also correlated with the expression of an antisense non-coding RNA transcribing through the CTCF-binding region indicating that non-coding RNA transcription could be the cause and the consequence of CTCF eviction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 827,
                    "text": "In osteosarcoma tumors, aberrant methylation of the IGF2/H19 ICR results in equally aberrant CTCF binding, yet expression of these genes does not correlate with CTCF binding."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10037138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 744,
                    "text": "We concluded that CTCF expression and activity is controlled at transcriptional and post-transcriptional levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 652,
                    "text": "In the fetal brain, CTCF binding is monoallelic and specific for the unmethylated ICR, yet IGF2/H19 expression is biallelic."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18662993",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 925,
                    "offsetInEndSection": 1092,
                    "text": "Thus, tumour subsets exist that display concurrent decreased BRCA1 expression, BRCA1 promoter methylation, cytoplasmic CTCF expression and with DNMT3b over-expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1093,
                    "offsetInEndSection": 1361,
                    "text": "We suggest that these altered CTCF and DNMT3b expression patterns represent (a) critical events responsible for the epigenetic inactivation of BRCA1 and (b) a diagnostic signature for epigenetic inactivation of other tumour suppressor genes in sporadic breast tumours."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12960026",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                "http://www.ncbi.nlm.nih.gov/pubmed/16149095",
                "http://www.ncbi.nlm.nih.gov/pubmed/18435766",
                "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/26600626",
                "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                "http://www.ncbi.nlm.nih.gov/pubmed/20722494"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nRecently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Mutations in LRRK2 (leucine-rich repeat kinase 2) (also known as PARK8 or dardarin) are responsible for the autosomal-dominant form of PD (Parkinson's disease)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Mutations in the leucine-rich kinase 2 gene (LRRK 2) encoding dardarin, on chromosome 12, are a common cause of familial and sporadic Parkinson's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18435766",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 188,
                    "text": "BACKGROUND AND PURPOSE\nMutations in LRRK2, encoding leucine-rich repeat kinase 2 (or Dardarin), cause autosomal dominant Parkinson's disease (AdPD) and are also found in sporadic PD (sPD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Mutations in the leucine-rich repeat kinase 2 (LRRK 2), encoding dardarin protein, have been demonstrated to be linked to autosomal dominant Parkinson's disease (PD)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16149095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26600626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 239,
                    "text": "INTRODUCTION\nMutations in the leucine-rich repeat kinase 2 gene (LRRK2 or Dardarin) are considered to be a common cause of autosomal dominant and sporadic Parkinson\u00b4s disease, but the prevalence of these mutations varies among populations."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20722494",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 329,
                    "text": "BACKGROUND\nPathogenic mutations in leucine-rich repeat kinase 2 (LRRK2; PARK8) encoding dardarin, implicated in patients with autosomal dominant and sporadic Parkinson's disease (PD) among different ethnic groups (Ashkenazi Jews, North African Arabs, Basques) might be of some help in diagnostic screening and genetic counseling."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22200771",
                "http://www.ncbi.nlm.nih.gov/pubmed/17186470",
                "http://www.ncbi.nlm.nih.gov/pubmed/16159874",
                "http://www.ncbi.nlm.nih.gov/pubmed/28376382",
                "http://www.ncbi.nlm.nih.gov/pubmed/15384984",
                "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                "http://www.ncbi.nlm.nih.gov/pubmed/23257444",
                "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                "http://www.ncbi.nlm.nih.gov/pubmed/22689679",
                "http://www.ncbi.nlm.nih.gov/pubmed/20378560"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17186470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Diamond-Blackfan anemia (DBA) is a rare congenital red-cell aplasia characterized by anemia, bone-marrow erythroblastopenia, and congenital anomalies and is associated with heterozygous mutations in the ribosomal protein (RP) S19 gene (RPS19) in approximately 25% of probands."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22200771",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 343,
                    "text": "U2AF1 is frequently mutated in myeloid hematopoietic malignancies, especially in myelodysplastic syndrome (MDS), and SF3B1 is frequently mutated in both MDS and chronic lymphocytic leukemia (CLL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "Mutations in the ribosomal protein (RP)S19 gene have been found in about 25% of the cases of Diamond-Blackfan anemia (DBA), a rare congenital hypoplastic anemia that includes variable physical malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17186470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 456,
                    "text": "We report identification of de novo nonsense and splice-site mutations in another RP, RPS24 (encoded by RPS24 [10q22-q23]) in approximately 2% of RPS19 mutation-negative probands."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22689679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 592,
                    "text": "As a proof of concept, we designed a multiplex ligation-dependent probe amplification assay targeted to screen the six genes that are most frequently mutated in Diamond-Blackfan anemia patients: RPS17, RPS19, RPS26, RPL5, RPL11, and RPL35A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23257444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 950,
                    "offsetInEndSection": 1090,
                    "text": "The hypospadias can be observed in some patients with RPS19 mutation and some dactyl anomalies are associated with RPL11 and RPL5 mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20378560",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1240,
                    "text": "Remarkably, cleft palate was seen in two patients with RPL5 mutations, and thumb anomalies were seen in six patients with an RPS19 or RPL5 mutation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17186470",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15384984",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23257444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 345,
                    "text": "Twenty-one cases of DBA admitted in our hospital from Dec 2008 to Aug 2012 were screened by PCR for mutations in the nine known genes associated with DBA: RPS19, RPS24, RPS17, RPL5, RPL11, RPS7, RPL35a, RPS10 and RPS26."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21783031",
                "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                "http://www.ncbi.nlm.nih.gov/pubmed/25829014",
                "http://www.ncbi.nlm.nih.gov/pubmed/2556801",
                "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                "http://www.ncbi.nlm.nih.gov/pubmed/12909351",
                "http://www.ncbi.nlm.nih.gov/pubmed/731708",
                "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                "http://www.ncbi.nlm.nih.gov/pubmed/16884525"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Enhancers of RNA polymerase I transcription in higher eukaryotes are repetitive elements within the intergenic spacers of rRNA genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Ribosomal gene promoter domains can function as artificial enhancers of RNA polymerase I transcription, supporting a promoter origin for natural enhancers in Xenopus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 881,
                    "text": "These data demonstrate functional relatedness between the promoter and enhancers, supporting the hypothesis that enhancers could have evolved from duplicated promoter domains that bind essential transcription factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 848,
                    "offsetInEndSection": 1039,
                    "text": "We estimated the time necessary to evolve, from genomic background, enhancers capable of driving complex gene expression patterns similar to those involved in early development in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 338,
                    "text": "In Xenopus and mouse, enhancers and the gene promoter bind the activator protein, upstream binding factor, and in Xenopus, enhancers also share sequence similarity with an upstream domain of the promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 93,
                    "offsetInEndSection": 339,
                    "text": "Although many studies have elucidated how individual enhancers can evolve, most of this work has focused on what are called 'minimal' enhancers, the smallest DNA regions that drive expression that approximates an aspect of native gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1379,
                    "offsetInEndSection": 1531,
                    "text": "The in silico evolved enhancers had, with a few interesting exceptions, site compositions similar to those seen in real enhancers for the same patterns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 378,
                    "offsetInEndSection": 488,
                    "text": "Many examples show that enhancers can evolve beyond recognizable sequence similarity while retaining function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 643,
                    "offsetInEndSection": 892,
                    "text": "Cis-regulatory changes are also a major source of morphological evolution, which might be facilitated by many biochemically functional elements that are selectively neutral and by the buffering function of redundant enhancers and 'shadow' enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 847,
                    "text": "We report on our investigation of enhancer evolution through the use of PEBCRES, a framework for evolutionary simulation of enhancers that employs a mechanistic and well-supported sequence-to-expression model to assign fitness to the evolving enhancer genotype."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                "http://www.ncbi.nlm.nih.gov/pubmed/3624987",
                "http://www.ncbi.nlm.nih.gov/pubmed/3627450",
                "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                "http://www.ncbi.nlm.nih.gov/pubmed/3980939",
                "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                "http://www.ncbi.nlm.nih.gov/pubmed/3713736",
                "http://www.ncbi.nlm.nih.gov/pubmed/3983046"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "We report a case of carpal tunnel syndrome associated with median nerve motor branch compression by a large superficial palmar branch of the radial artery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3225421",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Carpal tunnel syndrome associated with extra tunnel vascular compression of the median nerve motor branch."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A case of the entrapment neuropathy of the palmar cutaneous branch of the median nerve, concomitant with carpal tunnel syndrome is presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 355,
                    "text": "This report demonstrates that the Semmes-Weinstein monofilament test and nerve conduction studies can identify entrapment of the palmar cutaneous branch of the median nerve concomitant with carpal tunnel syndrome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12475522",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Entrapment neuropathy of the palmar cutaneous branch of the median nerve concomitant with carpal tunnel syndrome: a case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3627450",
                    "endSection": "abstract",
                    "offsetInBeginSection": 490,
                    "offsetInEndSection": 691,
                    "text": "Recognition of lumbrical sparing supports the electrodiagnosis of carpal tunnel syndrome when the distal latency to thenar muscles or the palm-to-wrist mixed median nerve conduction velocity is normal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 186,
                    "text": "Nerve abscess as a cause of acute carpal tunnel syndrome is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3713736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 257,
                    "offsetInEndSection": 430,
                    "text": "This phenomenon is only seen with coexistent carpal tunnel syndrome and median to ulnar nerve communication and suggests carpal tunnel syndrome is present in these patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Two cases of acute carpal tunnel syndrome due to median nerve abscess as a consequence of Hansen's disease are reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3624987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Complications of peripheral nerve injury arising from the surgical treatment of carpal tunnel syndrome are not uncommon."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27296552",
                "http://www.ncbi.nlm.nih.gov/pubmed/22528876",
                "http://www.ncbi.nlm.nih.gov/pubmed/19683237",
                "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/28036074",
                "http://www.ncbi.nlm.nih.gov/pubmed/25337249",
                "http://www.ncbi.nlm.nih.gov/pubmed/17981747",
                "http://www.ncbi.nlm.nih.gov/pubmed/24650661",
                "http://www.ncbi.nlm.nih.gov/pubmed/21546528"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 264,
                    "text": "Remodeling of the extracellular matrix (ECM), which is induced by lysyl oxidase (LOX), has been demonstrated to accompany tumor progression; however, the association between LOX expression levels and the malignant behavior of prostate cancer (Pca) remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17981747",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Lysyl oxidase (LOX) plays a pivotal role in extracellular matrix (ECM) maturation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19683237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Lysyl oxidase (LOX) is an enzyme critical for the stability of extracellular matrix and also known to have diverse biological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22528876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 317,
                    "text": "Lysyl oxidase (LOX) family oxidases, LOX and LOXL1-4, oxidize lysine residues in collagens and elastin, resulting in the covalent crosslinking and stabilization of these extracellular matrix (ECM) structural components, thus provide collagen and elastic fibers much of their tensile strength and structural integrity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25337249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "Lysyl oxidase (LOX) has been reported to regulate tumor metastasis and has been found to involve in modification of extracellular matrix (ECM) in the context of tumorigenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24650661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 426,
                    "offsetInEndSection": 525,
                    "text": "Heat shock protein 47 (HSP47) and lysyl oxidase (LOX) are known to be essential for ECM maturation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27296552",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "LOX is a novel mitotic spindle-associated protein essential for mitosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1018,
                    "offsetInEndSection": 1109,
                    "text": "Therefore, LOX expression level in the ECM may function as an independent predictor of Pca."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27296552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 69,
                    "offsetInEndSection": 183,
                    "text": "It is overexpressed in aggressive cancers and higher expression of LOX is associated with higher cancer mortality."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                "http://www.ncbi.nlm.nih.gov/pubmed/18184124",
                "http://www.ncbi.nlm.nih.gov/pubmed/24124831",
                "http://www.ncbi.nlm.nih.gov/pubmed/28859824",
                "http://www.ncbi.nlm.nih.gov/pubmed/24260027",
                "http://www.ncbi.nlm.nih.gov/pubmed/8763916",
                "http://www.ncbi.nlm.nih.gov/pubmed/15717387",
                "http://www.ncbi.nlm.nih.gov/pubmed/28381912",
                "http://www.ncbi.nlm.nih.gov/pubmed/18628905"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 203,
                    "text": "[In the article \"Hepatosplenic Cat Scratch Disease in Immunocompetent Adults: Report of 3 Cases and Review of the Literature\", the author name Asunci\u00f3n L\u00f3pez, MD was left out of the list of author names."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28859824",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 248,
                    "text": "This article has been removed at the request of the authors due to errors in the author list."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Hepatosplenic cat scratch disease in immunocompetent adults: report of 3 cases and review of the literature."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 291,
                    "text": "Please check old files, boxes, bookshelves, and other archives for other missing conferences listed here."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18184124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 114,
                    "offsetInEndSection": 177,
                    "text": "Article Title: Drug Interactions in Inflammatory Bowel Disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Christoph Steininger and colleagues explore how multiple infectious, autoimmune, metabolic, and neoplastic diseases have been associated with changes in the intestinal microbiome, although a cause-effect relationship is often difficult to establish."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 434,
                    "text": "The keys to successful outcome include: 1) early evaluation and listing for transplantation before the patient develops severe complications of cirrhosis; 2) control of comorbid conditions; and 3) a cooperative and dynamic interchange between the transplant center and other physicians involved in the care of the patient."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15717387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 185,
                    "text": "The abstracts of four major AIDS conferences that were unavailable online or in libraries around the world have now been found after AIDS Treatment News asked people to look for copies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25803522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 204,
                    "offsetInEndSection": 252,
                    "text": "The correct list of author names is given below."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18628905",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 612,
                    "text": "(For more background detail on these projects, please see our Featured Organism: Arabidopsis thaliana piece, also in this issue of CFG, or visit the websites listed below)."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                "http://www.ncbi.nlm.nih.gov/pubmed/20440461",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                "http://www.ncbi.nlm.nih.gov/pubmed/24361078",
                "http://www.ncbi.nlm.nih.gov/pubmed/9462465",
                "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                "http://www.ncbi.nlm.nih.gov/pubmed/6270951"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 892,
                    "offsetInEndSection": 1128,
                    "text": "Based on these lines of evidence, it is concluded that the large portion of androsterone UDPGT gene is deleted in LA Wistar rats, which results in the absence of androsterone UDPGT mRNA and consequently the corresponding enzyme protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 891,
                    "text": "Genomic DNA amplifications with synthetic primers which have nucleotide sequences corresponding to the 5'-region of androsterone UDPGT cDNA, suggested that androsterone UDPGT gene has exon 1 with a length of some 700 bp and that this exon is deleted in LA Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 537,
                    "offsetInEndSection": 764,
                    "text": "Differences in restriction fragment length observed on Southern blotting of genomic DNA from LA Wistar rats indicate that this inherited deficiency is the result of a deletion in the androsterone UDP-glucuronyltransferase gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Large deletion of androsterone UDP-glucuronosyltransferase gene in the inherited deficient strain of Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1337,
                    "offsetInEndSection": 1593,
                    "text": "In support of this model, we show here that mutations M265I or R331H, residues predicted by crystal structure to interact with the carboxylic acid tail of CDCA but not with androsterone, altered CDCA activation but had no effect on androsterone activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 533,
                    "offsetInEndSection": 622,
                    "text": "Southern blot analysis suggested a large deletion of androsterone UDPGT gene in the rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 364,
                    "offsetInEndSection": 536,
                    "text": "Northern blot analysis of total RNA from normal and androsterone glucuronidation deficient Wistar rats demonstrated that the mRNA encoding this protein was not synthesised."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 363,
                    "text": "This isoenzyme is absent from Wistar rats exhibiting the low androsterone (LA) UDP-glucuronyltransferase activity exhibiting the low androsterone (LA) UDP-glucuronyltransferase activity phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "A major UDP-glucuronyltransferase isoenzyme in rat liver (51 kDa), corresponding to androsterone glucuronidating activity, has been identified by immunoblot analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 439,
                    "offsetInEndSection": 532,
                    "text": "In Northern blot analysis, androsterone UDPGT mRNA was totally absent in LA Wistar rat liver."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25561755",
                "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                "http://www.ncbi.nlm.nih.gov/pubmed/20444377",
                "http://www.ncbi.nlm.nih.gov/pubmed/11599761",
                "http://www.ncbi.nlm.nih.gov/pubmed/21354008",
                "http://www.ncbi.nlm.nih.gov/pubmed/15062212",
                "http://www.ncbi.nlm.nih.gov/pubmed/11045697",
                "http://www.ncbi.nlm.nih.gov/pubmed/6200825",
                "http://www.ncbi.nlm.nih.gov/pubmed/25542678",
                "http://www.ncbi.nlm.nih.gov/pubmed/7774550"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 394,
                    "text": "PATIENTS METHODS AND RESULTS\nA 40-year-old woman with an ununited fracture of the tarsal navicular bone was treated with localized naviculocuneiform arthrodesis (arthrodesis of the navicular, the middle cuneiform, and the lateral cuneiform)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15062212",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The navicular bone, located in the midfoot, articulates with the head of the talus, cuboid, and the three cuneiform bones that are involved in the acetabulum pedis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11045697",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Osteochondritis dissecans of the tarsal navicular bone: imaging findings in four patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561755",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "AIMS\nNavicular fracture is still challenging disorder to treat because there is a risk of nonunion, avascular necrosis and symptomatic osteoarthritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 277,
                    "text": "Spontaneous osteonecrosis of the navicular in the adult is known as Mueller-Weiss syndrome, which is a rare disease characterized by a collapse of the lateral portion of the tarsal navicular combined with a medial protrusion of the talar head and peri-navicular osteoarthritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                    "endSection": "abstract",
                    "offsetInBeginSection": 583,
                    "offsetInEndSection": 762,
                    "text": "We believe that in cases where cerebral palsy patients with paralytic equinus complain of foot pain, the possibility of stress fracture of the navicular bone should be considered."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "A 14-year-old girl with cerebral palsy (spastic diplegia) underwent examination due to a chief complaint of right foot pain, and was diagnosed with a stress fracture of the central one third of the navicular bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25561755",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "Localized naviculocuneiform arthrodesis combined with osteosynthesis of fracture nonunion of the tarsal navicular bone using a locked plating system."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20444377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 349,
                    "text": "Key words: navicular bone of the wrist, pseudoarthrosis of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11599761",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "A case of osteonecrosis of the accessory navicular bone is reported."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                "http://www.ncbi.nlm.nih.gov/pubmed/24451198",
                "http://www.ncbi.nlm.nih.gov/pubmed/15708188",
                "http://www.ncbi.nlm.nih.gov/pubmed/22808822",
                "http://www.ncbi.nlm.nih.gov/pubmed/23537911",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/17600767"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1089,
                    "offsetInEndSection": 1534,
                    "text": "This suggests additional genetic factors contribute to the dilated cardiomyopathy phenotype.This study represents a meta-analysis of available canine dilated cardiomyopathy genetic datasets with the goal of determining potential multigenic interactions relating the sex chromosome genotype (XX vs. XY) with known dilated cardiomyopathy associated loci on chromosome 5 and the PDK4 gene in the incidence and progression of dilated cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24451198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 224,
                    "text": "We present the case of a child with dilated cardiomyopathy caused by a 624 kb duplication of 6q22.31, which includes the phospholamban gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 928,
                    "text": "Among the 145 differentially expressed lncRNAs identified in ICM hearts, we found a set of 35 lncRNAs that display strong positive expression correlation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "Long non-coding RNAs (lncRNAs) have emerged as critical regulators of genes at epigenetic, transcriptional and post-transcriptional levels, yet what genes are regulated by a specific lncRNA remains to be characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 874,
                    "offsetInEndSection": 1021,
                    "text": "Both search types are performed either by browsing a provided catalog of lncRNA names or by inserting lncRNA/target gene IDs/names in a search box."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "Homozygosity for the deletion allele of the angiotensin-converting enzyme gene (DD) has been associated with a variety of cardiovascular diseases, including ischemic and idiopathic dilated cardiomyopathy, in Caucasians."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 753,
                    "text": "Although multiple human loci have been implicated in the pathogenesis of dilated cardiomyopathy, the identified variants are typically associated with rare monogenic forms of dilated cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1672,
                    "offsetInEndSection": 1800,
                    "text": "Our results further indicate that lncRNAs may represent novel regulators of heart function and cardiac disorders, including ICM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557636",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1133,
                    "offsetInEndSection": 1322,
                    "text": "We overexpressed or knocked down selected lncRNAs in cardiac fibroblasts and our results suggest that lncRNAs are important regulators of fibrosis and the expression of ECM synthesis genes."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8783939",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                "http://www.ncbi.nlm.nih.gov/pubmed/10674376",
                "http://www.ncbi.nlm.nih.gov/pubmed/28030792",
                "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                "http://www.ncbi.nlm.nih.gov/pubmed/9665397",
                "http://www.ncbi.nlm.nih.gov/pubmed/11933208",
                "http://www.ncbi.nlm.nih.gov/pubmed/16704453",
                "http://www.ncbi.nlm.nih.gov/pubmed/25208914"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "Expression and functional analysis of a novel MYB gene, MdMYB110a_JP, responsible for red flesh, not skin color in apple fruit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 987,
                    "text": "However, comparison of the MSHR genotypes in dizygotic twin pairs discordant for red hair colour indicates that the MSHR gene cannot be solely responsible for the red hair phenotype, since five of 13 pairs tested had both haplotypes identical by state (with three of the five having both identical by descent)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Sequence polymorphism in the human melanocortin 1 receptor gene as an indicator of the red hair phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9665397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 301,
                    "text": "The identification of an association between variants in the human melanocortin 1 receptor (MC1R) gene and red hair and fair skin, as well as the relation between variants of this gene and coat color in animals, suggests that the MC1R is an integral control point in the normal pigmentation phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 205,
                    "text": "We describe a minisequencing protocol for screening DNA samples for the presence of 12 mutations in the human melanocortin 1 receptor gene (MC1R), eight of which are associated with the red hair phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1331,
                    "offsetInEndSection": 1520,
                    "text": "From the results, it was strongly suggested that the red-fleshed phenotype of 'JPP35' fruit was caused by up-regulation of the genes of anthocyanin pathway induced by the MdMYB110a_JP gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28030792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 888,
                    "offsetInEndSection": 1049,
                    "text": "Gene expression in normal skin from RHC cutaneous cells showed dysregulation in 8 out of 23 hub genes (CLN3, ATG10, WIPI2, SNX2, GABARAPL2, YWHA, PCNA and GBAS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25208914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1436,
                    "offsetInEndSection": 1770,
                    "text": "CONCLUSIONS\nWe hypothesize that differences in KRTAP gene repertoire and gene expression, together with distinct rates of gene conversion/recombination, pseudogenization and positive selection, are likely responsible for micro and macro-phenotypic hair diversification among mammals in response to adaptations to ecological pressures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "We have succeeded in isolating an MdMYB110a_JP gene responsible for a red-fleshed trait from a fruit of apple cultivar 'JPP35' ('Jonathan'\u00a0\u00d7\u00a0'Pink Pearl')."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1141,
                    "text": "Rather, it is likely that additional modifier genes exist, making variance in the MSHR gene necessary but not always sufficient, for red hair production."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                "http://www.ncbi.nlm.nih.gov/pubmed/210371",
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/2988201",
                "http://www.ncbi.nlm.nih.gov/pubmed/8370544",
                "http://www.ncbi.nlm.nih.gov/pubmed/1363938",
                "http://www.ncbi.nlm.nih.gov/pubmed/480473",
                "http://www.ncbi.nlm.nih.gov/pubmed/6090389",
                "http://www.ncbi.nlm.nih.gov/pubmed/25272021"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Human cytomegalovirus DNA: BamHI, EcoRI and PstI restriction endonuclease cleavage maps."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 172,
                    "text": "The cloned HindIII fragments of human cytomegalovirus (HCMV) strain AD169 DNA were mapped with respect to the BamHI, EcoRI and PstI restriction endonuclease cleavage sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "A restriction endonuclease obtained from Haemophilus gallinarum  (hgaI) cleaves polyoma DNA at four specific sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/210371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 389,
                    "text": "Using EcoRI and Hind III endonuclease restriction sites as reference, the two Pst I sites were mapped at 0.050; 0.265 and the Bam I site was mapped at 0.170 of the genome length, clockwise, from the single EcoRI cleavage site."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8370544",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "A new restriction endonuclease, TspEI, from the genus Thermus that generates cohesive termini compatible with those of EcoRI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                    "endSection": "abstract",
                    "offsetInBeginSection": 116,
                    "offsetInEndSection": 335,
                    "text": "Using the EcoRI, HindIII, and HpaII endonuclease restriction sites as reference, the four HgaI cleavage sites were mapped at 0.02, 0.14, 0.27, and 0.48 fractional lengths, clockwise, from the single EcoRI cleavage site."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/178910",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Restriction endonuclease from Haemophilus gallinarum (HgaI) cleaves polyoma DNA at four locations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6290339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 173,
                    "offsetInEndSection": 339,
                    "text": "Composite restriction endonuclease cleavage maps for the entire virus genome were constructed using the previously established linkages between the HindIII fragments."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Phenotypically cryptic EcoRI endonuclease activity specified by the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25272021",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 281,
                    "text": "A simple and facile approach was developed for monitoring EcoRI endonuclease activity and inhibition, in which a hairpin-like DNA containing restriction cutting site for EcoRI endonuclease acts as the sensing element and Hoechst dyes as the signal indicator in a label-free format."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                "http://www.ncbi.nlm.nih.gov/pubmed/24756600",
                "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                "http://www.ncbi.nlm.nih.gov/pubmed/3305608",
                "http://www.ncbi.nlm.nih.gov/pubmed/17539247",
                "http://www.ncbi.nlm.nih.gov/pubmed/12685889",
                "http://www.ncbi.nlm.nih.gov/pubmed/21330745",
                "http://www.ncbi.nlm.nih.gov/pubmed/11584993",
                "http://www.ncbi.nlm.nih.gov/pubmed/21905781",
                "http://www.ncbi.nlm.nih.gov/pubmed/27187754"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27187754",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Cryptococcal meningitis is a leading infectious disease worldwide as a result of the high burden of HIV and AIDS, although its cumulative incidence is very low in children compared with that in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1223,
                    "text": "The incidence rates of CNS opportunistic infections (cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy) and primary CNS lymphoma have decreased since the introduction of HAART."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 448,
                    "text": "Multiple studies now suggest that the incidence rates of HIV-associated neurological disease and central nervous system (CNS) opportunistic infections also are decreasing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Highly active antiretroviral therapy (HAART) is effective in suppressing systemic human immunodeficiency virus (HIV) viral load and has decreased mortality rates and the incidence of systemic opportunistic infections in patients with acquired immunodeficiency syndrome (AIDS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12685889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 334,
                    "text": "The incidence of extrapulmonary forms of tuberculosis and cryptococcosis has increased in areas with a high prevalence of human immunodeficiency virus (HIV) infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 415,
                    "text": "The incidence rates for HIV dementia, cryptococcal meningitis, and lymphoma decreased following the introduction of highly active antiretroviral therapy (HAART)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12491162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 698,
                    "offsetInEndSection": 860,
                    "text": "The incidence of HIV-associated distal sensory polyneuropathy has decreased, although the incidence of antiretroviral drug-induced toxic neuropathy has increased."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12685889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 636,
                    "text": "Atypical presentations of both tuberculosis and cryptococcosis should be considered in areas with a high incidence of these diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21330745",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "The incidence of cryptococcal infection is high in developing countries such as India."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11160967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 253,
                    "text": "This study examined the temporal trends in the incidence rates of HIV dementia, cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy, and CNS lymphoma from January 1990 to December 1998 in the Multicenter AIDS Cohort Study."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/26454018",
                "http://www.ncbi.nlm.nih.gov/pubmed/26564948",
                "http://www.ncbi.nlm.nih.gov/pubmed/23673643",
                "http://www.ncbi.nlm.nih.gov/pubmed/23227185",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                "http://www.ncbi.nlm.nih.gov/pubmed/17591274",
                "http://www.ncbi.nlm.nih.gov/pubmed/25788450",
                "http://www.ncbi.nlm.nih.gov/pubmed/20979669",
                "http://www.ncbi.nlm.nih.gov/pubmed/23348729"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "The genetic adaptation of Tibetans to high altitude hypoxia likely involves a group of genes in the hypoxic pathway, as suggested by earlier studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1060,
                    "text": "Collectively, we propose that EP300 harbors adaptive variants in Tibetans, which might contribute to high-altitude adaptation through regulating NO production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25788450",
                    "endSection": "abstract",
                    "offsetInBeginSection": 550,
                    "offsetInEndSection": 921,
                    "text": "Further analyses revealed that several candidate genes in the calcium-signaling pathway are possibly involved in adaptation to the hypoxia experienced by these chickens, as these genes appear to have experienced directional selection in the two Tibetan chicken populations, suggesting a potential genetic mechanism underlying high altitude adaptation in Tibetan chickens."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26454018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 702,
                    "offsetInEndSection": 1172,
                    "text": "An analysis of 2,269 orthologous genes among cave fish (Astyanax mexicanus), zebrafish (Danio rerio), large-scale loach (Paramisgurnus dabryanus), and Triplophysa fishes revealed that each of the terminal branches of the Triplophysa fishes had a significantly higher ratio of nonsynonymous to synonymous substitutions than that of the branches of the fishes from low altitudes, which provided consistent evidence for genome-wide rapid evolution in the Triplophysa genus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20979669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "Genome-wide scans demonstrate that genetic variants associated with high-altitude adaptation in Tibetans and Andeans arose independently as a result of convergent adaptation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23673643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 351,
                    "offsetInEndSection": 559,
                    "text": "Compared with other plain-dwelling mammals, the genome of the Tibetan antelope shows signals of adaptive evolution and gene-family expansion in genes associated with energy metabolism and oxygen transmission."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23348729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 999,
                    "offsetInEndSection": 1225,
                    "text": "METHODS\nTo measure for the effects of EGLN1 and EPAS1 altitude genotypes on hemoglobin concentration among Andean highlanders, we performed a multiple linear regression analysis of 10 candidate SNPs in or near these two genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23348729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 667,
                    "text": "One gene previously known to be important in cellular oxygen sensing, egl nine homolog 1 (EGLN1), shows evidence of positive selection in both Tibetans and Andeans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23673643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 560,
                    "offsetInEndSection": 715,
                    "text": "Both the highland American pika, and the Tibetan antelope have signals of positive selection for genes involved in DNA repair and the production of ATPase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 383,
                    "text": "Here we report on a hypoxia gene ( GCH1, GTP-cyclohydrolase I), involved in maintaining nitric oxide synthetase (NOS) function and normal blood pressure, that harbors many potentially adaptive variants in Tibetans."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23538704",
                "http://www.ncbi.nlm.nih.gov/pubmed/20374958",
                "http://www.ncbi.nlm.nih.gov/pubmed/28448947",
                "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                "http://www.ncbi.nlm.nih.gov/pubmed/26167402",
                "http://www.ncbi.nlm.nih.gov/pubmed/21641555",
                "http://www.ncbi.nlm.nih.gov/pubmed/6383576",
                "http://www.ncbi.nlm.nih.gov/pubmed/28128199",
                "http://www.ncbi.nlm.nih.gov/pubmed/9180264",
                "http://www.ncbi.nlm.nih.gov/pubmed/25428857"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 762,
                    "offsetInEndSection": 972,
                    "text": "These data indicate that, unlike liver, skeletal muscle, and whole carcass, BAT protein synthesis is not reduced in protein-restricted rats, and this may be related to activation of thermogenesis in the tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26167402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "Brown adipocytes help to maintain body temperature by the expression of a unique set of genes that facilitate cellular metabolic events including uncoupling protein 1-dependent thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28448947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 238,
                    "text": "Brown adipose tissue (BAT) is a specialized tissue critical for non-shivering thermogenesis producing heat through mitochondrial uncoupling; whereas white adipose tissue (WAT) is responsible of energy storage in the form of triglycerides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21641555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "While fatty acids (FAs) released by white adipose tissue (WAT) provide energy for other organs, lipolysis is also critical in brown adipose tissue (BAT), generating FAs for oxidation and UCP-1 activation for thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9180264",
                    "endSection": "abstract",
                    "offsetInBeginSection": 98,
                    "offsetInEndSection": 273,
                    "text": "The uncoupling protein-1 (UCP1) is the main effector of nonshivering thermogenesis in BAT and the recently described ubiquitous UCP2 [1] has been implicated in energy balance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 364,
                    "text": "The fact that BAT protein content, unlike that of other tissues, is unnaffected by protein deficiency prompted us to measure tissue protein synthesis in vivo in animals maintained on normal- (18.8%) and low- (7.6%) protein (LP) diets."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12033405",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Protein synthesis in liver, skeletal muscle, and brown adipose tissue of rats fed a protein-deficient diet."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28128199",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "The adipokine adipocyte fatty acid-binding protein (A-FABP) has been implicated in obesity-related cardio-metabolic complications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28128199",
                    "endSection": "abstract",
                    "offsetInBeginSection": 241,
                    "offsetInEndSection": 389,
                    "text": "We find that A-FABP levels are increased in both white (WAT) and brown (BAT) adipose tissues and the bloodstream in response to thermogenic stimuli."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25428857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 572,
                    "text": "The sympathetic neural outflow determining brown adipose tissue (BAT) thermogenesis is regulated by neural networks in the CNS which increase BAT sympathetic nerve activity in response to cutaneous and deep body thermoreceptor signals."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                "http://www.ncbi.nlm.nih.gov/pubmed/11996216",
                "http://www.ncbi.nlm.nih.gov/pubmed/24123070",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/16626609",
                "http://www.ncbi.nlm.nih.gov/pubmed/28208678",
                "http://www.ncbi.nlm.nih.gov/pubmed/19965127",
                "http://www.ncbi.nlm.nih.gov/pubmed/28387731",
                "http://www.ncbi.nlm.nih.gov/pubmed/23889826"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 348,
                    "text": "METHODS\nA double antibody sandwich ELISA was developed for detection of SFTSV based on SFTSV nucleocapsid (N) protein specific poly- and monoclonal antibodies, procedures were optimized and evaluated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "OBJECTIVE\nTo develop an assay for titration of severe fever with thrombocytopenia syndrome virus (SFTSV) based on double antibody sandwich ELISA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1166,
                    "offsetInEndSection": 1278,
                    "text": "An identical set of plasma samples were analyzed utilizing the Bio-Plex Pro\u2122 human cytokine 27-plex immunoassay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 349,
                    "offsetInEndSection": 460,
                    "text": "This ELISA based titration assay was compared with fluorescence assasy and plaque assay based titration method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 660,
                    "offsetInEndSection": 907,
                    "text": "CONCLUSION\nThe novel ELISA based titration method with high sensitivity and specificity is easy to manage and perform, and can overcome the subjectivity associated with result determination of the fluorescence assay and plaque assay based methods."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "[A double antibody sandwich ELISA based assay for titration of severe fever with thrombocytopenia syndrome virus]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319962",
                    "endSection": "abstract",
                    "offsetInBeginSection": 463,
                    "offsetInEndSection": 657,
                    "text": "RESULTS\nThe results suggested that the titers obtained by ELISA based method are consistent with those obtained by IFA based method (R = 0.999) and the plaque assay titration method (R = 0.949)."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11803517",
                "http://www.ncbi.nlm.nih.gov/pubmed/25747527",
                "http://www.ncbi.nlm.nih.gov/pubmed/2023912",
                "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                "http://www.ncbi.nlm.nih.gov/pubmed/10359483",
                "http://www.ncbi.nlm.nih.gov/pubmed/17692293",
                "http://www.ncbi.nlm.nih.gov/pubmed/20464528",
                "http://www.ncbi.nlm.nih.gov/pubmed/21295226",
                "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                "http://www.ncbi.nlm.nih.gov/pubmed/19302089"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Monoamine oxidase A (MAOA), a mitochondrial outer membrane enzyme, degrades biogenic amines including norepinephrine, dopamine and serotonin, which have been implicated in the expression of personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21295226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "OBJECTIVE\nPreclinical and human family studies clearly link monoamine oxidase A (MAOA) to aggression and antisocial personality (ASP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20464528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 996,
                    "text": "This finding suggests that T102C in 5-TH(2A) and Val158Met in COMT play roles in some human personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20464528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 533,
                    "offsetInEndSection": 884,
                    "text": "The results showed the T102C in 5-TH(2A) was associated with X3 (emotional and quiet alertness) and B (reasoning) (F = 4.71 and 6.23; p = 0.009 and 0.002), Val158Met in COMT with E (dominance) (F = 7.01; p = 0.0009), while the variations in DBH, DRD(2), DRD(3), MAOA, GRM(1), GRIN2B, and 5-TH(6) were not associated with any of the personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17692293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "BACKGROUND\nMonoamine oxidase A (MAOA) is involved in the pathogenesis of mood disorders and Alzheimer's disease (AD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 309,
                    "text": "We analyzed a novel functional 30-bp repeat polymorphism in the promoter region of the X-chromosomal monoamine oxidase A gene (MAOA) to test whether length variation of the repeat polymorphism contributes to variation in the individual vulnerability to antisocial behavior and liability to alcohol dependence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19302089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "BACKGROUND\nAntisocial alcoholism is related to dopamine and serotonin which are catalyzed by monoamine oxidase A (MAOA) and acetaldehyde dehydrogenase 2 (ALDH2)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                    "endSection": "abstract",
                    "offsetInBeginSection": 180,
                    "offsetInEndSection": 351,
                    "text": "Here, we investigated the influence of allelic variation of MAOA activity on aggression-related personality traits and disease risk in patients with personality disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "Genetic variants of the monoamine oxidase A (MAOA) have been associated with aggression-, anxiety-, and addiction-related behavior in several nonclinical and clinical populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19302089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 357,
                    "text": "The objective of this study is to determine whether the interaction between the MAOA and the ALDH2 genes is associated with subjects with antisocial personality disorder (ASPD) having alcoholism."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                "http://www.ncbi.nlm.nih.gov/pubmed/21253530",
                "http://www.ncbi.nlm.nih.gov/pubmed/21277938",
                "http://www.ncbi.nlm.nih.gov/pubmed/22715468",
                "http://www.ncbi.nlm.nih.gov/pubmed/16307490",
                "http://www.ncbi.nlm.nih.gov/pubmed/19855427",
                "http://www.ncbi.nlm.nih.gov/pubmed/18336298",
                "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                "http://www.ncbi.nlm.nih.gov/pubmed/21266250",
                "http://www.ncbi.nlm.nih.gov/pubmed/22621256"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 286,
                    "text": "HDAC is a family of enzymes involved in deacetylation of lysine residues on histone and non-histone proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 803,
                    "text": "This review provides a comprehensive examination of the transcriptional and post-translational mechanisms by which HDACs alter the expression and function of cancer-associated proteins and examines the general impact of HDAC activity in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 591,
                    "offsetInEndSection": 856,
                    "text": "While histones still represent a primary target for the physiological function of HDACs, the antitumor effect of HDAC inhibitors might also be attributed to transcription-independent mechanisms by modulating the acetylation status of a series of nonhistone targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 274,
                    "offsetInEndSection": 597,
                    "text": "HDACs and histone acetyltransferases can, by reversible acetylation, modify the structure and function of histones and proteins in transcription factor complexes, which are involved in the regulation of gene expression, as well as many non-histone proteins that are involved in regulating cell proliferation and cell death."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21253530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19855427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 264,
                    "text": "Classical zinc-dependent histone deacetylases (HDACs) catalyse the removal of acetyl groups from histone tails and also from many non-histone proteins, including the transcription factor FOXP3, a key regulator of the development and function of regulatory T cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16450343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 286,
                    "offsetInEndSection": 590,
                    "text": "Although they have been shown to regulate the transcription of a defined set of genes through chromatin remodeling, increasing evidence suggests that modifications of the epigenetic histone code may not be the primary mechanism for HDAC inhibitor-mediated growth inhibition and apoptosis in cancer cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 330,
                    "text": "By removal of acetyl groups from histones, HDACs create a non-permissive chromatin conformation that prevents the transcription of genes that encode proteins involved in tumorigenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21277938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1212,
                    "offsetInEndSection": 1384,
                    "text": "Thus, endogenous HDAC inhibitors represent a promising class of \"antitumor agents\" thanks to which oncogenic addiction pathways may be selectively therapeutically targeted."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1522894",
                "http://www.ncbi.nlm.nih.gov/pubmed/24510259",
                "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/23608054",
                "http://www.ncbi.nlm.nih.gov/pubmed/8811095",
                "http://www.ncbi.nlm.nih.gov/pubmed/7678553",
                "http://www.ncbi.nlm.nih.gov/pubmed/9276688",
                "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                "http://www.ncbi.nlm.nih.gov/pubmed/7509558"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 616,
                    "offsetInEndSection": 766,
                    "text": "The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Assessing intermolecular RNA:RNA interactions within a ribonucleoprotein complex using heavy metal cleavage mapping."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9276688",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 582,
                    "text": "Precise RNA cleavage site mapping in this divergent Old World virus, LRV2-1, confirms that cleavage is occurring within a region of homology to the LRV1 isolates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24510259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Mapping the precise position of endonucleolytic cleavage sites is a fundamental experimental technique used to describe the function of a homing endonuclease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                    "endSection": "abstract",
                    "offsetInBeginSection": 362,
                    "offsetInEndSection": 671,
                    "text": "Mapping of topoisomerase I-mediated irreversible cleavage sites on homopolymeric DNA substrates containing mismatches showed trapping of the enzyme in several positions in close vicinity of the DNA imperfection, with a strong preference for the 5' junction between the duplex DNA and the base-pairing anomaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23608054",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "The mapping of DNA footprints and affinity cleavage sites for small DNA ligands is affected by the choice of sequencing chemistry and end label, and the potential for indexing errors can be significant when mapping small ligand-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "Heavy metal cleavage mapping analysis of both assembling and fully mature ribonucleoprotein (RNP) complexes are informative techniques for assessing the intermolecular base pairing between small non-coding RNAs and their interacting target RNAs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10673027",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Mapping of eukaryotic DNA topoisomerase I catalyzed cleavage without concomitant religation in the vicinity of DNA structural anomalies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7509558",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "We have shown that Integration Host Factor of E. coli can successfully be used in the IHF-mediated Achilles' Heel Cleavage (IHF-AC) technique (Kur et al., 1992b), for generating rare natural cleavage sites."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1522894",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Reagents for the site-specific cleavage of megabase DNA."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3460332",
                "http://www.ncbi.nlm.nih.gov/pubmed/25837870",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/10395804",
                "http://www.ncbi.nlm.nih.gov/pubmed/7929013",
                "http://www.ncbi.nlm.nih.gov/pubmed/3023690",
                "http://www.ncbi.nlm.nih.gov/pubmed/8596958",
                "http://www.ncbi.nlm.nih.gov/pubmed/7590302",
                "http://www.ncbi.nlm.nih.gov/pubmed/8441634",
                "http://www.ncbi.nlm.nih.gov/pubmed/2037291"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "DNA Polymerase \u03b8: A Unique Multifunctional End-Joining Machine."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3460332",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "The gene encoding the large subunit of human RNA polymerase II is located on the short arm of chromosome 17."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8596958",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "An RNA polymerase II elongation factor encoded by the human ELL gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3460332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 247,
                    "offsetInEndSection": 384,
                    "text": "The results of our analysis demonstrate localization of the human RNA polymerase II large subunit gene to the short arm of chromosome 17."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8596958",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 376,
                    "text": "Here, ELL was shown to encode a previously uncharacterized elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by polymerase at multiple sites along the DNA."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10395804",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Cloning and chromosomal mapping of the human DNA polymerase theta (POLQ), the eighth human DNA polymerase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7929013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 303,
                    "text": "We report the sequence of the gene encoding the DNA polymerase of Methanococcus voltae and describe evidence that it lacks analogous intervening sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10395804",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "We have cloned the cDNA for the eighth human DNA polymerase, DNA polymerase &theta;."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7590302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 210,
                    "text": "The polA gene (encoding DNA polymerase I) from Mycobacterium tuberculosis was cloned using an internal gene segment probe generated by PCR amplification of genomic DNA [Mizrahi et al., Gene 136 (1993) 287-290]."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21194037",
                "http://www.ncbi.nlm.nih.gov/pubmed/12737315",
                "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                "http://www.ncbi.nlm.nih.gov/pubmed/12719373",
                "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                "http://www.ncbi.nlm.nih.gov/pubmed/18371406",
                "http://www.ncbi.nlm.nih.gov/pubmed/22511986",
                "http://www.ncbi.nlm.nih.gov/pubmed/17579573",
                "http://www.ncbi.nlm.nih.gov/pubmed/11468272",
                "http://www.ncbi.nlm.nih.gov/pubmed/10704448"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11468272",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 494,
                    "text": "Alternatively, antisense therapy can be used to induce destructive exon skipping of myostatin pre-mRNA, knocking down myostatin expression to enhance muscle strength and reduce fibrosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 764,
                    "offsetInEndSection": 936,
                    "text": "In DMD patient cells, bifunctional U7 snRNAs harboring silencer motifs induce complete skipping of exon 51, and thus restore dystrophin expression to near wild-type levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                    "endSection": "abstract",
                    "offsetInBeginSection": 495,
                    "offsetInEndSection": 801,
                    "text": "We have reported previously that intramuscular or intraperitoneal antisense administration inducing dual exon skipping of dystrophin and myostatin pre-mRNAs was beneficial in mdx mice, a mouse model of DMD, although therapeutic effects were muscle type restricted, possibly due to the delivery routes used."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11468272",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 771,
                    "text": "Considering that exon 45 is the single most frequently deleted exon in DMD, whereas exon (45+46) deletions cause only a mild form of BMD, we set up an antisense-based system to induce exon 46 skipping from the transcript in cultured myotubes of both mouse and human origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disorder caused by mutations in the dystrophin gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18371406",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Duchenne muscular dystrophy (DMD) is a hereditary disease caused by mutations that disrupt the dystrophin mRNA reading frame."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17579573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 314,
                    "text": "Duchenne muscular dystrophy is characterized by an absence of functional protein, whereas Becker muscular dystrophy, commonly caused by in-frame deletions, shows synthesis of partially functional protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28325281",
                    "endSection": "abstract",
                    "offsetInBeginSection": 183,
                    "offsetInEndSection": 307,
                    "text": "Such an approach can restore the disrupted reading frame of dystrophin pre-mRNA, generating a truncated form of the protein."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19455105",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24764460",
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/28323040",
                "http://www.ncbi.nlm.nih.gov/pubmed/22722835",
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/29086764",
                "http://www.ncbi.nlm.nih.gov/pubmed/19574298",
                "http://www.ncbi.nlm.nih.gov/pubmed/26722227",
                "http://www.ncbi.nlm.nih.gov/pubmed/21964070"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 747,
                    "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1105,
                    "offsetInEndSection": 1307,
                    "text": "We further show that the testis-specific circRNA, sex-determining region Y (Sry), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28323040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 251,
                    "offsetInEndSection": 513,
                    "text": "In addition to developing artificial miRNA sponges, scientists have sought endogenous RNA transcripts and found that long non-coding RNAs, competing endogenous RNAs, pseudogenes, circular RNAs, and coding RNAs could act as miRNA sponges under precise conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24764460",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 351,
                    "text": "Mammals have thousands of circRNAs with predicted miRNA binding sites, but only two circRNAs have been verified as being actual miRNA sponges."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24764460",
                    "endSection": "abstract",
                    "offsetInBeginSection": 709,
                    "offsetInEndSection": 945,
                    "text": "This decrease was similar to that of miRNA seed sites in 3' untranslated regions, suggesting that many of the predicted miRNA binding sites in circRNAs are functional and under similar selective pressure as miRNA binding sites in mRNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22722835",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1157,
                    "offsetInEndSection": 1341,
                    "text": "Argonaute also binds let-7 primary transcripts in human cells, demonstrating that the miRNA pathway targets non-coding RNAs in addition to protein-coding messenger RNAs across species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24764460",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "MOTIVATION\nCircular RNAs (circRNAs) are an abundant class of highly stable RNAs that can affect gene regulation by binding and preventing microRNAs (miRNAs) from regulating their messenger RNA (mRNA) targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 921,
                    "text": "Although the circRNA is completely resistant to miRNA-mediated target destabilization, it strongly suppresses miR-7 activity, resulting in increased levels of miR-7 targets."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27699049",
                "http://www.ncbi.nlm.nih.gov/pubmed/27595004",
                "http://www.ncbi.nlm.nih.gov/pubmed/27493758",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                "http://www.ncbi.nlm.nih.gov/pubmed/19553672",
                "http://www.ncbi.nlm.nih.gov/pubmed/20941585",
                "http://www.ncbi.nlm.nih.gov/pubmed/23251548",
                "http://www.ncbi.nlm.nih.gov/pubmed/24036685",
                "http://www.ncbi.nlm.nih.gov/pubmed/18338233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27532606"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 845,
                    "text": "As results, 132 bacterial genera and some unidentified operational taxonomic units within 29 phyla in the gut bacteria were detected, with Spirochaetes (11-55%), Firmicutes (7-18%), Bacteroidetes (7-31%), and Proteobacteria (8-14%) as the main phyla, and Treponema, TG5, Dysgonomonas, Tannerella, za29, Lactococcus, Pseudomonas, and SJA-88 as the common genera in all the four termites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 416,
                    "text": "Bacterial clone libraries of the gut microbiota of nurtured and starved Cylindroiulus fulviceps specimens displayed the predominance of the phyla Bacteroidetes (55 and 37 %, respectively) and Proteobacteria (40 and 35 %, respectively) and a high similarity to bacteria previously detected in the intestinal tract of termites and beetles, which are known to harbor symbiotic bacteria essential for digestive activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27699049",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "\"Lachnoclostridium touaregense,\" a new bacterial species isolated from the human gut microbiota."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27595004",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "'Lachnoclostridium massiliosenegalense', a new bacterial species isolated from the human gut microbiota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 846,
                    "offsetInEndSection": 1323,
                    "text": "The diversity of gut bacterial communities in the higher termite guts was significantly greater than that in the lower termites; while the gut microbiota in M. shangchengensis (wood-feeding higher termite) was more similar to those of the wood-feeding lower termites rather than that of O. formosanus (fungus-feeding higher termite), and phylum Spirochaetes and nitrogen-fixing bacteria were super-dominant in the wood-feeding termites, despite of their phylogenetic relations."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493758",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "\"Lachnoclostridium bouchesdurhonense,\" a new bacterial species isolated from human gut microbiota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27699049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "We report the main characteristics of \"Lachnoclostridium touaregense\" strain Marseille-P2415T (= CSUR P2415\u00a0=\u00a0DSM\u00a0102219), a new bacterial species isolated from the gut microbiota of a healthy young girl from Niger."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27595004",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "We report the main characteristics of 'Lachnoclostridium massiliosenegalense' strain mt23(T) (=CSUR P299\u00a0=DSM 102084), a new bacterial species isolated from the gut microbiota of a healthy young girl from Senegal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "We report the main characteristics of \"Lachnoclostridium bouchesdurhonense\" strain AT5(T) (=CSUR P2181), a new bacterial species isolated from the gut microbiota of an obese patient from Marseille."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23251548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 977,
                    "offsetInEndSection": 1112,
                    "text": "The putative core stomach microbiome comprised 5 OTUs in 3 phyla, while the putative core gut microbiome contained 44 OTUs in 12 phyla."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18831144",
                "http://www.ncbi.nlm.nih.gov/pubmed/21798462",
                "http://www.ncbi.nlm.nih.gov/pubmed/21324845",
                "http://www.ncbi.nlm.nih.gov/pubmed/3490922",
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043476",
                "http://www.ncbi.nlm.nih.gov/pubmed/9702244",
                "http://www.ncbi.nlm.nih.gov/pubmed/25242163",
                "http://www.ncbi.nlm.nih.gov/pubmed/26086636"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Yellow fever is an arthropod-borne disease with symptoms ranging from mild fever to acute hepatonephritis, hemorrhages and shock often fatal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 329,
                    "offsetInEndSection": 734,
                    "text": "WHO convened a working group of international experts to review factors important for the transmission of yellow fever virus and country-specific yellow fever information, to establish criteria for additions to or removal from the list of countries with risk for yellow fever virus transmission, to update yellow fever risk maps, and to revise the recommendations for vaccination for international travel."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18831144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 639,
                    "text": "We explore the research responses to a variety of disease outbreaks in Colombia in the context of the Rockefeller campaigns against yellow fever, from the time of Roberto Franco's initial description of \"yellow fever of the forests\" in 1907 until the consolidation of the concept of \"jungle yellow fever\" by Fred Soper in 1938."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 423,
                    "text": "In order to estimate the risk of an epidemic of urban yellow fever in a dengue-infested area we calculated the threshold in the basic reproduction number, R0, of dengue, above which any single sylvatic yellow fever-infected individual will trigger an urban yellow fever epidemic."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21324845",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 254,
                    "text": "The pathophysiology of severe yellow fever in humans and in monkeys susceptible to the virus is largely unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21324845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The 17D yellow fever vaccine is a live-virus vaccine that has been in use since the 1940s."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 800,
                    "offsetInEndSection": 965,
                    "text": "The theory proposed is illustrated by the case of S\u00e3o Paulo State in southern Brazil, where dengue is endemic and the risk of urban yellow fever is already imminent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11579875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Yellow fever and dengue are viral infections that in urban centres are transmitted by the same arthropod vector, a mosquito of the genus Aedes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 328,
                    "text": "The changing epidemiology of yellow fever and continued reports of rare but serious adverse events associated with yellow fever vaccine have drawn attention to the need to revisit criteria for the designation of areas with risk for yellow fever virus activity, and to revise the vaccine recommendations for international travel."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                "http://www.ncbi.nlm.nih.gov/pubmed/1085370",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/22076482",
                "http://www.ncbi.nlm.nih.gov/pubmed/19515095",
                "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                "http://www.ncbi.nlm.nih.gov/pubmed/7760986",
                "http://www.ncbi.nlm.nih.gov/pubmed/7558460",
                "http://www.ncbi.nlm.nih.gov/pubmed/28345562"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "From our results we can be sure that the colour test disk is at least as reliable for mass testing for colour blindness as the Ishihara isochromatic colour plates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                    "endSection": "abstract",
                    "offsetInBeginSection": 792,
                    "offsetInEndSection": 983,
                    "text": "These preliminary results suggest that the new test is effective for screening congenital red-green blindness and monitoring colour vision defects in acquired diseases such as optic neuritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 376,
                    "text": "Here, we show that dogs exhibit a behavioural response similar to that of red-green blind human subjects when tested with a modified version of a test commonly used for the diagnosis of human deuteranopia (i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29291080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 377,
                    "offsetInEndSection": 398,
                    "text": "the Ishihara's test)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 330,
                    "text": "The test, using an error score, examines both the red-green and blue-yellow axes, with four levels of difficulty for each axis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 272,
                    "text": "In practice the test disk has the advantage of constancy of testing conditions and easy and quick procedure."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22076482",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "The assessment of colour perception, naming and knowledge: a new test device with a case study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/301964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 273,
                    "offsetInEndSection": 411,
                    "text": "If it is necessary to differentiate between protopia and deuteropia the colour test disk is significantly better Ishihara's colour plates."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8763306",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 42,
                    "text": "A new colour vision test for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22076482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 361,
                    "offsetInEndSection": 593,
                    "text": "The norms, obtained from 96 healthy Italian participants, allow normality/pathology judgements on the basis of one-sided tolerance limits, after adjusting the score of each test for the demographic variables of the proband subjects."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11407860",
                "http://www.ncbi.nlm.nih.gov/pubmed/18798490",
                "http://www.ncbi.nlm.nih.gov/pubmed/11927395",
                "http://www.ncbi.nlm.nih.gov/pubmed/25828948",
                "http://www.ncbi.nlm.nih.gov/pubmed/7909420",
                "http://www.ncbi.nlm.nih.gov/pubmed/2547375",
                "http://www.ncbi.nlm.nih.gov/pubmed/7748187",
                "http://www.ncbi.nlm.nih.gov/pubmed/10355528",
                "http://www.ncbi.nlm.nih.gov/pubmed/12578586",
                "http://www.ncbi.nlm.nih.gov/pubmed/3790748"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11927395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 102,
                    "offsetInEndSection": 305,
                    "text": "Using the MCF-7 human breast adenocarcinoma cell line, it has been demonstrated that autocrine GH-stimulated mammary carcinoma cell proliferation decreased the apoptosis rate and enhanced cell spreading."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828948",
                    "endSection": "abstract",
                    "offsetInBeginSection": 145,
                    "offsetInEndSection": 326,
                    "text": "MCF-7 is the most studied human breast cancer cell line in the world, and results from this cell line have had a fundamental impact upon breast cancer research and patient outcomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11407860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 236,
                    "offsetInEndSection": 518,
                    "text": "Since BRCA1 is known to play a role in the maintenance of chromosomal integrity, the increase in chromosomal aberrations in MCF-7 clones suggests that downregulation of BRCA1 expression could be one of the possible mechanisms for increased chromosomal instability in this cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18798490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "OBJECTIVE\nTo investigate whether there are cancer stem cells in the MCF-7 human breast cancer cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18798490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 678,
                    "text": "CONCLUSION\nBreast cancer stem cell exists in MCF-7 and it mainly locates the subpopulation of CD44+ CD24- cells, CD44+ CD24+ cell possibly is breast cancer progenitor cell."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7909420",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828948",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "It is 45 years since a pleural effusion from a patient with metastatic breast cancer led to the generation of the MCF-7 breast cancer cell line."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2547375",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Tumor necrosis factor (TNF)-resistant variant of human mammary cancer MCF-7 cell line was isolated by stepwise selection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10355528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 376,
                    "offsetInEndSection": 569,
                    "text": "The major cell surface alterations in MCF-7/6 cells compared with the parental MCF-7 cell line were a markedly increased CD15 (LewisX) and CD44 antigen cell surface expression on MCF-7/6 cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11927395",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Pit-1/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11102759",
                "http://www.ncbi.nlm.nih.gov/pubmed/11054714",
                "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                "http://www.ncbi.nlm.nih.gov/pubmed/12366811",
                "http://www.ncbi.nlm.nih.gov/pubmed/10734230",
                "http://www.ncbi.nlm.nih.gov/pubmed/19008226",
                "http://www.ncbi.nlm.nih.gov/pubmed/8125750",
                "http://www.ncbi.nlm.nih.gov/pubmed/11348051",
                "http://www.ncbi.nlm.nih.gov/pubmed/19020750",
                "http://www.ncbi.nlm.nih.gov/pubmed/23840601"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "Amino acid sequence from tryptic peptides of three different bovine corneal keratan sulfate proteoglycan (KSPG) core proteins (designated 37A, 37B, and 25) showed similarities to the sequence of a chicken KSPG core protein lumican."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11102759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 666,
                    "text": "Decorin is highly expressed in sclera and sternum, whereas lumican is expressed in these tissues, as well as in liver, at very low levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11054714",
                    "endSection": "abstract",
                    "offsetInBeginSection": 321,
                    "offsetInEndSection": 502,
                    "text": "Western blot study showed that lumican protein is highly abundant relative to decorin, while biglycan and fibromodulin are only detected occasionally in breast tissues (n=15 cases)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                    "endSection": "title",
                    "offsetInBeginSection": 100,
                    "offsetInEndSection": 173,
                    "text": "Protein 37B represents bovine lumican and proteins 37A and 25 are unique."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19020750",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Lumican is a member of a small leucine-rich proteoglycan family and is highly expressed in several types of cancer cells and/or stromal tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11054714",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1006,
                    "offsetInEndSection": 1224,
                    "text": "Further evidence of altered lumican expression in breast cancer was manifested by discordance between lumican mRNA and protein localization in some regions of tumours but not in adjacent morphologically normal tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8125750",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1049,
                    "offsetInEndSection": 1364,
                    "text": "The rate of decorin precursor protein synthesis remained relatively low and constant throughout development, but lumican precursor protein synthesis increased dramatically between days 7 and 9 of embryonic development, to a value 80-fold higher than that of decorin, and then decreased exponentially through day 18."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8099356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 840,
                    "offsetInEndSection": 1099,
                    "text": "About two-thirds of the lumican protein consists of a series of 10 amino acid leucine-rich repeats that occur in regions of calculated high beta-hydrophobic moment, suggesting that the leucine-rich repeats contribute to beta-sheet formation in these proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11102759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 300,
                    "text": "Comparison of deduced amino acid sequences shows that two of five amino acid differences in the mature protein between quail and chick decorin, and two of three for lumican, are non-conservative."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12366811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Lumican is a member of a small leucine-rich proteoglycan family and its overexpression in human breast cancer tissues is reported to influence the growth of cancer cells."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12167569",
                "http://www.ncbi.nlm.nih.gov/pubmed/23852652",
                "http://www.ncbi.nlm.nih.gov/pubmed/24412072",
                "http://www.ncbi.nlm.nih.gov/pubmed/8633005",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/11257517",
                "http://www.ncbi.nlm.nih.gov/pubmed/22687401",
                "http://www.ncbi.nlm.nih.gov/pubmed/23846873",
                "http://www.ncbi.nlm.nih.gov/pubmed/21402137",
                "http://www.ncbi.nlm.nih.gov/pubmed/11432536"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 158,
                    "text": "The effect of rifampicin on cytochrome P450 isoforms in the CYP1A and CYP3A subfamilies has been studied in 72-h cultured precision-cut human liver slices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24412072",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "The HIV protease inhibitor (PI) ritonavir (RTV) has been widely used as a pharmacoenhancer for other PIs, which are substrates of cytochrome P450 3A (CYP3A)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432536",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 649,
                    "text": "The relative potency of the rifamycins as CYP3A inducers is rifampin > rifapentine > rifabutin; rifabutin is also a CYP3A substrate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257517",
                    "endSection": "abstract",
                    "offsetInBeginSection": 652,
                    "offsetInEndSection": 908,
                    "text": "Treatment with phenobarbitone caused CYP2B, CYP2C-2 and CYP3A21 levels to increase, rifampicin caused increases in CYP2B and CYP2C-1 and a decrease in CYP3A21 levels, whereas dioxin caused CYP1A1 and CYP1A2 levels to increase and CYP2E1 levels to decrease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432536",
                    "endSection": "abstract",
                    "offsetInBeginSection": 358,
                    "offsetInEndSection": 516,
                    "text": "The rifamycins are well-known inducers of enzyme systems involved in the metabolism of many drugs, most notably those metabolised by cytochrome P450 (CYP) 3A."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257517",
                    "endSection": "abstract",
                    "offsetInBeginSection": 949,
                    "offsetInEndSection": 1100,
                    "text": "P450 enzyme activities were assessed using 8 different substrates and increases were found after treatment with phenobarbitone, rifampicin, and dioxin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23852652",
                    "endSection": "abstract",
                    "offsetInBeginSection": 460,
                    "offsetInEndSection": 699,
                    "text": "Two Phase 1 clinical trials were conducted in healthy postmenopausal women; crossover designs examined the effects of pretreatment with the CYP modulators rifampicin, ketoconazole, fluconazole and omeprazole on ospemifene pharmacokinetics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 630,
                    "offsetInEndSection": 743,
                    "text": "These results demonstrate that rifampicin induces CYP3A isoforms, but not CYP1A2, in cultured human liver slices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12167569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1189,
                    "offsetInEndSection": 1372,
                    "text": "This mutation disrupts induction of a reporter gene construct by the glucocorticoids dexamethasone and hydrocortisone; yet induction by the potent PXR ligand rifampicin is unaffected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8633005",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 582,
                    "text": "The magnitude of CYP3A induction by rifampicin was compared in the human parental colon carcinoma cell line LS 180/WT (wild type) and in two derivative clones overexpressing the human multidrug resistance gene MDR1 (also designated PGY1) because of either drug selection (LS 180/ADR) or transfection with MDRI cDNA (LS 180/MDR)."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/17726612",
                "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                "http://www.ncbi.nlm.nih.gov/pubmed/23273016",
                "http://www.ncbi.nlm.nih.gov/pubmed/11673470",
                "http://www.ncbi.nlm.nih.gov/pubmed/16721377",
                "http://www.ncbi.nlm.nih.gov/pubmed/8009367",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Chromosome-Specific Centromere Sequences Provide an Estimate of the Ancestral Chromosome 2 Fusion Event in Hominin Genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 842,
                    "offsetInEndSection": 1239,
                    "text": "By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 578,
                    "offsetInEndSection": 786,
                    "text": "Experimental haploidisation of such diploids result in two types of products, those with a normal 7 chromosome karyotype and those with an abnormal 6 chromosome karyotype which contains the fusion chromosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 577,
                    "text": "Thus the chromosome number of the diploids is reduced from the normal 2n = 14 to 2n = 13 with the formation of an abnormally large acrocentric fusion chromosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 961,
                    "text": "We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1230,
                    "text": "Cytological examination of the karyotypes of haploid strains bearing the fusion chromosome suggest that chromosome 2 may correspond to linkage group II and chromosome 3 to linkage group VII."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7227041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 415,
                    "text": "These fusion chromosomes appear to be the products of the tandem translocation of most, if not all, of one acrocentric chromosome to the telomere of a second acrocentric."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 415,
                    "offsetInEndSection": 644,
                    "text": "The recombinant chromosome that harbors the beta/delta fusion gene in elephants is structurally similar to the \"anti-Lepore\" duplication mutant of humans (the reciprocal exchange product of the hemoglobin Lepore deletion mutant)."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22974215",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                "http://www.ncbi.nlm.nih.gov/pubmed/23409978",
                "http://www.ncbi.nlm.nih.gov/pubmed/17940847",
                "http://www.ncbi.nlm.nih.gov/pubmed/23988446",
                "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                "http://www.ncbi.nlm.nih.gov/pubmed/15922867",
                "http://www.ncbi.nlm.nih.gov/pubmed/18508627",
                "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                "http://www.ncbi.nlm.nih.gov/pubmed/25893293"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17940847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 244,
                    "text": "Among different species, the amino acid sequence of EpCAM is highly homologous, indicating that EpCAM is an evolutionary conserved protein."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22974215",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is a single-transmembrane protein, which is involved in numerous cellular processes including cell adhesion, proliferation, maintenance of stemness of embryonic cells and progenitors, migration and invasion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is best known as a tumor-associated protein highly expressed in carcinomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 912,
                    "text": "To test this hypothesis and to evaluate whether lack of EPCAM expression can already be detected in Lynch syndrome-associated adenomas, we analyzed four carcinomas and two adenomas from EPCAM germline deletion carriers for EPCAM protein expression and allelic deletion status of the EPCAM gene region by multiplex ligation-dependent probe amplification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23409978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 550,
                    "text": "To shed light on how proteolytic cleavage is involved in EpCAM signalling, we characterized the protein biochemically using antibodies binding to three different EpCAM domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1381,
                    "offsetInEndSection": 1519,
                    "text": "CONCLUSION\nThese results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1335,
                    "offsetInEndSection": 1524,
                    "text": "Moreover, we report lack of EPCAM protein expression in a colorectal adenoma, suggesting that EPCAM immunohistochemistry may detect EPCAM germline deletions already at a precancerous stage."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15922867",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18508627",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24401533",
                "http://www.ncbi.nlm.nih.gov/pubmed/25854486",
                "http://www.ncbi.nlm.nih.gov/pubmed/22595815",
                "http://www.ncbi.nlm.nih.gov/pubmed/22259168",
                "http://www.ncbi.nlm.nih.gov/pubmed/25895845",
                "http://www.ncbi.nlm.nih.gov/pubmed/23382458",
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/24554904",
                "http://www.ncbi.nlm.nih.gov/pubmed/23466963",
                "http://www.ncbi.nlm.nih.gov/pubmed/29138609"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29138609",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 420,
                    "text": "Apixaban belongs to this group of drugs, and is a factor Xa inhibitor that has emerged as a popular pharmacological agent worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 814,
                    "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25895845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "BACKGROUND AND OBJECTIVES\nApixaban is a direct oral anticoagulant (DOAC) targeting factor Xa and thus quenching thrombin generation and clot formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25854486",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "Four new oral anticoagulants (NOAC), apixaban, rivaroxaban, edoxaban, and dabigatran, are now available in the USA; however, only apixaban and rivaroxaban are FDA approved for the prevention of venous thromboembolism following orthopedic surgery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24401533",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "{blacktriangledown} Apixaban and {blacktriangledown} rivaroxaban for stroke prevention in AF."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24554904",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 38,
                    "text": "The new factor Xa inhibitor: Apixaban."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23466963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Novel oral anticoagulants (OACs), including dabigatran etexilate, rivaroxaban, and apixaban, are available alternative anticoagulant therapy to vitamin K antagonists."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29138609",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 287,
                    "text": "Initially, vitamin K antagonists were used as stroke prophylaxis; but more recently, a group of drugs known as novel oral anticoagulants have been developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24401533",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 937,
                    "text": "The use of dabigatran has increased significantly in the UK and two other drugs have been licensed for this indication (\u25beapixaban-Eliquis, Bristol-Myers Squibb/Pfizer; \u25berivaroxaban-Xarelto, Bayer plc).2-6 In addition, published drug safety alerts have highlighted the risk of serious haemorrhage associated with the use of these drugs.7-9 Here we review the evidence for apixaban and rivaroxaban for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25854486",
                    "endSection": "abstract",
                    "offsetInBeginSection": 247,
                    "offsetInEndSection": 441,
                    "text": "Apixaban, rivaroxaban, and edoxaban's anticoagulant activity can be measured using a chromogenic anti-factor Xa assay but there is no widely available means of measuring dabigatran blood levels."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27975249",
                "http://www.ncbi.nlm.nih.gov/pubmed/6421824",
                "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788226",
                "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                "http://www.ncbi.nlm.nih.gov/pubmed/26502977",
                "http://www.ncbi.nlm.nih.gov/pubmed/28106992",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358680",
                "http://www.ncbi.nlm.nih.gov/pubmed/19036972",
                "http://www.ncbi.nlm.nih.gov/pubmed/21705366"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 504,
                    "offsetInEndSection": 698,
                    "text": "Recently, it has become possible to assess the regional distribution and severity of tau burden in vivo with the development of novel radiotracers for positron emission tomography (PET) imaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26502977",
                    "endSection": "abstract",
                    "offsetInBeginSection": 588,
                    "offsetInEndSection": 839,
                    "text": "In particular, we assessed intracellular tau and extracellular tau, soluble tau, insoluble tau and phosphorylated tau at certain sites utilizing a combination of in vivo microdialysis, biochemical analysis and specific ELISAs recognizing each species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 1053,
                    "text": "In this article, we provide a comprehensive discussion of tau pathophysiology, its quantification with novel PET radiotracers, as well as a systematic review of tau PET imaging in normal aging and various dementia conditions: mild cognitive impairment, Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, and Lewy body dementia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 963,
                    "text": "The recent development of selective in-vivo tau PET imaging ligands including [(18)F]THK523, [(18)F]THK5117, [(18)F]THK5105 and [(18)F]THK5351, [(18)F]AV1451(T807) and [(11)C]PBB3 has provided information about the role of tau in the early phases of neurodegenerative diseases, and provided support for diagnosis, prognosis, and imaging biomarkers to track disease progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 124,
                    "offsetInEndSection": 543,
                    "text": "The introduction of these tracers, namely \u03b2-amyloid (A\u03b2) and later tau, are providing the tools to change the landscape and refine our understanding of A\u03b2 and tau deposition in the brain, allowing to investigate the causes, refine diagnosis and improve treatment of major neurodegenerative conditions such as Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE) and frontotemporal lobar degeneration (FTLD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6421824",
                    "endSection": "abstract",
                    "offsetInBeginSection": 482,
                    "offsetInEndSection": 657,
                    "text": "To study the mRNA and genomic complexity of tau protein, we used tau mRNA, purified from polysomes with tau antiserum, to isolate embryonic mouse tau complementary DNA clones."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 278,
                    "offsetInEndSection": 433,
                    "text": "In AD, it has been shown that the density of hyperphosphorylated tau tangles correlates closely with neuronal dysfunction and cell death, unlike \u03b2-amyloid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24788226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 310,
                    "offsetInEndSection": 588,
                    "text": "In the present study, we used Drosophila as a model to evaluate the toxicity of a set of truncated tau fragments in vivo and found that the flies harboring C-terminal-truncated tau exhibited less toxicity due to the unstable characteristic of C-terminal-truncated tau fragments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26572762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1117,
                    "offsetInEndSection": 1455,
                    "text": "In this review, we discuss the role of aggregated tau in tauopathies, the challenges posed in developing selective tau ligands as biomarkers, the state of development in tau tracers, and the new clinical information that has been uncovered, as well as the opportunities for improving diagnosis and designing clinical trials in the future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21705366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 624,
                    "text": "Here we studied how important is Tau phosphorylation for axonal transport and neurohormone release in vivo, using the Drosophila model."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/9274974",
                "http://www.ncbi.nlm.nih.gov/pubmed/14704478",
                "http://www.ncbi.nlm.nih.gov/pubmed/8826485",
                "http://www.ncbi.nlm.nih.gov/pubmed/11785912",
                "http://www.ncbi.nlm.nih.gov/pubmed/16603156",
                "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                "http://www.ncbi.nlm.nih.gov/pubmed/5103482",
                "http://www.ncbi.nlm.nih.gov/pubmed/3095571"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 318,
                    "text": "The formalin test, which is based on these observations, is now widely used as a model of pain produced by tissue injury, but the neural mechanisms of pain and analgesia in this test have not been identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 785,
                    "offsetInEndSection": 969,
                    "text": "These results suggest that the response to formalin is organized in the brain stem but the antinociceptive effect of morphine in this test is mediated by the diencephalon or forebrain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9274974",
                    "endSection": "abstract",
                    "offsetInBeginSection": 705,
                    "offsetInEndSection": 913,
                    "text": "These observations suggest that cyclooxygenase-2 may not be associated with spinal prostanoid synthesis acutely or with facilitated nociception which occurs within the limited time frame of the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16603156",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Although formalin-induced activity in primary afferent fibers and spinal dorsal horn is well described, the forebrain neural basis underlying each phase of behavior in formalin test has not yet been clarified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 682,
                    "text": "It is suggested that zimelidine produces a central antinociceptive effect, but elicits a peripheral hyperalgesia, which predominates in the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 324,
                    "text": "The selective inhibitor of the reuptake of 5-hydroxytryptamine (5-HT), zimelidine, was administered intraperitoneally to mice (10 mg/kg) and nociceptive sensitivity was evaluated using the formalin test (20 microliters of 1% formalin, injected subcutaneously) and the assay for substance P (5 ng administered intrathecally)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1427,
                    "offsetInEndSection": 1673,
                    "text": "CONCLUSION\nThese data suggest that this automated movement detection system for formalin test is a simple, validated measure with good pharmacological sensitivity suitable for discovering novel analgesics or investigating central pain mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16603156",
                    "endSection": "abstract",
                    "offsetInBeginSection": 406,
                    "offsetInEndSection": 808,
                    "text": "Formalin-induced neuronal activities were simultaneously recorded from primary somatosensory cortex (SI), anterior cingulate cortex (ACC) and medial dorsal (MD) and ventral posterior (VP) thalamus during different phases (i.e., first phase, interphase, second phase and third recovery phase starting from 70 min after injection) of formalin test, using a multi-channel, single-unit recording technique."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15659112",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "AIM\nTo investigate the validity and sensitivity of an automatic movement detection system developed by our laboratory for the formalin test in rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 784,
                    "text": "Doses of morphine that suppress the behavioral response to formalin in normal rats are not antinociceptive in the formalin test in decerebrate rats although sedation, catalepsy and inhibition of the tail-flick reflex still occur."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25983799",
                "http://www.ncbi.nlm.nih.gov/pubmed/12761012",
                "http://www.ncbi.nlm.nih.gov/pubmed/21397387",
                "http://www.ncbi.nlm.nih.gov/pubmed/26713152",
                "http://www.ncbi.nlm.nih.gov/pubmed/7434194",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                "http://www.ncbi.nlm.nih.gov/pubmed/1738436",
                "http://www.ncbi.nlm.nih.gov/pubmed/16150293",
                "http://www.ncbi.nlm.nih.gov/pubmed/8456713",
                "http://www.ncbi.nlm.nih.gov/pubmed/8886740"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25983799",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Anterior cervical discectomy and fusion(ACDF) is a surgical treatment for cervical radiculopathy and myelopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25983799",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 279,
                    "text": "Though this is a common surgery, spinal epidural hematomas occur rarely and an immediate treatment decision and surgical decompression are required in this situation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 914,
                    "offsetInEndSection": 1070,
                    "text": "A 22-yr-old man with a spontaneous spinal epidural hematoma who was receiving warfarin treatment for a mechanical aortic valve is presented in this article."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Spontaneous spinal epidural hematoma is an uncommon cause of spinal cord compression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 78,
                    "offsetInEndSection": 218,
                    "text": "This study reports a case of thoracic spinal epidural hematoma following spinal manipulative therapy in the absence of predisposing factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 511,
                    "text": "Spontaneous spinal epidural hematoma should be suspected in any patient receiving anticoagulant agents who complains of local or referred spinal pain associated with limb weakness, sensory deficits, or urinary retention."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16150293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 52,
                    "offsetInEndSection": 177,
                    "text": "Progressive neurologic deficits that are associated with epidural hematomas can develop rapidly and require prompt treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Spinal epidural hematoma associated with oral anticoagulation therapy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12761012",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Transient paraplegia revealed by intraoperative neurophysiological monitoring: was it caused by the epidural anesthetic or an epidural hematoma?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Spinal epidural hematoma is a rare complication of chiropractic manipulation."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                "http://www.ncbi.nlm.nih.gov/pubmed/10568516",
                "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                "http://www.ncbi.nlm.nih.gov/pubmed/23602499",
                "http://www.ncbi.nlm.nih.gov/pubmed/23560303",
                "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                "http://www.ncbi.nlm.nih.gov/pubmed/16205714",
                "http://www.ncbi.nlm.nih.gov/pubmed/26387956",
                "http://www.ncbi.nlm.nih.gov/pubmed/19692580",
                "http://www.ncbi.nlm.nih.gov/pubmed/29186753"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Eight severe inherited neurodegenerative diseases are caused by expansion of glutamine repeats in the affected proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 329,
                    "text": "In every case, proteins with repeats of fewer than 38 glutamine residues are harmless, but those with repeats of more than 41 glutamine residues form toxic neuronal nuclear aggregates in the affected neurons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 607,
                    "text": "Similarly, proteins that have repeats of fewer than 37 glutamine residues are soluble in vitro, whereas proteins with repeats of more than 40 glutamine residues precipitate as insoluble fibres, apparently because of a structural transition associated with the increased length."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "The expansion of homopolymeric glutamine (polyQ) or alanine (polyA) repeats in certain proteins owing to genetic mutations induces protein aggregation and toxicity, causing at least 18 human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10568516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 522,
                    "text": "Unfortunately, current methods for preparing recombinant constructs with large glutamine tracts either alter the coding region adjacent to the repeat or yield highly unstable pure CAG repeats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Glutamine repeats and neurodegenerative diseases: molecular aspects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10568516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 641,
                    "text": "We have developed a technique for expanding repeats that results in a more stable mix of CAG and CAA glutamine codons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "Homopolymeric amino acid repeat sequences in proteins are of particular interest due to the discovery that expanded copy numbers of these repeats are the molecular basis for a growing list of human genetic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10568516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "At least eight neurodegenerative diseases result from expansions of polyglutamine tracts encoded by CAG trinucleotide repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 617,
                    "text": "There is emerging evidence that expansions of amino acids encoded by other reading frames of CAG/CUG repeats, including polyalanine and polyleucine, could contribute to toxicity in the 'polyglutamine' diseases."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                "http://www.ncbi.nlm.nih.gov/pubmed/9811562",
                "http://www.ncbi.nlm.nih.gov/pubmed/2256928",
                "http://www.ncbi.nlm.nih.gov/pubmed/23142632",
                "http://www.ncbi.nlm.nih.gov/pubmed/11792821",
                "http://www.ncbi.nlm.nih.gov/pubmed/22265972",
                "http://www.ncbi.nlm.nih.gov/pubmed/10984438",
                "http://www.ncbi.nlm.nih.gov/pubmed/11470279",
                "http://www.ncbi.nlm.nih.gov/pubmed/11173535"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11470279",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 376,
                    "text": "The X-linked form of EDMD is caused by mutations in the emerin gene, whereas autosomal dominant EDMD is caused by mutations in the lamin A/C gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                    "endSection": "abstract",
                    "offsetInBeginSection": 172,
                    "offsetInEndSection": 509,
                    "text": "The nucleotide sequence and the deduced amino-acid sequence of the mouse lamin C are compared with the previously published human lamin A/C sequences with respect to (a) the general organisation, (b) homologies, (c) predictions for the essential structural characteristics of lamins and (d) the localization of the most conserved region."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Nucleotide sequence of the full-length mouse lamin C cDNA and its deduced amino-acid sequence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 211,
                    "offsetInEndSection": 502,
                    "text": "As has been reported for human lamin A/C cDNAs, a large part of the 5' sequence of our mouse lamin A clone was essentially identical with a previously reported mouse lamin C cDNA sequence, and the deduced C-terminal amino acid sequence shared strong homology with the human lamin A sequence."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Nucleotide sequence of a mouse lamin A cDNA and its deduced amino acid sequence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7916626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 78,
                    "text": "We have cloned and determined the nucleotide sequence of a mouse lamin A cDNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11173535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 755,
                    "text": "We also used the yeast two-hybrid system to clarify that this interaction requires the top half of the tail domain (amino acid 384-566) of lamin A. Lamin A and lamin C are alternative splicing products of the lamin A/C gene that is responsible for autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11173535",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 443,
                    "text": "Although the function of this protein is still unknown, we revealed that C-terminus transmembrane domain-truncated emerin (amino acid 1-225) binds to lamin A with higher affinity than lamin C. Screening for the emerin binding protein and immunoprecipitation analysis showed that lamin A binds to emerin specifically."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23142632",
                    "endSection": "abstract",
                    "offsetInBeginSection": 189,
                    "offsetInEndSection": 422,
                    "text": "Mutations of the lamin A/C gene are associated with several different neuromuscular diseases, and the detailed effect of disease-associated amino acid substitutions on the structure and stability of human lamin dimers is yet unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9811562",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 183,
                    "text": "The mechanism by which human nuclear lamin B is targeted and assembled has been studied by transfecting into mammalian cells lamin mutants deleted of three sequences unique to lamins."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7464911",
                "http://www.ncbi.nlm.nih.gov/pubmed/12589051",
                "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                "http://www.ncbi.nlm.nih.gov/pubmed/3096714",
                "http://www.ncbi.nlm.nih.gov/pubmed/2912448",
                "http://www.ncbi.nlm.nih.gov/pubmed/17702618",
                "http://www.ncbi.nlm.nih.gov/pubmed/20875424",
                "http://www.ncbi.nlm.nih.gov/pubmed/10461185",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                "http://www.ncbi.nlm.nih.gov/pubmed/3635476"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 350,
                    "text": "In this article, we discuss the structural properties of clathrin cages and the triskelions which assemble to form them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 351,
                    "offsetInEndSection": 564,
                    "text": "The function of clathrin depends on the structure of these triskelions and the interactions they make both with each other during assembly and with the adaptor protein network that drives coated vesicle formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 436,
                    "text": "Clathrin functions as a heterohexamer, adopting a three-legged triskelion structure of three clathrin light chains and three heavy chains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7464911",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 794,
                    "text": "Here we show that purified clathrin coats dissociate reversibly into triskelions, structures composed of three usually bent, rather flexible legs irradiated from a centre."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 565,
                    "offsetInEndSection": 750,
                    "text": "The atomic resolution structure of clathrin domains has been revealed by X-ray crystallography while scattering studies have enabled the shape of a triskelion in solution to be deduced."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Atomic structure of clathrin: a beta propeller terminal domain joins an alpha zigzag linker."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 946,
                    "text": "Cryo-electron microscopy maps have shown the secondary structure of entire cages, how individual triskelion legs are arranged to form a cage and enabled some bound adaptor proteins to be located."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 266,
                    "offsetInEndSection": 381,
                    "text": "The structure comprises the globular \"terminal domain\" and the linker that joins it to the end of a triskelion leg."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28271490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1282,
                    "offsetInEndSection": 1451,
                    "text": "It now remains to determine the precise nature of the interactions which occur between clathrin triskelions, light chain and heavy chain and the adaptor protein network."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7464911",
                    "endSection": "abstract",
                    "offsetInBeginSection": 795,
                    "offsetInEndSection": 975,
                    "text": "We have determined the molecular weight of these triskelions and conclude that they contain trimers of clathrin together with about three light molecular weight polypeptide chains."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/6157451",
                "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                "http://www.ncbi.nlm.nih.gov/pubmed/7520024",
                "http://www.ncbi.nlm.nih.gov/pubmed/18228513",
                "http://www.ncbi.nlm.nih.gov/pubmed/2462020",
                "http://www.ncbi.nlm.nih.gov/pubmed/27068622",
                "http://www.ncbi.nlm.nih.gov/pubmed/6680688",
                "http://www.ncbi.nlm.nih.gov/pubmed/27173133"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 940,
                    "offsetInEndSection": 1183,
                    "text": "The peripheral-central myelin transitional zone is in close proximity to the axonal pole in the vestibular ganglion cells, while in the cochlear nerve it is near the spiral foramina, at variable distance from the axonal pole of ganglion cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 265,
                    "text": "The perikaryal myelin is thin and partially loose, whereas axon and dendrite are enveloped by compacted myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 636,
                    "text": "The major myelin-associated glycoprotein is probably not present in compacted myelin, but immunocytochemical and subfractionation studies indicate that it is confined to the periaxonal and paranodal region of the myelin sheath."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Myelin-associated oligodendrocytic basic protein is a member of the proteins constituting the central nervous system myelin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7520024",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Myelin-associated glycoprotein is not detectable in perikaryal myelin of spiral ganglion neurons of adult mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 599,
                    "text": "In order to apply remyelinating strategies to these disorders, it is essential to know whether the myelin damage results from a primary attack on myelin or the oligodendrocyte or both, and whether indeed these lead to myelin breakdown and demyelination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 347,
                    "offsetInEndSection": 532,
                    "text": "It is known that the number of myelin lamellae increases linearly with axonal diameter, and that the rate of radial axonal growth is the factor controlling the rate of myelin formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 637,
                    "offsetInEndSection": 761,
                    "text": "In experimental demyelination and multiple sclerosis, the major glycoprotein is the first myelin constituent to be affected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9014171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 633,
                    "text": "Our data indicate that both in the cochlear and vestibular nerves the myelin of the perikaryon and dendrite is composed by specific peripheral myelin proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27173133",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Rapid nerve conduction in the CNS is facilitated by insulation of axons with myelin, a specialized oligodendroglial compartment distant from the cell body."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28183751",
                "http://www.ncbi.nlm.nih.gov/pubmed/27789633",
                "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                "http://www.ncbi.nlm.nih.gov/pubmed/26036697",
                "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                "http://www.ncbi.nlm.nih.gov/pubmed/11895955",
                "http://www.ncbi.nlm.nih.gov/pubmed/21976222",
                "http://www.ncbi.nlm.nih.gov/pubmed/15805518",
                "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                "http://www.ncbi.nlm.nih.gov/pubmed/16556309"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11895955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "Brucella is a facultative intracellular parasite that causes brucellosis in animals and humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805518",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucellosis is a worldwide disease of humans and livestock that is caused by a number of very closely related classical Brucella species in the alpha-2 subdivision of the Proteobacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27789633",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Brucella abortus is generally known to cause brucellosis in cattle and buffalo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 91,
                    "offsetInEndSection": 342,
                    "text": "Brucella melitensis, B. abortus and B. suis, which are transmitted between animals both vertically and horizontally, cause abortion and infertility in their primary natural hosts - goats and sheep (B. melitensis), cows (B. abortus) and sows (B. suis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "The bacterium that causes canine abortion has polynucleotide sequences similar, in deoxyribonucleic acid (DNA)-DNA homology studies, to those of Brucella suis and, by inference from previous data, those of B. abortus and B. melitensis as well as B. neotomae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16556309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 14,
                    "offsetInEndSection": 217,
                    "text": "are facultative intracellular pathogens that have the ability to survive and multiply in professional and non-professional phagocytes, and cause abortion in domestic animals and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28183751",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Brucellosis, which is among the most widespread global zoonotic diseases, is endemic in the nation of Georgia and causes substantial human morbidity and economic loss."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16556309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 671,
                    "offsetInEndSection": 814,
                    "text": "The strains that are pathogenic for humans (B. abortus, B. suis, B. melitensis) carry a smooth LPS involved in the virulence of these bacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "The use of whole-cell antigens in agglutination and agglutinin-absorption tests showed that the organism causing abortion in dogs is similar to rough Brucella abortus, B. melitensis, and B. ovis, but different from smooth Brucella cultures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26036697",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "BACKGROUND\nBrucellosis is a major zoonoses affects wide range of domesticated as well as wild animals."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                "http://www.ncbi.nlm.nih.gov/pubmed/3111268",
                "http://www.ncbi.nlm.nih.gov/pubmed/8855270",
                "http://www.ncbi.nlm.nih.gov/pubmed/25486780",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                "http://www.ncbi.nlm.nih.gov/pubmed/17027252",
                "http://www.ncbi.nlm.nih.gov/pubmed/402080",
                "http://www.ncbi.nlm.nih.gov/pubmed/26693966"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 524,
                    "text": "The availability of edible insects in East Asia aided the spread of the unaggressive, highly cooperative Neanderthals, who interbred with H. sapiens in Asia, resulting in a higher admixture of Neanderthal DNA in East Asian populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 565,
                    "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 648,
                    "text": "If the Neanderthal population was large compared to the Homo sapiens population at the beginning of the contact period, we show that genetic introgression should have been fast and complete meaning that most of the Neanderthal private alleles should be found in the modern human gene pool in case of ancient admixture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1139,
                    "text": "In contrast, we find that recent results implying that the Neanderthal sequences are products of PCR artifacts are not well supported, suffering from inadequate experimental design and a presumably high percentage (>68%) of chimeric sequences due to \"jumping PCR\" events."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 997,
                    "text": "We show that the power to reject ancient admixture increases as the ratio, at the time of putative admixture, of the population size of Homo sapiens over that of Neanderthal decreases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1139,
                    "text": "In the Sub-Saharan region, unaffected by Denisovan or Neanderthal interbreeding, H. sapiens interbred with H. heidelbergensis, because high humidity militated against fire-making and allowed the survival of these non-fire-making hominins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 998,
                    "offsetInEndSection": 1164,
                    "text": "We find that the power to reject ancient admixture might be particularly low if the population size of Homo sapiens was comparable to the Neanderthal population size."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 408,
                    "offsetInEndSection": 669,
                    "text": "Using Bayesian inference and the largest dataset to date, we find strong support for a monophyletic Neanderthal clade outside the diversity of contemporary humans, in agreement with the expectations of the Out-of-Africa replacement model of modern human origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/402080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 338,
                    "offsetInEndSection": 754,
                    "text": "Trends for tooth size over this period indicate that (1) human evolution does not stop with the appearance of \"anatomically modern Homo sapiens,\" (2) changes in tooth size fluctuate with increases in the efficiency and complexity of cultural systems, and (3) the Early Upper Paleolithic sample should be considered transitional between Wurm II European Neanderthals and later Upper Paleolithic and Mesolithic groups."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2926218",
                "http://www.ncbi.nlm.nih.gov/pubmed/8817754",
                "http://www.ncbi.nlm.nih.gov/pubmed/1769984",
                "http://www.ncbi.nlm.nih.gov/pubmed/20478727",
                "http://www.ncbi.nlm.nih.gov/pubmed/432317",
                "http://www.ncbi.nlm.nih.gov/pubmed/2883783",
                "http://www.ncbi.nlm.nih.gov/pubmed/3559089",
                "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                "http://www.ncbi.nlm.nih.gov/pubmed/5563816"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 422,
                    "offsetInEndSection": 609,
                    "text": "Comorbid conditions associated with Dupuytren's contracture are repetitive trauma to the hands, diabetes, and seizures, but it has never before been associated with neuromuscular disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20478727",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 45,
                    "text": "Dupuytren contracture is not a rare disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3559089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Severe recurrent digital Dupuytren's contracture, with pseudomotor changes and inadequate palmar tissue, is often treated with amputation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 421,
                    "text": "Dupuytren's contracture is a common disease, especially in Northern Europe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Limb-girdle muscular dystrophies (LGMDs) is a heterogeneous group of muscular dystrophies that mostly affect the pelvic and shoulder girdle muscle groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8817754",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 567,
                    "text": "The nosological individualization of this soft tissue rheumatism is analyzed based on a review of Dupuytren's lectures and of writings by XIXth century practitioners; the other two conditions included in Dupuytren's diathesis, namely Ledderhose's contracture and Peyronie's disease, are also discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 345,
                    "text": "We report here a case of neuromuscular disease associated with Dupuytren's contracture, which has never been described before as cosegregating with an autosomal dominant type of inheritance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2883783",
                    "endSection": "abstract",
                    "offsetInBeginSection": 258,
                    "offsetInEndSection": 373,
                    "text": "A disturbance of collagen metabolism must, therefore, be considered as a possible cause of Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5563816",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Dupuytren's contracture of the fingers: a simplified approach to the surgical treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5563816",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 290,
                    "text": "A new surgical approach to the disease that can correct the contractures without the attendant morbidity is urgently needed."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20477788",
                "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                "http://www.ncbi.nlm.nih.gov/pubmed/18366057",
                "http://www.ncbi.nlm.nih.gov/pubmed/22497627",
                "http://www.ncbi.nlm.nih.gov/pubmed/27664794",
                "http://www.ncbi.nlm.nih.gov/pubmed/9571181",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                "http://www.ncbi.nlm.nih.gov/pubmed/20634512",
                "http://www.ncbi.nlm.nih.gov/pubmed/16734695"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18366057",
                    "endSection": "abstract",
                    "offsetInBeginSection": 198,
                    "offsetInEndSection": 419,
                    "text": "We performed a meta-analysis on the association between the 9 most studied MC1R variants (p.V60L, p.D84E, p.V92M, p.R142H, p.R151C, p.I155T, p.R160W, p.R163Q and p.D294H) and melanoma and/or red hair, fair skin phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 502,
                    "text": "The R151C, R160W and D294H alleles, designated 'R', are strongly associated with the RHC phenotype and have been proposed to result in loss of function receptors due to impaired G-protein coupling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 736,
                    "text": "The V60L variant, which is common in the population may act as a partially penetrant recessive allele."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22497627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A single nucleotide polymorphism (MC1R: c.376A>G) in the MC1R gene was found to be highly correlated with pigment phenotype in the Gyrfalcon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                    "endSection": "abstract",
                    "offsetInBeginSection": 425,
                    "offsetInEndSection": 627,
                    "text": "In vitro expression studies revealed that variant receptors with reduced cell surface expression, including V60L, D84E, R151C, I155T, R160W and R163Q, showed a corresponding impairment in cAMP coupling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 633,
                    "text": "We have investigated 174 individuals from 11 large kindreds with a preponderance of red hair and an additional 99 unrelated redheads, for MC1R variants and have confirmed that red hair is usually inherited as a recessive characteristic with the R151C, R160W, D294H, R142H, 86insA and 537insC alleles at this locus."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18366057",
                    "endSection": "abstract",
                    "offsetInBeginSection": 999,
                    "offsetInEndSection": 1082,
                    "text": "No association with melanoma or phenotype was found for p.V60L and p.V92M variants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27664794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 1142,
                    "text": "Compared to the MC1R rufous allele, responsible for reddish coloration, the white allele was not only associated with an expected lower expression of melanogenic-related genes (TYR, TYRP1, OCA2, SLC45A2, KIT, DCT) but also with a lower MC1R expression and a higher expression of ASIP, the MC1R antagonist."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 817,
                    "offsetInEndSection": 1092,
                    "text": "Using immunofluorescence and ligand binding studies, we found that melanocytic cells exogenously or endogenously expressing MC1R show strong surface localization of the wild-type and D294H alleles but markedly reduced cell surface expression of the R151C and R160W receptors."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9683501",
                "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                "http://www.ncbi.nlm.nih.gov/pubmed/8421783",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/29094278",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/24668569",
                "http://www.ncbi.nlm.nih.gov/pubmed/23567048",
                "http://www.ncbi.nlm.nih.gov/pubmed/14729571",
                "http://www.ncbi.nlm.nih.gov/pubmed/24053231"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "The recent elucidation of protein structures based upon repeating amino acid motifs, including the armadillo motif, the HEAT motif and tetratricopeptide repeats, reveals that they belong to the class of helical repeat proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 438,
                    "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1088,
                    "text": "HEAT repeats were also found in the TBP-associated TIP120 protein, a global enhancer of transcription, and in the budding yeast Mot1p protein, which is a member of the SWI2/SNF2 family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 462,
                    "text": "In order to investigate the origin of the stability of these proteins, we dissect the subdomain architecture of the giant repeat protein PR65/A, which comprises 15 \u03b1-helical HEAT repeats, using a series of truncations and deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1266,
                    "offsetInEndSection": 1498,
                    "text": "HEAT repeats also were found in dis1-TOG family and cofactor D family microtubule-associated proteins, which, owing to their roles in microtubule dynamics, perform functions related to mitotic progression and chromosome segregation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1645,
                    "text": "Hence, our analysis predicts structural features of these proteins and suggests that HEAT repeats may play important roles in chromosome dynamics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 707,
                    "offsetInEndSection": 902,
                    "text": "Clathrin adaptor and COP-I coatomer subunits, which function in vesicle coat assembly and were previously noted to share weak sequence similarity to condensin subunits, also contain HEAT repeats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23567048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 310,
                    "text": "Conversion of HSF from a monomer to a homotrimer or heterotrimer is essential for its binding to heat shock elements (HSEs) comprised of inverted repeats of the pentamer nGAAn."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                "http://www.ncbi.nlm.nih.gov/pubmed/15173609",
                "http://www.ncbi.nlm.nih.gov/pubmed/1715506",
                "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                "http://www.ncbi.nlm.nih.gov/pubmed/23825692",
                "http://www.ncbi.nlm.nih.gov/pubmed/27684355",
                "http://www.ncbi.nlm.nih.gov/pubmed/12952867",
                "http://www.ncbi.nlm.nih.gov/pubmed/27264314",
                "http://www.ncbi.nlm.nih.gov/pubmed/23962426",
                "http://www.ncbi.nlm.nih.gov/pubmed/10720679"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1338,
                    "offsetInEndSection": 1384,
                    "text": "Gid4 is also a metabolically unstable protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 452,
                    "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27684355",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 791,
                    "text": "Here we describe assays to examine the half-life of misfolded proteins in mammalian cells using a highly aggregation-prone protein, Ataxin-1 with an extended polyglutamine (polyQ) stretch, and a conformationally unstable luciferase mutant as models."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "Although it is widely appreciated that the use of global translation inhibitors, such as cycloheximide, in protein degradation assays may result in artefacts, these inhibitors continue to be employed, owing to the absence of robust alternatives."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1090,
                    "offsetInEndSection": 1141,
                    "text": "a specific ubiquitin ligase) is itself short-lived."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12952867",
                    "endSection": "abstract",
                    "offsetInBeginSection": 754,
                    "offsetInEndSection": 865,
                    "text": "We excluded a potential transcriptional impairment by performing quantitative RT-PCR on the patient's material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 576,
                    "text": "In PRT assays, one measures, during a chase, the ratio of a test protein to a long-lived reference protein, a dihydrofolate reductase (DHFR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264314",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 438,
                    "text": "For example, Huntington's disease (HD) is an incurable hereditary neurodegenerative disorder caused by the cytotoxicity of mutant huntingtin protein (mHTT)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1385,
                    "offsetInEndSection": 1566,
                    "text": "Through analyses of short-lived Mdh2 as a target of short-lived Gid4, we illustrate the advantages of PRT over degradation assays that lack a reference and/or involve cycloheximide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 246,
                    "offsetInEndSection": 434,
                    "text": "We describe here the promoter reference technique (PRT), an assay for protein degradation with two advantageous features: a reference protein and a gene-specific inhibition of translation."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                "http://www.ncbi.nlm.nih.gov/pubmed/26983831",
                "http://www.ncbi.nlm.nih.gov/pubmed/22200143",
                "http://www.ncbi.nlm.nih.gov/pubmed/28203202",
                "http://www.ncbi.nlm.nih.gov/pubmed/28603750",
                "http://www.ncbi.nlm.nih.gov/pubmed/15790784"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "The RNA exosome is a multisubunit 3' to 5' exoribonuclease complex that participates in degradation and processing of cellular RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 580,
                    "offsetInEndSection": 889,
                    "text": "How exosomes target recipient cells in vivo remains largely unknown, however, exosomes are selectively enriched in some transmembrane proteins that can be genetically engineered to display ligands/homing peptides on their surface, which confers exosome targeting capability to cells bearing cognate receptors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "The exosome consists of a core often essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 816,
                    "text": "Comparative biochemical analysis between purified subunits and reconstituted exosomes using AU-rich, polyadenylated (poly[A]), generic, and structured RNA substrates reveals processive phosphorolytic activities for human Rrp41/Rrp45 and the 9-subunit human exosome, processive hydrolytic activities for yeast Rrp44 and the yeast 10-subunit exosome, distributive hydrolytic activities for Rrp6, and processive and distributive hydrolytic activities for the yeast 11-subunit exosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The exosome consists of a core of ten essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 705,
                    "offsetInEndSection": 855,
                    "text": "Here, we review cofactors and functions of the cytoplasmic exosome and provide unanswered questions on the mechanisms of cytoplasmic exosome function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 708,
                    "offsetInEndSection": 858,
                    "text": "Here, we review cofactors and functions of the cytoplasmic exosome and provide unanswered questions on the mechanisms of cytoplasmic exosome function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 376,
                    "text": "The cytoplasmic exosome has been extensively characterized in the budding yeast Saccharomyces cerevisiae and some characterization of its metazoan counterpart indicates that most functional aspects are conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 377,
                    "text": "The cytoplasmic exosome has been extensively characterized in the budding yeast Saccharomyces cerevisiae and some characterization of its metazoan counterpart indicates that most functional aspects are conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 817,
                    "offsetInEndSection": 1033,
                    "text": "To elucidate the architecture of a eukaryotic exosome, its conserved surfaces, and the structural basis for RNA decay, we report the X-ray structure determination for the 286 kDa nine-subunit human exosome at 3.35 A."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                "http://www.ncbi.nlm.nih.gov/pubmed/8390924",
                "http://www.ncbi.nlm.nih.gov/pubmed/26864944",
                "http://www.ncbi.nlm.nih.gov/pubmed/2556801",
                "http://www.ncbi.nlm.nih.gov/pubmed/8356050",
                "http://www.ncbi.nlm.nih.gov/pubmed/3031592",
                "http://www.ncbi.nlm.nih.gov/pubmed/21783031",
                "http://www.ncbi.nlm.nih.gov/pubmed/26106594",
                "http://www.ncbi.nlm.nih.gov/pubmed/23479409"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 881,
                    "text": "These data demonstrate functional relatedness between the promoter and enhancers, supporting the hypothesis that enhancers could have evolved from duplicated promoter domains that bind essential transcription factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8356050",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 418,
                    "text": "Nonetheless, the arrangement of functional elements, such as spacer promoters and enhancers, is thought to be highly conserved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Enhancers of RNA polymerase I transcription in higher eukaryotes are repetitive elements within the intergenic spacers of rRNA genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Ribosomal gene promoter domains can function as artificial enhancers of RNA polymerase I transcription, supporting a promoter origin for natural enhancers in Xenopus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26864944",
                    "endSection": "abstract",
                    "offsetInBeginSection": 519,
                    "offsetInEndSection": 674,
                    "text": "In a search of the DHRS4-AS1 region for nearby enhancers, we identified an enhancer located 13.8 kb downstream of the DHRS4-AS1 transcriptional start site."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 718,
                    "offsetInEndSection": 947,
                    "text": "We confirm that the pM and pH promoters are activated independently of each other and, in particular, we show that the activation of pM in fast muscle is not responsible for the downregulation of the downstream pH in this tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 302,
                    "text": "In transgenic mice, the upstream pN and the downstream pH promoters are ubiquitous, whereas the pM promoter, located between pN and pH, is activated specifically in fast skeletal muscles."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26864944",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26106594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 801,
                    "offsetInEndSection": 937,
                    "text": "The content of TES in lincRNA genes is substantially higher than that in protein-coding genes, especially in exons and promoter regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 734,
                    "text": "The results indicated the porcine CD4 promoters and enhancers could effectively direct expression of a foreign gene in human cells."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16475045",
                "http://www.ncbi.nlm.nih.gov/pubmed/17462889",
                "http://www.ncbi.nlm.nih.gov/pubmed/27575436",
                "http://www.ncbi.nlm.nih.gov/pubmed/27697443",
                "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                "http://www.ncbi.nlm.nih.gov/pubmed/25696904",
                "http://www.ncbi.nlm.nih.gov/pubmed/23160865",
                "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                "http://www.ncbi.nlm.nih.gov/pubmed/17629847"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 739,
                    "offsetInEndSection": 943,
                    "text": "Andexanet alfa (r-Antidote, PRT064445; Portola Pharmaceuticals) is a truncated form of enzymatically inactive factor Xa, which binds and reverses the anticoagulant action of the factor Xa inhibitors (e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1329,
                    "offsetInEndSection": 1569,
                    "text": "In addition, the specific antidote anivamersen (RB007; Regado Biosciences Inc.) is an RNA aptamer in clinical development to reverse the anticoagulant effect of the parenteral factor IXa inhibitor pegnivacogin, which is also in development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25494843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 577,
                    "offsetInEndSection": 738,
                    "text": "Idarucizumab (BI 655075; Boehringer Ingelheim) is a fragment of an antibody (Fab), which is a specific antidote to the oral direct thrombin inhibitor dabigatran."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 450,
                    "text": "Major advances have been made in targeting downstream clotting factors in the coagulation cascade, resulting in two major new classes of drugs: direct thrombin inhibitors and factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 310,
                    "text": "These new agents exert their anticoagulant effect via direct inhibition of a single Factor within the coagulation cascade (such as Factor Xa or thrombin)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23160865",
                    "endSection": "abstract",
                    "offsetInBeginSection": 414,
                    "offsetInEndSection": 597,
                    "text": "However, no antidote exists for DTIs or FXa inhibitors though replacement of coagulation factors using clotting factor concentrates is routinely considered in some clinical scenarios."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1207,
                    "text": "Although the mechanism of action differs between the direct Factor Xa and direct thrombin inhibitors, phase III studies of these new agents confirmed that both Factor Xa and thrombin are viable anticoagulation targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27575436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "Oral Factor Xa (FXa) inhibitors, a growing class of direct-acting anticoagulants, are frequently used to prevent stroke and systemic embolism in patients with atrial fibrillation and to prevent and treat venous thromboembolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20888031",
                    "endSection": "abstract",
                    "offsetInBeginSection": 488,
                    "offsetInEndSection": 719,
                    "text": "Rivaroxaban competitively inhibits Factor Xa and is more than 10,000-fold more selective for Factor Xa than other related serine proteases, and it does not require cofactors (such as antithrombin) to exert its anticoagulant effect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16475045",
                    "endSection": "abstract",
                    "offsetInBeginSection": 106,
                    "offsetInEndSection": 230,
                    "text": "A new strategy for the design of new antithrombotic drugs is based on selective inhibition of a specific coagulation factor."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1381443",
                "http://www.ncbi.nlm.nih.gov/pubmed/27766310",
                "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                "http://www.ncbi.nlm.nih.gov/pubmed/9804357",
                "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                "http://www.ncbi.nlm.nih.gov/pubmed/4027181",
                "http://www.ncbi.nlm.nih.gov/pubmed/10494094",
                "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                "http://www.ncbi.nlm.nih.gov/pubmed/15347343",
                "http://www.ncbi.nlm.nih.gov/pubmed/9036937"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Mutations in genes encoding the keratin intermediate filaments expressed in basal cells have been identified in some families with epidermolysis bullosa simplex as the proximate cause of the fragility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Epidermolysis bullosa simplex is a group of blistering skin disorders caused by defects in one of the keratin genes, KRT5 and KRT14."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "We examined keratin K14 and K5 genes mutation in a Japanese Dowling-Meara epidermolysis bullosa simplex patient with severe generalized blistering and erosions at birth."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1381443",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "Linkage of epidermolysis bullosa simplex to keratin gene loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1381443",
                    "endSection": "abstract",
                    "offsetInBeginSection": 778,
                    "offsetInEndSection": 882,
                    "text": "The Weber-Cockayne form of EBS is genetically heterogeneous with linkage to different keratin gene loci."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9036937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The KRT5 and KRT14 genes encode the proteins keratin 5 and 14, respectively, which are the primary structural components of the 10-nm intermediate filaments of the mitotic epidermal basal cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8757772",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "A novel keratin K5 gene mutation in Dowling-Meara epidermolysis bullosa simplex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9804357",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "We report novel keratin 5 and 14 gene mutations in four unrelated German families with the localized subtype of the dominantly inherited blistering disease epidermolysis bullosa simplex Weber-Cockayne (MIM# 131800)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10494094",
                    "endSection": "abstract",
                    "offsetInBeginSection": 861,
                    "offsetInEndSection": 962,
                    "text": "So far, other mutations in the same or in other genes have not been reported in patients with EBS-MP."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                "http://www.ncbi.nlm.nih.gov/pubmed/8629992",
                "http://www.ncbi.nlm.nih.gov/pubmed/24777963",
                "http://www.ncbi.nlm.nih.gov/pubmed/22562473",
                "http://www.ncbi.nlm.nih.gov/pubmed/10608502",
                "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                "http://www.ncbi.nlm.nih.gov/pubmed/3570498",
                "http://www.ncbi.nlm.nih.gov/pubmed/3066690",
                "http://www.ncbi.nlm.nih.gov/pubmed/1829107",
                "http://www.ncbi.nlm.nih.gov/pubmed/15984957"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8629992",
                    "endSection": "abstract",
                    "offsetInBeginSection": 769,
                    "offsetInEndSection": 1091,
                    "text": "These data demonstrate that activated lymphocytes have the ability to induce the promoter of the TCA3 gene in mast cells through a mechanism requiring cell-to-cell contact, and suggest the possibility that activated lymphocytes may effect other biologic processes in mast cells as well through such heterotypic activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 418,
                    "offsetInEndSection": 760,
                    "text": "Despite the mast cell's well-deserved reputation as a promoter of inflammation, others and we have used bone marrow-derived cultured mast cell (BMCMC) engrafted mast cell-deficient c-kit-mutant mice (so-called \"mast cell knock-in\" mice) to show that mast cells can also have important antiinflammatory and immunosuppressive functions in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10608502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 566,
                    "text": "However, mast cells may also influence many other biologic responses, including tissue remodeling and angiogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22562473",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "The mast cells are multi-effector cells with wide distribution in the different body parts and traditionally their role has been well-defined in the development of IgE-mediated hypersensitivity reactions including bronchial asthma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Mast cells are widely distributed throughout the body and express effector functions in allergic reactions, inflammatory diseases, and host defense."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10608502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 450,
                    "text": "Recent work shows that mast cells can also participate in innate immunity to bacterial infection and that the expression of such mast cell-dependent natural immunity can be significantly enhanced by long-term treatment of mice with the kit ligand, stem cell factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24777963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 79,
                    "offsetInEndSection": 423,
                    "text": "Upon activation by diverse mechanisms, mast cells can secrete a broad array of biologically active products that either are stored in the cytoplasmic granules of the cells (e.g., histamine, heparin, various proteases) or are produced de novo upon cell stimulation (e.g., prostaglandins, leukotrienes, cytokines, chemokines, and growth factors)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 985,
                    "offsetInEndSection": 1289,
                    "text": "Subsequently, it was reported that mast cells can mediate negative immunomodulatory effects following Anopheles mosquito bites, and in peripheral tolerance to skin allografts; however, the mechanism(s) by which mast cells mediate immunosuppressive functions in these two studies remains to be elucidated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20941613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 417,
                    "text": "Through the release of biologically active products, mast cells function as important effector and immunoregulatory cells in diverse immunological reactions and other biological responses; for example, mast cells promote inflammation and other tissue changes in immunoglobulin E (IgE)-associated allergic disorders, as well as in certain innate and adaptive immune responses that are thought to be independent of IgE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24777963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1214,
                    "offsetInEndSection": 1400,
                    "text": "We discuss how using in vivo tumor models in combination with models in which mast cell function can be modulated has implicated mast cells in the regulation of host responses to tumors."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                "http://www.ncbi.nlm.nih.gov/pubmed/10943924",
                "http://www.ncbi.nlm.nih.gov/pubmed/21904954",
                "http://www.ncbi.nlm.nih.gov/pubmed/26075659",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777267",
                "http://www.ncbi.nlm.nih.gov/pubmed/28308787",
                "http://www.ncbi.nlm.nih.gov/pubmed/7478512",
                "http://www.ncbi.nlm.nih.gov/pubmed/1343229",
                "http://www.ncbi.nlm.nih.gov/pubmed/24113466",
                "http://www.ncbi.nlm.nih.gov/pubmed/6228713"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21904954",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Ultraviolet (UV) radiation has detrimental effects on marine ecosystems, in particular in the polar regions where stratospheric ozone reduction causes higher levels of solar radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 264,
                    "text": "Four billion years ago, sea-level UV exposure was more than 400 times as intense as today, the dose from solar cosmic rays was five times present levels, and galactic cosmic rays accounted for only about 10% their current contribution to sea-level radiation doses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Inconstant sun: how solar evolution has affected cosmic and ultraviolet radiation exposure over the history of life on Earth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7478512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Exposure to solar ultraviolet (UV) light is a major cause of skin cancer, the most common human neoplasm."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26075659",
                    "endSection": "abstract",
                    "offsetInBeginSection": 428,
                    "offsetInEndSection": 604,
                    "text": "Epidemiological data strongly implicate UV radiation exposure as a major cause of melanoma and other cancers, as UVR promotes mutations in oncogenes and tumor-suppressor genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10943924",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 226,
                    "text": "Radiochromic film is tested for its broad-band response to ultraviolet (UV) B (290-320 nm) and A (320 nm400 nm), visible and infrared radiation produced by a solar simulator and examined for dosimetry in ultraviolet radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12645767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 769,
                    "text": "The sun has evolved significantly over its life; in the past there were higher levels of particulate radiation and lower UV emissions from the sun, and a stronger solar wind reduced radiation dose in the inner solar system from galactic cosmic rays."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24113466",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Measurement of solar ultraviolet (UV) radiation is an important aspect of dosimetry for the improved knowledge of UV exposure and its associated health related issues."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26075659",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Solar ultraviolet radiation from cancer induction to cancer prevention: solar ultraviolet radiation and cell biology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28308787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1346,
                    "text": "This \"solar UV equivalent\" caused inactivation of 50% of exposed eggs within 12 min, whereas exposition to full overhead sunlight produced the same effect only within 3 hrs.It is concluded that the inactivating effect of solar UV (300-310 nm) is counteracted by repair mechanisms requiring light of longer wavelengths (320-480 nm) which are also emitted by the sun.The type of photoreactivation described is difficult to understand within the established framework of nucleic acid repair."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25982799",
                "http://www.ncbi.nlm.nih.gov/pubmed/10569341",
                "http://www.ncbi.nlm.nih.gov/pubmed/16220412",
                "http://www.ncbi.nlm.nih.gov/pubmed/9727688",
                "http://www.ncbi.nlm.nih.gov/pubmed/21099678",
                "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                "http://www.ncbi.nlm.nih.gov/pubmed/22083030",
                "http://www.ncbi.nlm.nih.gov/pubmed/10535368",
                "http://www.ncbi.nlm.nih.gov/pubmed/12955433",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10569341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 402,
                    "text": "In patients without left atrial spontaneous echo contrast, 78% had some embolic sources other than left atrial thrombus or spontaneous echo contrast, suggesting that these embolic sources play an important role in patients with nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 238,
                    "offsetInEndSection": 439,
                    "text": "Among the causes in our country, rheumatic mitral valvular disease topped the list followed by rheumatic multiple valvular disease IHD, HHD; lone atrial fibrillation came in the aetiology sequentially."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9727688",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Role of the atrioventricular node in atrial fibrillation: what have we learned from radiofrequency catheter modification of the atrioventricular junction in patients with refractory atrial fibrillation?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16220412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Paroxysmal atrial fibrillation (AF) is a common arrhythmia that may occur after various triggers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16220412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 587,
                    "text": "Marijuana smoking should be included in the list of possible triggers in young adults presenting with paroxysmal AF, once cardiac disease and other common causes of AF have been excluded."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25982799",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and a major cause of morbidity and mortality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 694,
                    "text": "Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1262,
                    "text": "Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21099678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 365,
                    "offsetInEndSection": 515,
                    "text": "Sleep-disordered breathing contributes to cardiac chamber enlargement, which may be responsible for increasing atrial fibrillation in this population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14574041",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 419,
                    "text": "Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9188637",
                "http://www.ncbi.nlm.nih.gov/pubmed/11278953",
                "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                "http://www.ncbi.nlm.nih.gov/pubmed/10101797",
                "http://www.ncbi.nlm.nih.gov/pubmed/23412358",
                "http://www.ncbi.nlm.nih.gov/pubmed/7761466",
                "http://www.ncbi.nlm.nih.gov/pubmed/10348347",
                "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                "http://www.ncbi.nlm.nih.gov/pubmed/8557038",
                "http://www.ncbi.nlm.nih.gov/pubmed/15846087"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "The tumor suppressor protein p53 is a critical stress response transcription factor that induces the expression of genes leading to cell cycle arrest, apoptosis, and tumor suppression."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9188637",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Simian virus 40 T antigen can regulate p53-mediated transcription independent of binding p53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 1000,
                    "text": "Concurrently, HBx enhanced p53 DNA occupancy to other response elements either alone by displacing specific transcription factors such as CEBPB and NFkB1, or in complex with distinct interacting co-factors Sp1, JUN and E2F1."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23550211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 676,
                    "text": "Genetic or RNA interference (RNAi)-mediated knockdown of IPMK resulted in decreased activation of p53, decreased recruitment of p53 and p300 to target gene promoters, abrogated transcription of p53 target genes, and enhanced cell viability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15846087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 505,
                    "text": "In this study we tested whether p53, p63, and p73 have different mechanisms of activating transcription and if such a difference could explain how each factor stimulates the transcription of distinct sets of genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15846087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 140,
                    "offsetInEndSection": 290,
                    "text": "The p53 protein is homologous to p63 and p73, proteins that regulate transcription via the same promoter sequences but which activate different genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27302019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "BACKGROUND\nThe tumour suppressor p53 is a central player in transcription regulation and cell fate determination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11278953",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1276,
                    "offsetInEndSection": 1446,
                    "text": "Together, these results suggest a model in which p53 requires the cooperation of Sp1 or a Sp1-like factor to mediate transcriptional activation of the human BAX promoter."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8422752",
                "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                "http://www.ncbi.nlm.nih.gov/pubmed/8083219",
                "http://www.ncbi.nlm.nih.gov/pubmed/23791361",
                "http://www.ncbi.nlm.nih.gov/pubmed/26364852",
                "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                "http://www.ncbi.nlm.nih.gov/pubmed/9573825",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                "http://www.ncbi.nlm.nih.gov/pubmed/22898924",
                "http://www.ncbi.nlm.nih.gov/pubmed/28282874"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8422752",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "The gene coding for cystatin D (CST5), a cysteine proteinase inhibitor, was mapped by fluorescent in situ hybridization to human chromosome 20p11.21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 402,
                    "offsetInEndSection": 528,
                    "text": "Since 1985 cystatin C has been studied mainly in serum/plasma as an alternative biomarker to serum creatinine to estimate GFR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1481,
                    "offsetInEndSection": 1638,
                    "text": "In conclusion, urinary cystatin C, \u03b22-microglobulin, clusterin, GST-\u03bc, KIM-1, and osteopontin could be useful biomarkers of diabetic nephropathy in ZDF rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8083219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Human cystatin D is a novel member of the cystatin superfamily of cysteine proteinase inhibitors present in saliva and tears."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8083219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 1504,
                    "text": "The inhibitory characteristics of the two cystatin D variants were studied, by determination of dissociation equilibrium constants (Ki) for their complexes with papain and with the mammalian cysteine proteinases, cathepsins B, H, L, and S. The results demonstrate that 1) cystatin D has a characteristic inhibition profile since it does not inhibit cathepsin B (Ki > 1 microM), and when compared to cystatin C and all other known cystatins it is a much poorer inhibitor of cathepsin L (mean Ki 25 nM) but binds cathepsin H and S relatively tightly (mean Ki values of 8.5 and 0.24 nM, respectively); and 2) the inhibitory activities of the two cystatin D variants are not significantly different, demonstrating that the presence of an extra cysteine residue in the cystatin D molecule affects neither the stability nor the functional activity of the inhibitor, thus explaining the widespread distribution of the Cys26-cystatin D encoding allele in the population."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                "http://www.ncbi.nlm.nih.gov/pubmed/9097542",
                "http://www.ncbi.nlm.nih.gov/pubmed/21540377",
                "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                "http://www.ncbi.nlm.nih.gov/pubmed/19450402",
                "http://www.ncbi.nlm.nih.gov/pubmed/17552105",
                "http://www.ncbi.nlm.nih.gov/pubmed/8138981",
                "http://www.ncbi.nlm.nih.gov/pubmed/9740286",
                "http://www.ncbi.nlm.nih.gov/pubmed/18843217"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Leishmania donovani in India causes visceral infection (kala-azar) and dermal infection (post-kala-azar dermal leishmaniasis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9097542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Diffuse cutaneous leishmaniasis (DCL) is an unusual form of cutaneous leishmaniasis mainly caused by infection with Leishmania aethiopica in the Old World."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 339,
                    "text": "Identification of 5 isolates from 4 CL patients by enzyme analysis during 2002 showed that they were all Leishmania donovani zymodeme MON-37, the parasite which also causes visceral leishmaniasis in India and East Africa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 380,
                    "text": "We report here the identification of polymorphism in a well-defined genetic locus among the Leishmania parasites causing the visceral and dermal manifestations, in a comparison of 15 post-kala-azar dermal leishmaniasis and 12 kala-azar patient isolates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 233,
                    "text": "Leishmania(Leishmania) infantum, causing cutaneous leishmaniasis, has been described in patients living in areas where visceral leishmaniasis is endemic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27007566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Cutaneous leishmaniasis is caused by different species of the Leishmania genus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17552105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 158,
                    "offsetInEndSection": 361,
                    "text": "We identified Leishmania donovani as the agent of Sri Lanka cutaneous leishmaniasis and showed that these parasites are closely related to those causing visceral leishmaniasis in the Indian subcontinent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19450402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Cutaneous leishmaniasis is caused by the intracellular protozoan parasite belonging to the genus leishmania and is characterized by a myriad of clinical lesions including papules, nodules, and ulcers."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                "http://www.ncbi.nlm.nih.gov/pubmed/15199454",
                "http://www.ncbi.nlm.nih.gov/pubmed/19179293",
                "http://www.ncbi.nlm.nih.gov/pubmed/26990117",
                "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                "http://www.ncbi.nlm.nih.gov/pubmed/22594507",
                "http://www.ncbi.nlm.nih.gov/pubmed/6808349",
                "http://www.ncbi.nlm.nih.gov/pubmed/24281558",
                "http://www.ncbi.nlm.nih.gov/pubmed/1464277",
                "http://www.ncbi.nlm.nih.gov/pubmed/940363"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 403,
                    "offsetInEndSection": 645,
                    "text": "Since the possible interactions between these two classes of drugs have been poorly explored in literature, with a risk to the patients who use them, we reviewed the pharmacology of warfarin and its possible interactions with antidepressants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15199454",
                    "endSection": "abstract",
                    "offsetInBeginSection": 582,
                    "offsetInEndSection": 815,
                    "text": "The pharmacokinetic and pharmacodynamic properties of warfarin as well as its narrow therapeutic index make it particularly susceptible to interactions with other prescription and nonprescription drugs, including dietary supplements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26990117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 318,
                    "offsetInEndSection": 606,
                    "text": "We demonstrate here the utility of model-based DDI prediction for a clinically relevant warfarin regimen, using the example of epacadostat (INCB024360), the first-in-class indoleamine 2,3-dioxygenase 1 inhibitor in clinical development as a novel orally active immuno-oncological therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to interact with the oral anticoagulant warfarin and can cause a serious bleeding complication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/940363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 338,
                    "text": "The results indicated that among the different drugs tested phenylbutazone, indomethacin, warfarin and tolbutamide were, in the order listed, the most effective in displacing diftalone from its binding site(s)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1021,
                    "offsetInEndSection": 1204,
                    "text": "In conclusion, special caution is required when an NSAID is administered to warfarin users if patients are taking warfarin >40 mg/week and other medications interacting with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19179293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 880,
                    "text": "A substantial number of studies demonstrate that common variants of two genes, VKORC1 and CYP2C9, along with other nongenetic factors, correlate significantly with warfarin dosing."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15199454",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24281558",
                    "endSection": "abstract",
                    "offsetInBeginSection": 390,
                    "offsetInEndSection": 444,
                    "text": "Warfarin interacts with several medications and foods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15199454",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 364,
                    "text": "Warfarin, a racemic mixture of R- and S-enantiomers, exerts its anticoagulant effect by interfering with the hepatic synthesis of vitamin K-dependent clotting factors II, VII, IX, and X and proteins C and S. Warfarin displays stereospecific pharmacokinetic and pharmacodynamic properties, and the isomers are differentially metabolized by cytochrome p450 isozymes."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/869834",
                "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                "http://www.ncbi.nlm.nih.gov/pubmed/12144477",
                "http://www.ncbi.nlm.nih.gov/pubmed/17119338",
                "http://www.ncbi.nlm.nih.gov/pubmed/25274322",
                "http://www.ncbi.nlm.nih.gov/pubmed/8368603",
                "http://www.ncbi.nlm.nih.gov/pubmed/1516375",
                "http://www.ncbi.nlm.nih.gov/pubmed/12297573",
                "http://www.ncbi.nlm.nih.gov/pubmed/29207625",
                "http://www.ncbi.nlm.nih.gov/pubmed/26712259"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                    "endSection": "abstract",
                    "offsetInBeginSection": 712,
                    "offsetInEndSection": 967,
                    "text": "The topological body map was assessed by means of the \"Frontal body-evocation subtest\" (Daurat-Hmeljiak, Stambak, & Berges, 1978), in which participants have to put tiles (each representing a body part) on a small wooden board on which a head is depicted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/869834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 304,
                    "text": "If the body is only loosely padded in the experimental apparatus, then apparent motion of part of the body surface may be experienced sometime after rotation has been terminated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 934,
                    "offsetInEndSection": 1179,
                    "text": "CONCLUSION\nThese results can be accounted for by the assumption that body part coding of gestures depends on left hemisphere function and that additional right hemisphere contributions are afforded when demands on perceptual discrimination rise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297573",
                    "endSection": "abstract",
                    "offsetInBeginSection": 337,
                    "offsetInEndSection": 460,
                    "text": "OBJECTIVE\nTo assess body part specificity of disturbances of imitation for meaningless gestures of fingers, hand, and foot."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1516375",
                    "endSection": "abstract",
                    "offsetInBeginSection": 93,
                    "offsetInEndSection": 274,
                    "text": "It also has been reported that psoriasis of the face is more prevalent in children than in adults, and when it does occur, at any age, the face is never the only body part involved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26712259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 395,
                    "offsetInEndSection": 497,
                    "text": "Failure to identify and release the acute constriction may result in amputation of affected body part."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 312,
                    "text": "Processing the position and the relations among different body parts is necessary to build up a specific body representation, that is, the visuospatial body map (or topological map of the body)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/869834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 487,
                    "text": "This somatosensory motion aftereffect of opposite sign is temporarily abolished if one looks at the affected body area, but is again re-experienced when the gaze is shifted elswhere."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26712259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 330,
                    "text": "A strand or strands of hair act like a circumferential constriction band and subsequently strangulate the body appendages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24799290",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "OBJECTIVE\nBody representation is a complex process involving different sources of top-down and bottom-up information."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                "http://www.ncbi.nlm.nih.gov/pubmed/19116360",
                "http://www.ncbi.nlm.nih.gov/pubmed/26679725",
                "http://www.ncbi.nlm.nih.gov/pubmed/22814459",
                "http://www.ncbi.nlm.nih.gov/pubmed/9239499",
                "http://www.ncbi.nlm.nih.gov/pubmed/26064878"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 692,
                    "text": "BORSA cannot be classified as either truly methicillin-resistant or truly methicillin-susceptible strains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1), but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 455,
                    "text": "BORSA strains show low, borderline resistance to penicillinase-resistant penicillins (PRPs), with oxacillin MICs typically equal to 1-8\u2009\u00b5g\u2009ml-1, and in contrast to methicillin-resistant S. aureus (MRSA), do not have an altered penicillin-binding protein, PBP2a, encoded by the mecA or mecC gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA) in the clinical laboratory."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1175,
                    "text": "This clearly shows that BORSA may be misidentified as MRSA while heteroresistant MRSA may appear to be BORSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 921,
                    "offsetInEndSection": 1123,
                    "text": "The epidemiology and clinical presentation of BORSA infections seem to be similar to those for MRSA; these infections are usually more severe than those caused by methicillin-sensitive S. aureus (MSSA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 576,
                    "text": "Under these conditions, ampicillin/sulbactam appears to be more accurate than amoxicillin/clavulanic acid for differentiating BORSA from MRSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 896,
                    "offsetInEndSection": 1065,
                    "text": "Under conditions used to elicit intrinsic methicillin resistance in Staphylococcus aureus, a large percentage of BORSA appeared resistant to amoxicillin/clavulanic acid."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22874921",
                "http://www.ncbi.nlm.nih.gov/pubmed/15986890",
                "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                "http://www.ncbi.nlm.nih.gov/pubmed/2905685",
                "http://www.ncbi.nlm.nih.gov/pubmed/15685218",
                "http://www.ncbi.nlm.nih.gov/pubmed/12073014",
                "http://www.ncbi.nlm.nih.gov/pubmed/12524352",
                "http://www.ncbi.nlm.nih.gov/pubmed/3607875",
                "http://www.ncbi.nlm.nih.gov/pubmed/20870045"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15685218",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 561,
                    "text": "The discovery of a mutation in FOXP2 in a family with a speech and language disorder has enabled neuroscientists to trace the neural expression of this gene during embryological development, track the effects of this gene mutation on brain structure and function, and so begin to decipher that part of our neural inheritance that culminates in articulate speech."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "BACKGROUND\nMutations in the human FOXP2 gene cause speech and language impairments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2905685",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Antennapedia (Antp), a homeotic gene of Drosophila required for proper differentiation of the thorax of the fly, is expressed in complex spatial patterns during development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15986890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 847,
                    "offsetInEndSection": 972,
                    "text": "The other interesting feature is that two polyadenylation signal sequences (AATAAA) exist in 3'UTR of the pig myostatin gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Multiple microRNAs regulate human FOXP2 gene expression by targeting sequences in its 3' untranslated region."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "The moleskin gene product is essential for Caudal-mediated constitutive antifungal Drosomycin gene expression in Drosophila epithelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "The homeobox gene, Caudal, encodes the DNA-binding nuclear transcription factor that plays a crucial role during development and innate immune response."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15157233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 712,
                    "text": "Furthermore, Caudal-mediated constitutive expression of antifungal Drosomycin gene was severely affected in the moleskin-RNAi flies, showing a local Drosomycin expression pattern indistinguishable from that of the Caudal-RNAi flies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1168,
                    "offsetInEndSection": 1338,
                    "text": "CONCLUSIONS\nOur results reveal novel regulatory functions of the human FOXP2 3' UTR sequence and regulatory interactions between multiple miRNAs and the human FOXP2 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22874921",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 477,
                    "text": "By this means, we find that Foxp2, a transcription factor associated with speech and language development and evolution, is a novel miRNA target."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892",
                    "endSection": "abstract",
                    "offsetInBeginSection": 654,
                    "offsetInEndSection": 926,
                    "text": "The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID(50) of 0.161\u2009mg/ml (P < .05)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1647,
                    "offsetInEndSection": 1826,
                    "text": "Structural comparison of PdeM with its homologs showed that it lacked critical residues required for dimerization, cAMP hydrolysis, and for the high affinity binding of bis(pNPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1399,
                    "text": "Overexpression of PdeM in E.coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 532,
                    "offsetInEndSection": 702,
                    "text": "The + MP plant lines, as compared with other transgenic plants, exhibited higher nucleotide-phosphodiesterase activity in the soluble as well as in the membrane fraction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 703,
                    "offsetInEndSection": 961,
                    "text": "Substrate concentration kinetic studies revealed the presence of a nucleotide-phospho-diesterase with a high substrate affinity in the +MP extracts in addition to the enzyme with a relatively low substrate affinity present also in the - MP transgenic plants."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27418254",
                "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                "http://www.ncbi.nlm.nih.gov/pubmed/26695521",
                "http://www.ncbi.nlm.nih.gov/pubmed/27486138",
                "http://www.ncbi.nlm.nih.gov/pubmed/26695146",
                "http://www.ncbi.nlm.nih.gov/pubmed/26162196",
                "http://www.ncbi.nlm.nih.gov/pubmed/26910273",
                "http://www.ncbi.nlm.nih.gov/pubmed/27061298",
                "http://www.ncbi.nlm.nih.gov/pubmed/19432981"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 984,
                    "text": "We also give a framework for performing and interpreting investigations performed in the style of Mendelian randomization, but where the choice of genetic variants is statistically, rather than biologically motivated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 122,
                    "offsetInEndSection": 304,
                    "text": "If genetic variants which are instrumental variables for a risk factor are shown to be additionally associated with a disease outcome, then the risk factor is a cause of the disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2503,
                    "offsetInEndSection": 2707,
                    "text": "As an increasing number of epidemiologists employ Mendelian randomization methods in their research, caution is therefore needed in drawing conclusions from these studies if these assumptions are not met."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27061298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 696,
                    "offsetInEndSection": 930,
                    "text": "In a simulation analysis, it is shown to have better finite-sample Type 1 error rates than the inverse-variance weighted method, and is complementary to the recently proposed MR-Egger (Mendelian randomization-Egger) regression method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 770,
                    "offsetInEndSection": 871,
                    "text": "The authors conclude that Mendelian randomization is a powerful addition to etiologic research tools."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26695146",
                    "endSection": "abstract",
                    "offsetInBeginSection": 257,
                    "offsetInEndSection": 475,
                    "text": "The incorporation of Mendelian randomization (MR) with a meta-analysis has revolutionized traditional practice and is emerging as a viable technique to strengthen causal unconfounded inferences from observational data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2146,
                    "offsetInEndSection": 2376,
                    "text": "CONCLUSION\nGiven an inheritance of gene expression from parents, Mendelian randomization studies not only need to assume a random distribution of alleles in the offspring, but also a random distribution of epigenetic changes (e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 769,
                    "text": "In this paper, the authors discuss some of the challenges facing epidemiologists in the analysis and interpretation of Mendelian randomization studies, particularly those that become apparent when the analogy with randomized controlled trials is closely examined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27486138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1093,
                    "text": "An observed association between the genetic instrumental variable and the outcome supports the hypothesis that the exposure in question is causally related to the outcome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27061298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 193,
                    "offsetInEndSection": 460,
                    "text": "However, obtaining reliable results from a Mendelian randomization investigation remains problematic, as the conventional inverse-variance weighted method only gives consistent estimates if all of the genetic variants in the analysis are valid instrumental variables."
                }
            ]
        }
    ]
}